NPORT-P
    false
    
      
      
        
          0000872625
          XXXXXXXX
        
      
      
      
      
        S000006882
        C000128862
        C000018631
        C000081539
        C000141458
      
      
      
    
  
  
    
      Franklin Strategic Series
      811-06243
      0000872625
      549300NDWC0J6DXVSX36
      One Franklin Parkway
      San Mateo
      
      94403-1906
      650-312-2000
      Franklin Biotechnology Discovery Fund
      S000006882
      6N5133EDK315FXQQM036
      2022-04-30
      2021-07-31
      N
    
    
      1368380280.15
      36504529.29
      1331875750.86
      0.00000000
      0.00000000
      0.00000000
      0.00000000
      0.00000000
      0.00000000
      0.00000000
      0.00000000
      0.00000000
      0.00000000
      1898000.00000000
      0.00000000
      0.00000000
      1317710.06000000
      
        
        
        
        
        
        
        
        
        
        
        
        
        
      
      N
      
        
          
          
          
          
        
        
          
            
            
            
            
              
              
              
            
            
              
              
              
            
            
              
              
              
            
            
              
              
              
            
            
              
              
              
            
            
              
              
              
            
            
              
              
              
            
          
          
            
            
            
            
              
              
              
            
            
              
              
              
            
            
              
              
              
            
            
              
              
              
            
            
              
              
              
            
            
              
              
              
            
            
              
              
              
            
          
          
            
            
            
            
              
              
              
            
            
              
              
              
            
            
              
              
              
            
            
              
              
              
            
            
              
              
              
            
            
              
              
              
            
            
              
              
              
            
          
          
            
            
            
            
              
              
              
            
            
              
              
              
            
            
              
              
              
            
            
              
              
              
            
            
              
              
              
            
            
              
              
              
            
            
              
              
              
            
          
          
            
            
            
            
              
              
              
            
            
              
              
              
            
            
              
              
              
            
            
              
              
              
            
            
              
              
              
            
            
              
              
              
            
            
              
              
              
            
          
          
            
            
            
            
              
              
              
            
            
              
              
              
            
            
              
              
              
            
            
              
              
              
            
            
              
              
              
            
            
              
              
              
            
            
              
              
              
            
          
        
        
        
        
      
      
      
      
      
      
    
    
      
        Applied Therapeutics, Inc.
        549300KL3IJPHZM2GR04
        Applied Therapeutics, Inc.
        03828A101
        
          
          
        
        311757.00000000
        NS
        USD
        5365337.97000000
        0.402840727938
        Long
        EC
        CORP
        US
        N
        
        1
        
          N
          N
          N
        
      
      
        Heron Therapeutics, Inc.
        549300DR2I1DOPD2IX53
        Heron Therapeutics, Inc.
        427746102
        
          
          
        
        1739677.00000000
        NS
        USD
        21502407.72000000
        1.614445469565
        Long
        EC
        CORP
        US
        N
        
        1
        
          N
          N
          N
        
      
      
        Prometheus Biosciences, Inc.
        N/A
        Prometheus Biosciences, Inc.
        74349U108
        
          
          
        
        207500.00000000
        NS
        USD
        4351275.00000000
        0.326702772176
        Long
        EC
        CORP
        US
        N
        
        1
        
          N
          N
          
        
      
      
        Akouos, Inc.
        N/A
        Akouos, Inc.
        00973J101
        
          
          
        
        157600.00000000
        NS
        USD
        1713112.00000000
        0.128624010077
        Long
        EC
        CORP
        US
        N
        
        1
        
          N
          N
          N
        
      
      
        BioMarin Pharmaceutical, Inc.
        NSLL8ITTRR0J5HEMR848
        BioMarin Pharmaceutical, Inc.
        09061G101
        
          
          
        
        142456.00000000
        NS
        USD
        10930648.88000000
        0.820695839904
        Long
        EC
        CORP
        US
        N
        
        1
        
          N
          N
          N
        
      
      
        Reneo Pharmaceuticals, Inc.
        N/A
        Reneo Pharmaceuticals, Inc.
        75974E103
        
          
          
        
        194700.00000000
        NS
        USD
        1594593.00000000
        0.119725357186
        Long
        EC
        CORP
        US
        N
        
        1
        
          N
          N
          
        
      
      
        Soaring Eagle Acquisition Corp.
        N/A
        Soaring Eagle Acquisition Corp., Class A
        N/A
        
          
        
        189800.00000000
        NS
        USD
        1898000.00000000
        0.142505785451
        Long
        EC
        CORP
        KY
        
        Y
        
        3
        
          N
          N
          N
        
      
      
        Horizon Therapeutics plc
        529900P0GSQ79OOZEV53
        Horizon Therapeutics plc
        N/A
        
          
          
        
        488349.00000000
        NS
        USD
        48844666.98000000
        3.667359132295
        Long
        EC
        CORP
        IE
        
        N
        
        1
        
          N
          N
          N
        
      
      
        Merus NV
        549300W8GPUWU8QNU293
        Merus NV
        N/A
        
          
          
        
        73200.00000000
        NS
        USD
        1259040.00000000
        0.094531340418
        Long
        EC
        CORP
        NL
        N
        
        1
        
          N
          N
          N
        
      
      
        Jazz Pharmaceuticals plc
        635400GAUMJCLEZRRV50
        Jazz Pharmaceuticals plc
        N/A
        
          
          
        
        222400.00000000
        NS
        USD
        37701248.00000000
        2.830688070989
        Long
        EC
        CORP
        IE
        
        N
        
        1
        
          N
          N
          N
        
      
      
        89bio, Inc.
        N/A
        89bio, Inc.
        282559103
        
          
          
        
        284400.00000000
        NS
        USD
        4453704.00000000
        0.334393354419
        Long
        EC
        CORP
        US
        N
        
        1
        
          N
          N
          N
        
      
      
        Harpoon Therapeutics, Inc.
        549300VFZL0TEVXILA36
        Harpoon Therapeutics, Inc.
        41358P106
        
          
          
        
        220200.00000000
        NS
        USD
        2155758.00000000
        0.161858791903
        Long
        EC
        CORP
        US
        N
        
        1
        
          N
          N
          N
        
      
      
        Social Capital Suvretta Holdings Corp. III
        N/A
        Social Capital Suvretta Holdings Corp. III, Class A
        N/A
        
          
          
        
        143000.00000000
        NS
        USD
        1405690.00000000
        0.105542127266
        Long
        EC
        CORP
        KY
        
        N
        
        1
        
          N
          N
          
        
      
      
        Neurocrine Biosciences, Inc.
        549300FECER0XBN49756
        Neurocrine Biosciences, Inc.
        64125C109
        
          
          
        
        215800.00000000
        NS
        USD
        20114718.00000000
        1.510254840739
        Long
        EC
        CORP
        US
        N
        
        1
        
          N
          N
          N
        
      
      
        Insmed, Inc.
        529900Q55QAG41CCAC11
        Insmed, Inc.
        457669307
        
          
          
        
        906600.00000000
        NS
        USD
        22302360.00000000
        1.674507549641
        Long
        EC
        CORP
        US
        N
        
        1
        
          N
          N
          N
        
      
      
        Dyne Therapeutics, Inc.
        N/A
        Dyne Therapeutics, Inc.
        26818M108
        
          
          
        
        100400.00000000
        NS
        USD
        1814228.00000000
        0.136216009551
        Long
        EC
        CORP
        US
        N
        
        1
        
          N
          N
          N
        
      
      
        Biogen, Inc.
        W8J5WZB5IY3K0NDQT671
        Biogen, Inc.
        09062X103
        
          
          
        
        148175.00000000
        NS
        USD
        48413217.75000000
        3.634965027236
        Long
        EC
        CORP
        US
        N
        
        1
        
          N
          N
          N
        
      
      
        Kura Oncology, Inc.
        5493005QORQTZCZYOP39
        Kura Oncology, Inc.
        50127T109
        
          
          
        
        132400.00000000
        NS
        USD
        2507656.00000000
        0.188280025248
        Long
        EC
        CORP
        US
        N
        
        1
        
          N
          N
          N
        
      
      
        ARYA Sciences Acquisition Corp.
        N/A
        ARYA Sciences Acquisition Corp.
        N/A
        
          
        
        415600.00000000
        NS
        USD
        3258304.00000000
        0.244640237491
        Long
        EC
        CORP
        KY
        
        Y
        
        3
        
          N
          N
          N
        
      
      
        Pliant Therapeutics, Inc.
        5493002Q5LITR7VHZH02
        Pliant Therapeutics, Inc.
        729139105
        
          
          
        
        149100.00000000
        NS
        USD
        3011820.00000000
        0.226133706395
        Long
        EC
        CORP
        US
        N
        
        1
        
          N
          N
          N
        
      
      
        Trillium Therapeutics, Inc.
        N/A
        Trillium Therapeutics, Inc.
        89620X506
        
          
          
        
        884024.00000000
        NS
        USD
        5772676.72000000
        0.433424568040
        Long
        EC
        CORP
        CA
        N
        
        1
        
          N
          N
          N
        
      
      
        Alpha Teknova, Inc.
        N/A
        Alpha Teknova, Inc.
        02080L102
        
          
          
        
        89600.00000000
        NS
        USD
        1990912.00000000
        0.149481811551
        Long
        EC
        CORP
        US
        N
        
        1
        
          N
          N
          N
        
      
      
        Mirati Therapeutics, Inc.
        529900GYRW59IDQV6N54
        Mirati Therapeutics, Inc.
        60468T105
        
          
          
        
        243619.00000000
        NS
        USD
        38993657.14000000
        2.927724835805
        Long
        EC
        CORP
        US
        N
        
        1
        
          N
          N
          N
        
      
      
        Argenx SE
        7245009C5FZE6G9ODQ71
        Argenx SE
        04016X101
        
          
          
        
        51298.00000000
        NS
        USD
        15616650.14000000
        1.172530555490
        Long
        EC
        CORP
        NL
        N
        
        1
        
          N
          N
          N
        
      
      
        Olema Pharmaceuticals, Inc.
        N/A
        Olema Pharmaceuticals, Inc.
        68062P106
        
          
          
        
        154500.00000000
        NS
        USD
        3627660.00000000
        0.272372253767
        Long
        EC
        CORP
        US
        N
        
        1
        
          N
          N
          
        
      
      
        Blueprint Medicines Corp.
        5299004CC60O9T5HVM83
        Blueprint Medicines Corp.
        09627Y109
        
          
          
        
        117200.00000000
        NS
        USD
        10298364.00000000
        0.773222576756
        Long
        EC
        CORP
        US
        N
        
        1
        
          N
          N
          N
        
      
      
        Intra-Cellular Therapies, Inc.
        5299002U2KGF193IJA20
        Intra-Cellular Therapies, Inc.
        46116X101
        
          
          
        
        487600.00000000
        NS
        USD
        16739308.00000000
        1.256822041334
        Long
        EC
        CORP
        US
        N
        
        1
        
          N
          N
          N
        
      
      
        Metacrine, Inc.
        N/A
        Metacrine, Inc.
        59101E103
        
          
          
        
        260919.00000000
        NS
        USD
        735791.58000000
        0.055244761346
        Long
        EC
        CORP
        US
        N
        
        1
        
          N
          N
          N
        
      
      
        Kodiak Sciences, Inc.
        254900IXI5NI8C9OQE24
        Kodiak Sciences, Inc.
        50015M109
        
          
          
        
        77300.00000000
        NS
        USD
        6480832.00000000
        0.486594338534
        Long
        EC
        CORP
        US
        N
        
        1
        
          N
          N
          N
        
      
      
        Reata Pharmaceuticals, Inc.
        5299005F094GH9QDDD80
        Reata Pharmaceuticals, Inc., Class A
        75615P103
        
          
          
        
        215756.00000000
        NS
        USD
        27036384.36000000
        2.029947939403
        Long
        EC
        CORP
        US
        N
        
        1
        
          N
          N
          N
        
      
      
        Sage Therapeutics, Inc.
        5493000JX4BJS9W6CN35
        Sage Therapeutics, Inc.
        78667J108
        
          
          
        
        101070.00000000
        NS
        USD
        4419791.10000000
        0.331847103391
        Long
        EC
        CORP
        US
        N
        
        1
        
          N
          N
          N
        
      
      
        Cytokinetics, Inc.
        549300BE5DY1HW7IHA64
        Cytokinetics, Inc.
        23282W605
        
          
          
        
        254100.00000000
        NS
        USD
        7541688.00000000
        0.566245612260
        Long
        EC
        CORP
        US
        N
        
        1
        
          N
          N
          N
        
      
      
        Gemini Therapeutics, Inc.
        N/A
        Gemini Therapeutics, Inc.
        36870G105
        
          
          
        
        103589.00000000
        NS
        USD
        421607.23000000
        0.031655147240
        Long
        EC
        CORP
        US
        N
        
        1
        
          N
          N
          N
        
      
      
        Sutro Biopharma, Inc.
        5493005U6P15VD25P851
        Sutro Biopharma, Inc.
        869367102
        
          
          
        
        669974.00000000
        NS
        USD
        11409657.22000000
        0.856660781805
        Long
        EC
        CORP
        US
        N
        
        1
        
          N
          N
          N
        
      
      
        Illumina, Inc.
        SQ95QG8SR5Q56LSNF682
        Illumina, Inc.
        452327109
        
          
          
        
        150900.00000000
        NS
        USD
        74808675.00000000
        5.616790826899
        Long
        EC
        CORP
        US
        N
        
        1
        
          N
          N
          N
        
      
      
        Pipeline Therapeutics, Inc.
        N/A
        Pipeline Therapeutics, Inc., Series C
        N/A
        
          
        
        779505.00000000
        NS
        USD
        1504536.63000000
        0.112963737723
        Long
        EC
        CORP
        US
        Y
        
        3
        
          N
          N
          N
        
      
      
        Fate Therapeutics, Inc.
        549300L14Q4UHOODLA90
        Fate Therapeutics, Inc.
        31189P102
        
          
          
        
        242110.00000000
        NS
        USD
        20046708.00000000
        1.505148508564
        Long
        EC
        CORP
        US
        N
        
        1
        
          N
          N
          N
        
      
      
        Centessa Pharmaceuticals plc
        213800GIDAARDSKOI827
        Centessa Pharmaceuticals plc
        152309100
        
          
          
        
        71600.00000000
        NS
        USD
        1477824.00000000
        0.110958097934
        Long
        EC
        CORP
        GB
        
        N
        
        1
        
          N
          N
          N
        
      
      
        Yumanity Therapeutics, Inc.
        549300GNQLMQP5WNHC81
        Yumanity Therapeutics, Inc.
        98872L102
        
          
          
        
        90804.00000000
        NS
        USD
        831764.64000000
        0.062450618194
        Long
        EC
        CORP
        US
        N
        
        1
        
          N
          N
          
        
      
      
        Cullinan Oncology, Inc.
        N/A
        Cullinan Oncology, Inc.
        230031106
        
          
          
        
        113700.00000000
        NS
        USD
        2607141.00000000
        0.195749565852
        Long
        EC
        CORP
        US
        N
        
        1
        
          N
          N
          N
        
      
      
        PTC Therapeutics, Inc.
        549300UJLWOIWFDGB318
        PTC Therapeutics, Inc.
        69366J200
        
          
          
        
        799400.00000000
        NS
        USD
        30641002.00000000
        2.300590124883
        Long
        EC
        CORP
        US
        N
        
        1
        
          N
          N
          N
        
      
      
        Ultragenyx Pharmaceutical, Inc.
        529900EV44GVDN1DCX77
        Ultragenyx Pharmaceutical, Inc.
        90400D108
        
          
          
        
        83996.00000000
        NS
        USD
        6705400.68000000
        0.503455421849
        Long
        EC
        CORP
        US
        N
        
        1
        
          N
          N
          N
        
      
      
        Kinnate Biopharma, Inc.
        549300YVIWV7HJ5WHI66
        Kinnate Biopharma, Inc.
        49705R105
        
          
          
        
        19806.00000000
        NS
        USD
        427413.48000000
        0.032091092560
        Long
        EC
        CORP
        US
        N
        
        1
        
          N
          N
          
        
      
      
        Panacea Acquisition Corp. II
        N/A
        Panacea Acquisition Corp. II, Class A
        N/A
        
          
          
        
        195100.00000000
        NS
        USD
        1942220.50000000
        0.145825952514
        Long
        EC
        CORP
        KY
        
        N
        
        1
        
          N
          N
          N
        
      
      
        Equillium, Inc.
        549300OC7SSPSNNGHE64
        Equillium, Inc.
        29446K106
        
          
          
        
        294800.00000000
        NS
        USD
        1597816.00000000
        0.119967346726
        Long
        EC
        CORP
        US
        N
        
        1
        
          N
          N
          
        
      
      
        Omega Alpha SPAC
        N/A
        Omega Alpha SPAC, Class A
        N/A
        
          
          
        
        294400.00000000
        NS
        USD
        2891008.00000000
        0.217062890298
        Long
        EC
        CORP
        KY
        
        N
        
        1
        
          N
          N
          N
        
      
      
        AstraZeneca plc
        PY6ZZQWO2IZFZC3IOL08
        AstraZeneca plc
        046353108
        
          
          
        
        240200.00000000
        NS
        USD
        13749048.00000000
        1.032307104557
        Long
        EC
        CORP
        GB
        N
        
        1
        
          N
          N
          N
        
      
      
        Taysha Gene Therapies, Inc.
        N/A
        Taysha Gene Therapies, Inc.
        877619106
        
          
          
        
        138156.22650000
        NS
        USD
        2388721.16000000
        0.179350150226
        Long
        EC
        CORP
        US
        N
        
        1
        
          N
          N
          N
        
      
      
        Arcutis Biotherapeutics, Inc.
        N/A
        Arcutis Biotherapeutics, Inc.
        03969K108
        
          
          
        
        125200.00000000
        NS
        USD
        2920916.00000000
        0.219308445109
        Long
        EC
        CORP
        US
        N
        
        1
        
          N
          N
          N
        
      
      
        Deciphera Pharmaceuticals, Inc.
        529900QR4WAPYY0CBF25
        Deciphera Pharmaceuticals, Inc.
        24344T101
        
          
          
        
        678554.00000000
        NS
        USD
        20689111.46000000
        1.553381495731
        Long
        EC
        CORP
        US
        N
        
        1
        
          N
          N
          N
        
      
      
        Nuvation Bio, Inc.
        N/A
        Nuvation Bio, Inc.
        67080N119
        
          
          
        
        115266.00000000
        NS
        USD
        255890.52000000
        0.019212792171
        Long
        
        CORP
        US
        N
        
        1
        
          N
          N
          N
        
      
      
        Nuvation Bio, Inc.
        N/A
        Nuvation Bio, Inc.
        67080N101
        
          
          
        
        345800.00000000
        NS
        USD
        2987712.00000000
        0.224323627641
        Long
        EC
        CORP
        US
        N
        
        1
        
          N
          N
          
        
      
      
        Gemini Therapeutics, Inc.
        N/A
        Gemini Therapeutics, Inc.
        36870G105
        
          
          
        
        473100.00000000
        NS
        USD
        1925517.00000000
        0.144571819012
        Long
        EC
        CORP
        US
        N
        
        1
        
          N
          N
          N
        
      
      
        Health Sciences Acquisitions Corp. 2
        N/A
        Health Sciences Acquisitions Corp. 2
        N/A
        
          
          
        
        171600.00000000
        NS
        USD
        1700556.00000000
        0.127681279496
        Long
        EC
        CORP
        KY
        
        N
        
        1
        
          N
          N
          N
        
      
      
        Protara Therapeutics, Inc.
        549300VWUGH3220TG273
        Protara Therapeutics, Inc.
        74365U107
        
          
          
        
        145500.00000000
        NS
        USD
        1153815.00000000
        0.086630828683
        Long
        EC
        CORP
        US
        N
        
        1
        
          N
          N
          N
        
      
      
        Iovance Biotherapeutics, Inc.
        549300220Z2GHH33XL82
        Iovance Biotherapeutics, Inc.
        462260100
        
          
          
        
        1395901.00000000
        NS
        USD
        31086715.27000000
        2.334055203717
        Long
        EC
        CORP
        US
        N
        
        1
        
          N
          N
          N
        
      
      
        Keros Therapeutics, Inc.
        N/A
        Keros Therapeutics, Inc.
        492327101
        
          
          
        
        148751.00000000
        NS
        USD
        5474036.80000000
        0.411002062051
        Long
        EC
        CORP
        US
        N
        
        1
        
          N
          N
          N
        
      
      
        Ascendis Pharma A/S
        549300B66JN3W3J8GH73
        Ascendis Pharma A/S
        04351P101
        
          
          
        
        222800.00000000
        NS
        USD
        26332732.00000000
        1.977116257503
        Long
        EC
        CORP
        DK
        N
        
        1
        
          N
          N
          N
        
      
      
        Novavax, Inc.
        529900J4GJHPEPQ23205
        Novavax, Inc.
        670002401
        
          
          
        
        203218.00000000
        NS
        USD
        36443083.94000000
        2.736222497967
        Long
        EC
        CORP
        US
        N
        
        1
        
          N
          N
          N
        
      
      
        Taysha Gene Therapies, Inc.
        N/A
        Taysha Gene Therapies, Inc.
        877619106
        
          
          
        
        166100.00000000
        NS
        USD
        2871869.00000000
        0.215625894393
        Long
        EC
        CORP
        US
        N
        
        1
        
          N
          N
          
        
      
      
        ALX Oncology Holdings, Inc.
        N/A
        ALX Oncology Holdings, Inc.
        00166B105
        
          
          
        
        86100.00000000
        NS
        USD
        5042016.00000000
        0.378565042328
        Long
        EC
        CORP
        US
        N
        
        1
        
          N
          N
          N
        
      
      
        Amunix Pharmaceuticals, Inc.
        N/A
        Amunix Pharmaceuticals, Inc., Series B
        N/A
        
          
        
        2333755.00000000
        NS
        USD
        3349197.47000000
        0.251464708163
        Long
        EC
        CORP
        US
        Y
        
        3
        
          N
          N
          N
        
      
      
        Repare Therapeutics, Inc.
        N/A
        Repare Therapeutics, Inc.
        760273102
        
          
          
        
        57098.00000000
        NS
        USD
        1907073.20000000
        0.143187020168
        Long
        EC
        CORP
        CA
        N
        
        1
        
          N
          N
          N
        
      
      
        Alector, Inc.
        549300Z8RQOIY1JMHC25
        Alector, Inc.
        014442107
        
          
          
        
        677446.00000000
        NS
        USD
        16282414.61000000
        1.222517535850
        Long
        EC
        CORP
        US
        N
        
        1
        
          N
          N
          N
        
      
      
        Arcus Biosciences, Inc.
        N/A
        Arcus Biosciences, Inc.
        03969F109
        
          
          
        
        519014.00000000
        NS
        USD
        16302229.74000000
        1.224005297001
        Long
        EC
        CORP
        US
        N
        
        1
        
          N
          N
          N
        
      
      
        Kezar Life Sciences, Inc.
        549300EV1V8GXBV18004
        Kezar Life Sciences, Inc.
        49372L100
        
          
          
        
        853550.00000000
        NS
        USD
        4156788.50000000
        0.312100321468
        Long
        EC
        CORP
        US
        N
        
        1
        
          N
          N
          N
        
      
      
        Marinus Pharmaceuticals, Inc.
        549300NCT4OJF7JV1084
        Marinus Pharmaceuticals, Inc.
        56854Q200
        
          
          
        
        149200.00000000
        NS
        USD
        2193240.00000000
        0.164673018379
        Long
        EC
        CORP
        US
        N
        
        1
        
          N
          N
          
        
      
      
        ACADIA Pharmaceuticals, Inc.
        529900O3044NO0PEA039
        ACADIA Pharmaceuticals, Inc.
        004225108
        
          
          
        
        294600.00000000
        NS
        USD
        6372198.00000000
        0.478437871992
        Long
        EC
        CORP
        US
        N
        
        1
        
          N
          N
          N
        
      
      
        Vertex Pharmaceuticals, Inc.
        54930015RAQRRZ5ZGJ91
        Vertex Pharmaceuticals, Inc.
        92532F100
        
          
          
        
        213133.00000000
        NS
        USD
        42963350.14000000
        3.225777638211
        Long
        EC
        CORP
        US
        N
        
        1
        
          N
          N
          N
        
      
      
        Social Capital Suvretta Holdings Corp. I
        N/A
        Social Capital Suvretta Holdings Corp. I, Class A
        N/A
        
          
          
        
        143000.00000000
        NS
        USD
        1408550.00000000
        0.105756862011
        Long
        EC
        CORP
        KY
        
        N
        
        1
        
          N
          N
          N
        
      
      
        Silverback Therapeutics, Inc.
        N/A
        Silverback Therapeutics, Inc.
        82835W108
        
          
          
        
        109252.00000000
        NS
        USD
        3308150.56000000
        0.248382820834
        Long
        EC
        CORP
        US
        N
        
        1
        
          N
          N
          
        
      
      
        Revance Therapeutics, Inc.
        549300N33TFDZHS81H11
        Revance Therapeutics, Inc.
        761330109
        
          
          
        
        275500.00000000
        NS
        USD
        8011540.00000000
        0.601523077120
        Long
        EC
        CORP
        US
        N
        
        1
        
          N
          N
          N
        
      
      
        Centessa Pharmaceuticals plc
        213800GIDAARDSKOI827
        Centessa Pharmaceuticals plc
        N/A
        
          
        
        189736.50000000
        NS
        
        3720080.86000000
        0.279311404055
        Long
        EC
        CORP
        GB
        
        Y
        
        3
        
          N
          N
          N
        
      
      
        Day One Biopharmaceuticals, Inc.
        N/A
        Day One Biopharmaceuticals, Inc.
        N/A
        
          
        
        370698.00000000
        NS
        USD
        8131794.06000000
        0.610552001922
        Long
        EC
        CORP
        US
        Y
        
        3
        
          N
          N
          N
        
      
      
        Point Biopharma Global, Inc.
        N/A
        Point Biopharma Global, Inc.
        730541109
        
          
          
        
        429800.00000000
        NS
        USD
        3524360.00000000
        0.264616275033
        Long
        EC
        CORP
        US
        N
        
        1
        
          N
          N
          N
        
      
      
        Praxis Precision Medicines, Inc.
        N/A
        Praxis Precision Medicines, Inc.
        74006W108
        
          
          
        
        103600.00000000
        NS
        USD
        1616160.00000000
        0.121344652378
        Long
        EC
        CORP
        US
        N
        
        1
        
          N
          N
          N
        
      
      
        Legend Biotech Corp.
        254900EIUFZTW136H859
        Legend Biotech Corp.
        52490G102
        
          
          
        
        207725.00000000
        NS
        USD
        8938406.75000000
        0.671114159427
        Long
        EC
        CORP
        KY
        
        N
        
        1
        
          N
          N
          N
        
      
      
        Karuna Therapeutics, Inc.
        N/A
        Karuna Therapeutics, Inc.
        48576A100
        
          
          
        
        42300.00000000
        NS
        USD
        4831506.00000000
        0.362759513932
        Long
        EC
        CORP
        US
        N
        
        1
        
          N
          N
          N
        
      
      
        Dyne Therapeutics, Inc.
        N/A
        Dyne Therapeutics, Inc.
        26818M108
        
          
          
        
        115139.00000000
        NS
        USD
        2080561.73000000
        0.156212899638
        Long
        EC
        CORP
        US
        N
        
        1
        
          N
          N
          N
        
      
      
        Codiak Biosciences, Inc.
        549300QVVVW74Y10Q230
        Codiak Biosciences, Inc.
        192010106
        
          
          
        
        252600.00000000
        NS
        USD
        4369980.00000000
        0.328107182458
        Long
        EC
        CORP
        US
        N
        
        1
        
          N
          N
          N
        
      
      
        Relmada Therapeutics, Inc.
        549300217EASRZ9JSF81
        Relmada Therapeutics, Inc.
        75955J402
        
          
          
        
        91266.00000000
        NS
        USD
        2372916.00000000
        0.178163465959
        Long
        EC
        CORP
        US
        N
        
        1
        
          N
          N
          N
        
      
      
        Intellia Therapeutics, Inc.
        5493002T5BCPE5DZC723
        Intellia Therapeutics, Inc.
        45826J105
        
          
          
        
        121053.00000000
        NS
        USD
        17171368.05000000
        1.289262008029
        Long
        EC
        CORP
        US
        N
        
        1
        
          N
          N
          N
        
      
      
        Acumen Pharmaceuticals, Inc.
        N/A
        Acumen Pharmaceuticals, Inc.
        00509G209
        
          
          
        
        336100.00000000
        NS
        USD
        5202828.00000000
        0.390639141574
        Long
        EC
        CORP
        US
        N
        
        1
        
          N
          N
          N
        
      
      
        Institutional Fiduciary Trust Money Market Portfolio
        N/A
        Institutional Fiduciary Trust Money Market Portfolio
        8611239C3
        
          
        
        32703779.95000000
        NS
        USD
        32703779.95000000
        2.455467781351
        Long
        STIV
        RF
        US
        N
        
        1
        
          
          N
          N
        
      
      
        EyePoint Pharmaceuticals, Inc.
        549300QE1RU34T50MR69
        EyePoint Pharmaceuticals, Inc.
        30233G209
        
          
          
        
        836730.00000000
        NS
        USD
        6877920.60000000
        0.516408576067
        Long
        EC
        CORP
        US
        N
        
        1
        
          N
          N
          N
        
      
      
        Acceleron Pharma, Inc.
        529900TQRID2UY164805
        Acceleron Pharma, Inc.
        00434H108
        
          
          
        
        142114.00000000
        NS
        USD
        17772776.84000000
        1.334417030156
        Long
        EC
        CORP
        US
        N
        
        1
        
          N
          N
          N
        
      
      
        Nautilus Biotechnology, Inc.
        N/A
        Nautilus Biotechnology, Inc.
        63909J108
        
          
          
        
        212500.00000000
        NS
        USD
        1666000.00000000
        0.125086743183
        Long
        EC
        CORP
        US
        N
        
        1
        
          N
          N
          
        
      
      
        Scholar Rock Holding Corp.
        549300Z1FLPGL4OWJ459
        Scholar Rock Holding Corp.
        80706P103
        
          
          
        
        41500.00000000
        NS
        USD
        1296875.00000000
        0.097372070867
        Long
        EC
        CORP
        US
        N
        
        1
        
          N
          N
          N
        
      
      
        Intarcia Therapeutics, Inc.
        N/A
        Intarcia Therapeutics, Inc.
        N/A
        
          
        
        80195.00000000
        NS
        USD
        0.00000000
        0.000000
        Long
        EC
        CORP
        US
        Y
        
        3
        
          N
          N
          N
        
      
      
        PMV Pharmaceuticals, Inc.
        N/A
        PMV Pharmaceuticals, Inc.
        69353Y103
        
          
          
        
        83100.00000000
        NS
        USD
        2826231.00000000
        0.212199298483
        Long
        EC
        CORP
        US
        N
        
        1
        
          N
          N
          N
        
      
      
        Bridgebio Pharma, Inc.
        54930028YG89VTY2J114
        Bridgebio Pharma, Inc.
        10806X102
        
          
          
        
        118800.00000000
        NS
        USD
        6349860.00000000
        0.476760688517
        Long
        EC
        CORP
        US
        N
        
        1
        
          N
          N
          N
        
      
      
        FS Development Corp. II
        N/A
        FS Development Corp. II, Class A
        30318F100
        
          
          
        
        164600.00000000
        NS
        USD
        1627894.00000000
        0.122225665490
        Long
        EC
        CORP
        US
        N
        
        1
        
          N
          N
          N
        
      
      
        Singular Genomics Systems, Inc.
        N/A
        Singular Genomics Systems, Inc.
        82933R100
        
          
          
        
        181900.00000000
        NS
        USD
        3283295.00000000
        0.246516613721
        Long
        EC
        CORP
        US
        N
        
        1
        
          N
          N
          
        
      
      
        Rocket Pharmaceuticals, Inc.
        549300R7VV82YUIN4Y93
        Rocket Pharmaceuticals, Inc.
        77313F106
        
          
          
        
        375771.00000000
        NS
        USD
        13460117.22000000
        1.010613580982
        Long
        EC
        CORP
        US
        N
        
        1
        
          N
          N
          N
        
      
      
        Amgen, Inc.
        62QBXGPJ34PQ72Z12S66
        Amgen, Inc.
        031162100
        
          
          
        
        318700.00000000
        NS
        USD
        76978798.00000000
        5.779728172864
        Long
        EC
        CORP
        US
        N
        
        1
        
          N
          N
          N
        
      
      
        Zogenix, Inc.
        54930089H3HF4C32SK78
        Zogenix, Inc.
        98978L204
        
          
          
        
        1144759.00000000
        NS
        USD
        18556543.39000000
        1.393263851978
        Long
        EC
        CORP
        US
        N
        
        1
        
          N
          N
          N
        
      
      
        Candel Therapeutics, Inc.
        N/A
        Candel Therapeutics, Inc.
        137404109
        
          
          
        
        400800.00000000
        NS
        USD
        3042072.00000000
        0.228405089441
        Long
        EC
        CORP
        US
        N
        
        1
        
          N
          N
          N
        
      
      
        Social Capital Suvretta Holdings Corp. II
        N/A
        Social Capital Suvretta Holdings Corp. II, Class A
        N/A
        
          
          
        
        143000.00000000
        NS
        USD
        1409980.00000000
        0.105864229383
        Long
        EC
        CORP
        KY
        
        N
        
        1
        
          N
          N
          N
        
      
      
        Global Blood Therapeutics, Inc.
        549300U4G0QKK99GRT15
        Global Blood Therapeutics, Inc.
        37890U108
        
          
          
        
        391500.00000000
        NS
        USD
        10699695.00000000
        0.803355342500
        Long
        EC
        CORP
        US
        N
        
        1
        
          N
          N
          N
        
      
      
        Kronos Bio, Inc.
        N/A
        Kronos Bio, Inc.
        50107A104
        
          
          
        
        167371.00000000
        NS
        USD
        3422736.95000000
        0.256986205191
        Long
        EC
        CORP
        US
        N
        
        1
        
          N
          N
          
        
      
      
        KalVista Pharmaceuticals, Inc.
        529900Q7IDA3WUGRZA51
        KalVista Pharmaceuticals, Inc.
        483497103
        
          
          
        
        366100.00000000
        NS
        USD
        7373254.00000000
        0.553599237409
        Long
        EC
        CORP
        US
        N
        
        1
        
          N
          N
          N
        
      
      
        Krystal Biotech, Inc.
        549300YONUY68210OE41
        Krystal Biotech, Inc.
        501147102
        
          
          
        
        52100.00000000
        NS
        USD
        3044724.00000000
        0.228604207114
        Long
        EC
        CORP
        US
        N
        
        1
        
          N
          N
          N
        
      
      
        VistaGen Therapeutics, Inc.
        N/A
        VistaGen Therapeutics, Inc.
        92840H202
        
          
          
        
        3617653.00000000
        NS
        USD
        9622956.98000000
        0.722511613698
        Long
        EC
        CORP
        US
        N
        
        1
        
          N
          N
          
        
      
      
        Zymeworks, Inc.
        894500AHOYAGYLYZJL67
        Zymeworks, Inc.
        98985W102
        
          
          
        
        471320.00000000
        NS
        USD
        15124658.80000000
        1.135590822960
        Long
        EC
        CORP
        CA
        N
        
        1
        
          N
          N
          N
        
      
      
        Applied Molecular Transport, Inc.
        N/A
        Applied Molecular Transport, Inc.
        03824M109
        
          
          
        
        138000.00000000
        NS
        USD
        3868140.00000000
        0.290427992063
        Long
        EC
        CORP
        US
        N
        
        1
        
          N
          N
          
        
      
      
        Angion Biomedica Corp.
        N/A
        Angion Biomedica Corp.
        03476J107
        
          
          
        
        256000.00000000
        NS
        USD
        2721280.00000000
        0.204319359237
        Long
        EC
        CORP
        US
        N
        
        1
        
          N
          N
          N
        
      
      
        Regeneron Pharmaceuticals, Inc.
        549300RCBFWIRX3HYQ56
        Regeneron Pharmaceuticals, Inc.
        75886F107
        
          
          
        
        138309.00000000
        NS
        USD
        79473734.49000000
        5.967053190861
        Long
        EC
        CORP
        US
        N
        
        1
        
          N
          N
          N
        
      
      
        LogicBio Therapeutics, Inc.
        549300GHIQDMXT6NPC14
        LogicBio Therapeutics, Inc.
        54142F102
        
          
          
        
        661200.00000000
        NS
        USD
        2757204.00000000
        0.207016607834
        Long
        EC
        CORP
        US
        N
        
        1
        
          N
          N
          
        
      
      
        ARYA Sciences Acquisition Corp. IV
        N/A
        ARYA Sciences Acquisition Corp. IV, Class A
        N/A
        
          
          
        
        162200.00000000
        NS
        USD
        1649574.00000000
        0.123853444957
        Long
        EC
        CORP
        KY
        
        N
        
        1
        
          N
          N
          N
        
      
      
        CRISPR Therapeutics AG
        506700O6IRRIQLT3W370
        CRISPR Therapeutics AG
        N/A
        
          
          
        
        130614.00000000
        NS
        USD
        15806906.28000000
        1.186815381974
        Long
        EC
        CORP
        CH
        N
        
        1
        
          N
          N
          N
        
      
      
        Gilead Sciences, Inc.
        549300WTZWR07K8MNV44
        Gilead Sciences, Inc.
        375558103
        
          
          
        
        893078.00000000
        NS
        USD
        60988296.62000000
        4.579128089134
        Long
        EC
        CORP
        US
        N
        
        1
        
          N
          N
          N
        
      
      
        Social Capital Suvretta Holdings Corp. IV
        N/A
        Social Capital Suvretta Holdings Corp. IV, Class A
        N/A
        
          
          
        
        143000.00000000
        NS
        USD
        1405690.00000000
        0.105542127266
        Long
        EC
        CORP
        KY
        
        N
        
        1
        
          N
          N
          N
        
      
      
        Jiya Acquisition Corp.
        N/A
        Jiya Acquisition Corp., Class A
        47760M102
        
          
          
        
        208800.00000000
        NS
        USD
        2037888.00000000
        0.153008867282
        Long
        EC
        CORP
        US
        N
        
        1
        
          N
          N
          N
        
      
      
        Thermo Fisher Scientific, Inc.
        HCHV7422L5HDJZCRFL38
        Thermo Fisher Scientific, Inc.
        883556102
        
          
          
        
        31300.00000000
        NS
        USD
        16902313.00000000
        1.269060795579
        Long
        EC
        CORP
        US
        N
        
        1
        
          N
          N
          N
        
      
      
        Artiva Biotherapeutics, Inc.
        N/A
        Artiva Biotherapeutics, Inc.
        N/A
        
          
        
        189499.00000000
        NS
        USD
        2084489.00000000
        0.156507767233
        Long
        EC
        CORP
        US
        Y
        
        3
        
          N
          N
          N
        
      
      
        Institutional Fiduciary Trust - Money Market Portfolio
        549300M4TP89K77LG374
        Institutional Fiduciary Trust - Money Market Portfolio
        457756500
        
          
          
        
        9598633.53100000
        NS
        USD
        9598633.52000000
        0.720685357759
        Long
        STIV
        RF
        US
        N
        
        1
        
          N
          N
          N
        
      
      
        Forte Biosciences, Inc.
        529900Z84WFDHPS3JP76
        Forte Biosciences, Inc.
        34962G109
        
          
          
        
        279964.00000000
        NS
        USD
        8387721.44000000
        0.629767561620
        Long
        EC
        CORP
        US
        N
        
        1
        
          N
          N
          
        
      
      
        Athira Pharma, Inc.
        N/A
        Athira Pharma, Inc.
        04746L104
        
          
          
        
        779576.00000000
        NS
        USD
        7491725.36000000
        0.562494313389
        Long
        EC
        CORP
        US
        N
        
        1
        
          N
          N
          
        
      
      
        Moderna, Inc.
        549300EI6OKH5K5Q2G38
        Moderna, Inc.
        60770K107
        
          
          
        
        114200.00000000
        NS
        USD
        40381120.00000000
        3.031898431511
        Long
        EC
        CORP
        US
        N
        
        1
        
          N
          N
          N
        
      
      
        Metacrine, Inc.
        N/A
        Metacrine, Inc.
        59101E103
        
          
          
        
        251900.00000000
        NS
        USD
        710358.00000000
        0.053335155290
        Long
        EC
        CORP
        US
        N
        
        1
        
          N
          N
          N
        
      
      
        VYNE Therapeutics, Inc.
        N/A
        VYNE Therapeutics, Inc.
        92941V209
        
          
          
        
        720650.00000000
        NS
        USD
        1945755.00000000
        0.146091330121
        Long
        EC
        CORP
        US
        N
        
        1
        
          N
          N
          
        
      
      
        Albireo Pharma, Inc.
        549300835H8LC7O8VC29
        Albireo Pharma, Inc.
        01345P106
        
          
          
        
        102400.00000000
        NS
        USD
        2929664.00000000
        0.219965263134
        Long
        EC
        CORP
        US
        N
        
        1
        
          N
          N
          N
        
      
    
    
      
    
    
      2021-08-30
      Franklin Strategic Series
      Robert Kubilis
      Robert Kubilis
      Chief Financial Officer, Chief Accounting Officer and Treasurer
    
  
  XXXX




Not
FDIC
Insured
May
Lose
Value
No
Bank
Guarantee
FSS-Q1PH
1
Statements
of
Investments
(unaudited)
Franklin
Biotechnology
Discovery
Fund
2
Franklin
Growth
Opportunities
Fund
6
Franklin
Natural
Resources
Fund
12
Franklin
Small
Cap
Growth
Fund
16
Franklin
Small-Mid
Cap
Growth
Fund
22
Franklin
Strategic
Income
Fund
28
Notes
to
Statements
of
Investments
53
Franklin
Strategic
Series
Statement
of
Investments
(unaudited),
July
31,
2021
Franklin
Biotechnology
Discovery
Fund
Quarterly
Statement
of
Investments
See
Notes
to
Statements
of
Investments.
2
2
a
a
Country
Shares
a
Value
a
a
a
a
a
a
Common
Stocks
98.7%
Biotechnology
78.2%
a
89bio,
Inc.
...........................................
United
States
284,400
$
4,453,704
a
ACADIA
Pharmaceuticals,
Inc.
...........................
United
States
294,600
6,372,198
a
Acceleron
Pharma,
Inc.
.................................
United
States
142,114
17,772,777
a
Acumen
Pharmaceuticals,
Inc.
...........................
United
States
336,100
5,202,828
a
Akouos
,
Inc.
.........................................
United
States
157,600
1,713,112
a
Albireo
Pharma,
Inc.
...................................
United
States
102,400
2,929,664
a
Alector
,
Inc.
..........................................
United
States
677,446
16,282,415
a
ALX
Oncology
Holdings,
Inc.
.............................
United
States
86,100
5,042,016
Amgen,
Inc.
.........................................
United
States
318,700
76,978,798
a,b
Applied
Molecular
Transport,
Inc.
.........................
United
States
138,000
3,868,140
a
Applied
Therapeutics,
Inc.
...............................
United
States
311,757
5,365,338
a
Arcus
Biosciences,
Inc.
.................................
United
States
519,014
16,302,230
a
Arcutis
Biotherapeutics
,
Inc.
.............................
United
States
125,200
2,920,916
a
Argenx
SE,
ADR
......................................
Netherlands
51,298
15,616,650
a
Ascendis
Pharma
A/S,
ADR
.............................
Denmark
222,800
26,332,732
a
Biogen,
Inc.
.........................................
United
States
148,175
48,413,218
a
BioMarin
Pharmaceutical,
Inc.
............................
United
States
142,456
10,930,649
a
Blueprint
Medicines
Corp.
...............................
United
States
117,200
10,298,364
a
Bridgebio
Pharma,
Inc.
.................................
United
States
118,800
6,349,860
a
Candel
Therapeutics,
Inc.
...............................
United
States
400,800
3,042,072
a,c,d
Centessa
Pharmaceuticals
plc
...........................
United
States
189,737
3,720,081
a
Centessa
Pharmaceuticals
plc,
ADR
.......................
United
States
71,600
1,477,824
a
Codiak
Biosciences,
Inc.
................................
United
States
252,600
4,369,980
a
CRISPR
Therapeutics
AG
...............................
Switzerland
130,614
15,806,906
a
Cullinan
Oncology,
Inc.
.................................
United
States
113,700
2,607,141
a
Cytokinetics,
Inc.
......................................
United
States
254,100
7,541,688
a,c,d
Day
One
Biopharmaceuticals,
Inc.
.........................
United
States
370,698
8,131,794
a
Deciphera
Pharmaceuticals,
Inc.
..........................
United
States
678,554
20,689,111
a
Dyne
Therapeutics,
Inc.
................................
United
States
215,539
3,894,790
a,b
Equillium
,
Inc.
........................................
United
States
294,800
1,597,816
a
Fate
Therapeutics,
Inc.
.................................
United
States
242,110
20,046,708
a,b
Forte
Biosciences,
Inc.
.................................
United
States
279,964
8,387,721
a
Gemini
Therapeutics,
Inc.
...............................
United
States
576,689
2,347,124
Gilead
Sciences,
Inc.
..................................
United
States
893,078
60,988,297
a
Global
Blood
Therapeutics,
Inc.
...........................
United
States
391,500
10,699,695
a
Harpoon
Therapeutics,
Inc.
..............................
United
States
220,200
2,155,758
a
Heron
Therapeutics,
Inc.
................................
United
States
1,739,677
21,502,408
a
Horizon
Therapeutics
plc
................................
United
States
488,349
48,844,667
a
Insmed
,
Inc.
.........................................
United
States
906,600
22,302,360
a,c,d
Intarcia
Therapeutics,
Inc.,
DD
...........................
United
States
80,195
a
Intellia
Therapeutics,
Inc.
................................
United
States
121,053
17,171,368
a
Iovance
Biotherapeutics
,
Inc.
.............................
United
States
1,395,901
31,086,715
a
KalVista
Pharmaceuticals,
Inc.
...........................
United
States
366,100
7,373,254
a
Karuna
Therapeutics,
Inc.
...............................
United
States
42,300
4,831,506
a
Keros
Therapeutics,
Inc.
................................
United
States
148,751
5,474,037
a
Kezar
Life
Sciences,
Inc.
................................
United
States
853,550
4,156,788
a,b
Kinnate
Biopharma,
Inc.
................................
United
States
19,606
423,097
a
Kodiak
Sciences,
Inc.
..................................
United
States
77,300
6,480,832
a,b
Kronos
Bio,
Inc.
......................................
United
States
167,371
3,422,737
a
Krystal
Biotech,
Inc.
...................................
United
States
52,100
3,044,724
a
Kura
Oncology,
Inc.
....................................
United
States
132,400
2,507,656
a
Legend
Biotech
Corp.,
ADR
.............................
United
States
207,725
8,938,407
a,b
LogicBio
Therapeutics,
Inc.
..............................
United
States
661,200
2,757,204
a
Merus
NV
...........................................
Netherlands
73,200
1,259,040
a
Metacrine
,
Inc.
.......................................
United
States
512,819
1,446,150
a
Mirati
Therapeutics,
Inc.
................................
United
States
243,619
38,993,657
a
Moderna
,
Inc.
........................................
United
States
114,200
40,381,120
a
Neurocrine
Biosciences,
Inc.
.............................
United
States
215,800
20,114,718
Franklin
Strategic
Series
Statement
of
Investments
(unaudited)
Franklin
Biotechnology
Discovery
Fund
(continued)
See
Notes
to
Statements
of
Investments.
Quarterly
Statement
of
Investments
3
a
a
Country
Shares
a
Value
a
a
a
a
a
a
Common
Stocks
(continued)
Biotechnology
(continued)
a
Novavax
,
Inc.
........................................
United
States
203,218
$
36,443,084
a,b
Olema
Pharmaceuticals,
Inc.
.............................
United
States
154,500
3,627,660
a
PMV
Pharmaceuticals,
Inc.
..............................
United
States
83,100
2,826,231
a
Point
Biopharma
Global,
Inc.
.............................
United
States
429,800
3,524,360
a
Praxis
Precision
Medicines,
Inc.
..........................
United
States
103,600
1,616,160
a,b
Prometheus
Biosciences,
Inc.
............................
United
States
207,500
4,351,275
a
Protara
Therapeutics,
Inc.
...............................
United
States
145,500
1,153,815
a
PTC
Therapeutics,
Inc.
.................................
United
States
799,400
30,641,002
a
Regeneron
Pharmaceuticals,
Inc.
.........................
United
States
138,309
79,473,734
a,b
Reneo
Pharmaceuticals,
Inc.
.............................
United
States
194,700
1,594,593
a
Repare
Therapeutics,
Inc.
...............................
Canada
58,108
1,940,807
a
Rocket
Pharmaceuticals,
Inc.
............................
United
States
375,771
13,460,117
a
Sage
Therapeutics,
Inc.
................................
United
States
101,070
4,419,791
a
Scholar
Rock
Holding
Corp.
.............................
United
States
41,500
1,296,875
a,b
Silverback
Therapeutics,
Inc.
.............................
United
States
109,252
3,308,151
a
Sutro
Biopharma,
Inc.
..................................
United
States
669,974
11,409,657
a
Taysha
Gene
Therapies,
Inc.
.............................
United
States
138,156
2,388,721
a,b
Taysha
Gene
Therapies,
Inc.
.............................
United
States
166,100
2,871,869
a
Trillium
Therapeutics,
Inc.
...............................
Canada
884,024
5,772,677
a
Ultragenyx
Pharmaceutical,
Inc.
..........................
United
States
83,996
6,705,401
a
Vertex
Pharmaceuticals,
Inc.
.............................
United
States
213,133
42,963,350
a,b
VistaGen
Therapeutics,
Inc.
.............................
United
States
3,617,653
9,622,957
a,b
Yumanity
Therapeutics,
Inc.
.............................
United
States
90,804
831,765
a
Zymeworks
,
Inc.
......................................
Canada
471,320
15,124,659
1,040,531,271
Capital
Markets
1.7%
a,c,d
ARYA
Sciences
Acquisition
Corp.
.........................
United
States
415,600
3,258,304
a
ARYA
Sciences
Acquisition
Corp.
IV,
A
......................
United
States
162,200
1,649,574
a
FS
Development
Corp.
II,
A
..............................
United
States
164,600
1,627,894
a
Health
Sciences
Acquisitions
Corp.
2
.......................
United
States
171,600
1,700,556
a
Jiya
Acquisition
Corp.,
A
................................
United
States
208,800
2,037,888
a
Omega
Alpha
SPAC,
A
.................................
United
States
294,400
2,891,008
a
Panacea
Acquisition
Corp.
II,
A
...........................
United
States
195,100
1,942,220
a,c,d,e
Soaring
Eagle
Acquisition
Corp.,
A
.........................
United
States
189,800
1,898,000
a
Social
Capital
Suvretta
Holdings
Corp.
I,
A
...................
United
States
143,000
1,408,550
a
Social
Capital
Suvretta
Holdings
Corp.
II,
A
..................
United
States
143,000
1,409,980
a,b
Social
Capital
Suvretta
Holdings
Corp.
III,
A
..................
United
States
143,000
1,405,690
a
Social
Capital
Suvretta
Holdings
Corp.
IV,
A
..................
United
States
143,000
1,405,690
22,635,354
Life
Sciences
Tools
&
Services
7.4%
a
Alpha
Teknova
,
Inc.
....................................
United
States
89,600
1,990,912
a
Illumina,
Inc.
.........................................
United
States
150,900
74,808,675
a,b
Nautilus
Biotechnology,
Inc.
..............................
United
States
212,500
1,666,000
a,b
Singular
Genomics
Systems,
Inc.
.........................
United
States
181,900
3,283,295
Thermo
Fisher
Scientific,
Inc.
............................
United
States
31,300
16,902,313
98,651,195
Pharmaceuticals
11.4%
a
Angion
Biomedica
Corp.
................................
United
States
256,000
2,721,280
AstraZeneca
plc,
ADR
..................................
United
Kingdom
240,200
13,749,048
a,b
Athira
Pharma,
Inc.
....................................
United
States
779,576
7,491,725
a
EyePoint
Pharmaceuticals,
Inc.
...........................
United
States
836,730
6,877,921
a
Intra-Cellular
Therapies,
Inc.
.............................
United
States
487,600
16,739,308
a
Jazz
Pharmaceuticals
plc
...............................
United
States
222,400
37,701,248
a,b
Marinus
Pharmaceuticals,
Inc.
............................
United
States
149,200
2,193,240
a,b
Nuvation
Bio,
Inc.
.....................................
United
States
345,800
2,987,712
Franklin
Strategic
Series
Statement
of
Investments
(unaudited)
Franklin
Biotechnology
Discovery
Fund
(continued)
Quarterly
Statement
of
Investments
See
Notes
to
Statements
of
Investments.
4
a
a
Country
Shares
a
Value
a
a
a
a
a
a
Common
Stocks
(continued)
Pharmaceuticals
(continued)
a
Pliant
Therapeutics,
Inc.
................................
United
States
149,100
$
3,011,820
a
Reata
Pharmaceuticals,
Inc.,
A
...........................
United
States
215,756
27,036,384
a
Relmada
Therapeutics,
Inc.
..............................
United
States
91,266
2,372,916
a
Revance
Therapeutics,
Inc.
..............................
United
States
275,500
8,011,540
a,b
VYNE
Therapeutics,
Inc.
................................
United
States
720,650
1,945,755
a
Zogenix
,
Inc.
.........................................
United
States
1,144,759
18,556,544
151,396,441
Total
Common
Stocks
(Cost
$865,747,872)
.....................................
1,313,214,261
Preferred
Stocks
0.5%
Biotechnology
0.3%
a,c,d
Amunix
Pharmaceuticals,
Inc.,
B
..........................
United
States
2,333,755
3,349,197
a,c,d
Pipeline
Therapeutics,
Inc.,
C
............................
United
States
779,505
1,504,537
4,853,734
Health
Care
Providers
&
Services
0.2%
a,c,d,f
Artiva
Biotherapeutics
,
Inc.,
B
............................
United
States
189,499
2,084,489
a
Total
Preferred
Stocks
(Cost
$8,298,863)
.......................................
6,938,223
Warrants
Warrants
0.0%
Pharmaceuticals
0.0%
a
Nuvation
Bio,
Inc.,
7/07/27
..............................
United
States
115,266
255,891
Total
Warrants
(Cost
$—)
.....................................................
255,891
Total
Long
Term
Investments
(Cost
$874,046,735)
...............................
1,320,408,375
a
Short
Term
Investments
3.3%
a
a
Country
Shares
a
Value
a
Money
Market
Funds
0.8%
g,h
Institutional
Fiduciary
Trust
-
Money
Market
Portfolio,
0.01%
.....
United
States
10,915,304
10,915,304
Total
Money
Market
Funds
(Cost
$10,915,304)
..................................
10,915,304
a
a
a
a
a
Investments
from
Cash
Collateral
Received
for
Loaned
Securities
2.5%
Money
Market
Funds
2.5%
g,h
Institutional
Fiduciary
Trust
-
Money
Market
Portfolio,
0.01%
.....
United
States
32,629,380
32,629,380
Total
Investments
from
Cash
Collateral
Received
for
Loaned
Securities
(Cost
$32,629,380)
...........................................................
32,629,380
Total
Short
Term
Investments
(Cost
$43,544,684
)
................................
43,544,684
a
Total
Investments
(Cost
$917,591,419)
102.5%
..................................
$1,363,953,059
Other
Assets,
less
Liabilities
(2.5)%
...........................................
(32,563,319)
Net
Assets
100.0%
...........................................................
$1,331,389,740
Franklin
Strategic
Series
Statement
of
Investments
(unaudited)
Franklin
Biotechnology
Discovery
Fund
(continued)
See
Notes
to
Statements
of
Investments.
Quarterly
Statement
of
Investments
5
See
Abbreviations
on
page
79
.
Rounds
to
less
than
0.1%
of
net
assets.
a
Non-income
producing.
b
A
portion
or
all
of
the
security
is
on
loan
at
July
31,
2021.
c
Fair
valued
using
significant
unobservable
inputs.
See
Note
10
regarding
fair
value
measurements.
d
See
Note
7
regarding
restricted
securities.
e
A
portion
or
all
of
the
security
purchased
on
a
delayed
delivery
basis.
f
See
Note
8
regarding
holdings
of
5%
voting
securities.
g
See
Note
9
regarding
investments
in
affiliated
management
investment
companies.
h
The
rate
shown
is
the
annualized
seven-day
effective
yield
at
period
end.
Franklin
Strategic
Series
Statement
of
Investments
(unaudited),
July
31,
2021
Franklin
Growth
Opportunities
Fund
Quarterly
Statement
of
Investments
See
Notes
to
Statements
of
Investments.
6
a
a
Country
Shares
a
Value
a
a
a
a
a
a
Common
Stocks
96.6%
Airlines
0.7%
a,b,c
Wheels
Up
Experience,
Inc.
.............................
Singapore
3,500,000
$
28,000,000
a,b,c,d
Wheels
Up
Experience,
Inc.,
A
...........................
Singapore
2,315,191
16,305,393
44,305,393
Auto
Components
0.5%
b
Aptiv
plc
............................................
United
States
193,320
32,255,442
Automobiles
0.8%
b
Tesla,
Inc.
...........................................
United
States
70,993
48,786,390
Beverages
1.1%
Constellation
Brands,
Inc.,
A
.............................
United
States
163,151
36,601,295
b
Monster
Beverage
Corp.
................................
United
States
331,280
31,246,330
67,847,625
Biotechnology
1.4%
b
Heron
Therapeutics,
Inc.
................................
United
States
2,090,035
25,832,833
b
Iovance
Biotherapeutics,
Inc.
.............................
United
States
268,504
5,979,584
b
Novavax,
Inc.
........................................
United
States
197,463
35,411,040
b
PTC
Therapeutics,
Inc.
.................................
United
States
466,661
17,887,116
85,110,573
Capital
Markets
5.8%
b
Dragoneer
Growth
Opportunities
Corp.
.....................
United
States
1,112,700
10,615,158
a,b,d
Dragoneer
Growth
Opportunities
Corp.
II
....................
United
States
416,700
3,852,684
Intercontinental
Exchange,
Inc.
...........................
United
States
249,025
29,840,666
a,b,d,e
Lucid
Group,
Inc.
.....................................
United
States
2,167,003
46,426,867
MarketAxess
Holdings,
Inc.
..............................
United
States
59,706
28,370,500
MSCI,
Inc.
...........................................
United
States
199,360
118,810,586
S&P
Global,
Inc.
......................................
United
States
195,666
83,885,927
b
Soaring
Eagle
Acquisition
Corp.
..........................
United
States
1,160,400
11,940,516
a,b,d,e
Soaring
Eagle
Acquisition
Corp.,
A
.........................
United
States
1,500,000
15,000,000
b
TPG
Pace
Beneficial
II
Corp.,
A
...........................
United
States
662,600
6,519,984
355,262,888
Chemicals
1.2%
Ecolab,
Inc.
..........................................
United
States
126,472
27,928,812
Linde
plc
............................................
United
Kingdom
156,944
48,243,016
76,171,828
Commercial
Services
&
Supplies
0.4%
a,b,d
Celonis
SE
..........................................
Germany
16,669
6,164,029
Republic
Services,
Inc.
.................................
United
States
158,671
18,780,300
24,944,329
Consumer
Finance
0.4%
b,f
SoFi
Technologies,
Inc.
.................................
United
States
1,385,827
21,397,169
Electric
Utilities
0.4%
NextEra
Energy,
Inc.
...................................
United
States
336,418
26,206,962
Entertainment
1.0%
b
Sea
Ltd.,
ADR
........................................
Taiwan
109,742
30,306,351
b
Walt
Disney
Co.
(The)
..................................
United
States
191,533
33,713,638
64,019,989
Equity
Real
Estate
Investment
Trusts
(REITs)
2.5%
American
Tower
Corp.
..................................
United
States
82,664
23,377,379
Franklin
Strategic
Series
Statement
of
Investments
(unaudited)
Franklin
Growth
Opportunities
Fund
(continued)
See
Notes
to
Statements
of
Investments.
Quarterly
Statement
of
Investments
7
a
a
Country
Shares
a
Value
a
a
a
a
a
a
Common
Stocks
(continued)
Equity
Real
Estate
Investment
Trusts
(REITs)
(continued)
SBA
Communications
Corp.
.............................
United
States
377,164
$
128,609,153
151,986,532
Food
Products
1.1%
b
Freshpet,
Inc.
........................................
United
States
207,987
30,459,696
Lamb
Weston
Holdings,
Inc.
.............................
United
States
359,009
23,971,031
b
Nomad
Foods
Ltd.
....................................
United
Kingdom
606,792
15,849,407
70,280,134
Health
Care
Equipment
&
Supplies
9.0%
Danaher
Corp.
.......................................
United
States
305,906
91,003,976
b
Edwards
Lifesciences
Corp.
.............................
United
States
556,359
62,462,425
a,b,d
Figs,
Inc.
............................................
United
States
2,077,218
72,352,101
b,f
Figs,
Inc.,
A
..........................................
United
States
589,100
21,443,240
b
IDEXX
Laboratories,
Inc.
................................
United
States
98,571
66,883,381
b
Intuitive
Surgical,
Inc.
..................................
United
States
81,180
80,486,723
b
Nevro
Corp.
.........................................
United
States
258,917
40,132,135
West
Pharmaceutical
Services,
Inc.
........................
United
States
297,356
122,430,386
557,194,367
Health
Care
Providers
&
Services
1.9%
b
Guardant
Health,
Inc.
..................................
United
States
170,094
18,676,321
UnitedHealth
Group,
Inc.
................................
United
States
240,563
99,164,880
117,841,201
Health
Care
Technology
2.0%
b
Veeva
Systems,
Inc.,
A
.................................
United
States
366,940
122,084,607
Hotels,
Restaurants
&
Leisure
1.6%
b
Chipotle
Mexican
Grill,
Inc.
..............................
United
States
42,937
80,010,523
Starbucks
Corp.
......................................
United
States
133,795
16,246,727
96,257,250
Industrial
Conglomerates
1.5%
Honeywell
International,
Inc.
.............................
United
States
161,234
37,694,897
Roper
Technologies,
Inc.
................................
United
States
113,478
55,756,280
93,451,177
Interactive
Media
&
Services
4.2%
b
Alphabet,
Inc.,
C
......................................
United
States
65,168
176,241,643
b,f
Bumble,
Inc.,
A
.......................................
United
States
280,959
14,295,194
b
Facebook,
Inc.,
A
.....................................
United
States
142,781
50,872,870
b
ZoomInfo
Technologies,
Inc.,
A
...........................
United
States
302,278
16,247,442
257,657,149
Internet
&
Direct
Marketing
Retail
7.7%
b
Amazon.com,
Inc.
.....................................
United
States
138,179
459,803,059
b,f
Coupang,
Inc.
........................................
South
Korea
452,500
16,434,800
476,237,859
IT
Services
13.5%
b,f
Dlocal
Ltd.
..........................................
Uruguay
299,049
13,499,072
a,b,d
Marqeta,
Inc.
.........................................
United
States
1,396,875
36,110,134
b,f
Marqeta,
Inc.,
A
.......................................
United
States
218,900
5,873,087
Mastercard,
Inc.,
A
....................................
United
States
634,990
245,068,041
b
Okta,
Inc.
...........................................
United
States
96,161
23,827,734
b
Paymentus
Holdings,
Inc.,
A
.............................
United
States
102,000
2,958,000
Franklin
Strategic
Series
Statement
of
Investments
(unaudited)
Franklin
Growth
Opportunities
Fund
(continued)
Quarterly
Statement
of
Investments
See
Notes
to
Statements
of
Investments.
8
a
a
Country
Shares
a
Value
a
a
a
a
a
a
Common
Stocks
(continued)
IT
Services
(continued)
b
PayPal
Holdings,
Inc.
..................................
United
States
439,575
$
121,116,100
b
Shopify,
Inc.,
A
.......................................
Canada
50,064
75,092,495
b
Snowflake,
Inc.,
A
.....................................
United
States
61,992
16,472,514
b
Twilio,
Inc.,
A
.........................................
United
States
279,542
104,434,096
Visa,
Inc.,
A
..........................................
United
States
761,041
187,512,892
831,964,165
Life
Sciences
Tools
&
Services
1.3%
b
Illumina,
Inc.
.........................................
United
States
69,033
34,223,110
b
Maravai
LifeSciences
Holdings,
Inc.,
A
.....................
United
States
131,900
5,799,643
b,g
Wuxi
Biologics
Cayman,
Inc.,
144A,
Reg
S
..................
China
2,794,182
42,678,781
82,701,534
Machinery
0.7%
a,b,d
Proterra,
Inc.
.........................................
United
States
3,595,577
35,255,331
b,f
Proterra,
Inc.
.........................................
United
States
579,458
6,391,422
a,b
Proterra,
Inc.
.........................................
United
States
127,451
41,646,753
Media
0.5%
b
Liberty
Broadband
Corp.,
C
..............................
United
States
182,900
32,462,921
Pharmaceuticals
1.3%
AstraZeneca
plc,
ADR
..................................
United
Kingdom
604,858
34,622,072
b
Catalent,
Inc.
........................................
United
States
271,018
32,470,666
b
Reata
Pharmaceuticals,
Inc.,
A
...........................
United
States
114,500
14,347,995
81,440,733
Professional
Services
3.6%
b
CoStar
Group,
Inc.
....................................
United
States
1,324,948
117,721,630
a,b,d
Legalzoom.com,
Inc.
...................................
United
States
1,673,284
58,905,940
b
Legalzoom.com,
Inc.
...................................
United
States
8,700
319,986
TransUnion
..........................................
United
States
363,075
43,590,784
220,538,340
Road
&
Rail
0.9%
Union
Pacific
Corp.
....................................
United
States
243,411
53,248,590
Semiconductors
&
Semiconductor
Equipment
4.4%
b
Alphawave
IP
Group
plc
................................
United
Kingdom
585,000
3,466,772
Analog
Devices,
Inc.
...................................
United
States
250,576
41,951,434
Monolithic
Power
Systems,
Inc.
...........................
United
States
170,285
76,502,239
NVIDIA
Corp.
........................................
United
States
751,120
146,460,889
268,381,334
Software
19.2%
b
Adobe,
Inc.
..........................................
United
States
202,780
126,054,131
b,f
AppLovin
Corp.,
A
.....................................
United
States
256,004
15,736,566
b
Atlassian
Corp.
plc,
A
..................................
United
States
80,156
26,060,319
b
Avalara,
Inc.
.........................................
United
States
38,000
6,352,460
a,b,c,d
Avidxchange,
Inc.
.....................................
United
States
255,039
15,627,737
b
Bill.com
Holdings,
Inc.
..................................
United
States
560,964
116,018,574
b
Black
Knight,
Inc.
.....................................
United
States
360,298
29,836,277
a,b,d
Confluent,
Inc.
.......................................
United
States
642,459
24,249,400
b,f
Confluent,
Inc.,
A
......................................
United
States
121,900
4,777,261
b
Crowdstrike
Holdings,
Inc.,
A
.............................
United
States
58,503
14,836,946
b
DocuSign,
Inc.
.......................................
United
States
165,414
49,299,989
Intuit,
Inc.
...........................................
United
States
151,480
80,279,856
Franklin
Strategic
Series
Statement
of
Investments
(unaudited)
Franklin
Growth
Opportunities
Fund
(continued)
See
Notes
to
Statements
of
Investments.
Quarterly
Statement
of
Investments
9
a
a
Country
Shares
a
Value
a
a
a
a
a
a
Common
Stocks
(continued)
Software
(continued)
Microsoft
Corp.
.......................................
United
States
870,656
$
248,058,601
b
Paycom
Software,
Inc.
.................................
United
States
66,255
26,502,000
b,f
Procore
Technologies,
Inc.
..............................
United
States
162,383
16,770,916
b
PTC,
Inc.
...........................................
United
States
278,539
37,728,107
b
salesforce.com,
Inc.
...................................
United
States
200,696
48,554,383
b
ServiceNow,
Inc.
......................................
United
States
268,410
157,795,555
b,f
Sprinklr,
Inc.,
A
.......................................
United
States
256,700
4,964,578
b
Synopsys,
Inc.
.......................................
United
States
171,819
49,482,154
b
Tyler
Technologies,
Inc.
.................................
United
States
64,331
31,692,024
b
Workday,
Inc.,
A
......................................
United
States
127,073
29,785,911
b
Zendesk,
Inc.
........................................
United
States
185,645
24,232,242
1,184,695,987
Specialty
Retail
0.3%
b
Burlington
Stores,
Inc.
..................................
United
States
51,461
17,229,143
Technology
Hardware,
Storage
&
Peripherals
3.8%
Apple,
Inc.
..........................................
United
States
1,619,864
236,273,363
Textiles,
Apparel
&
Luxury
Goods
1.1%
NIKE,
Inc.,
B
.........................................
United
States
401,518
67,258,280
Wireless
Telecommunication
Services
0.8%
b
T-Mobile
US,
Inc.
.....................................
United
States
338,813
48,795,848
Total
Common
Stocks
(Cost
$2,019,713,284)
....................................
5,955,935,855
Convertible
Preferred
Stocks
1.0%
Internet
&
Direct
Marketing
Retail
0.4%
a,b,d
Fanatics,
Inc.,
E
......................................
United
States
920,577
25,425,038
a,b,d
Fanatics,
Inc.,
F
......................................
United
States
109,362
3,814,966
29,240,004
Software
0.6%
a,b,d
Databricks,
Inc.,
G
....................................
United
States
112,760
24,846,328
a,b,d
OneTrust
LLC,
C
......................................
United
States
517,056
11,406,255
36,252,583
Total
Convertible
Preferred
Stocks
(Cost
$49,869,857)
...........................
65,492,587
Preferred
Stocks
2.5%
Commercial
Services
&
Supplies
0.2%
a,b,c,d
Optoro,
Inc.,
E
.......................................
United
States
509,182
12,978,872
b
Food
&
Staples
Retailing
0.3%
a,b,d
Sweetgreen,
Inc.,
H
...................................
United
States
928,488
14,560,423
a,b,d
Sweetgreen,
Inc.,
I
....................................
United
States
100,835
1,772,862
a,b,d
Sweetgreen,
Inc.,
J
....................................
United
States
76,670
1,347,997
17,681,282
Health
Care
Providers
&
Services
0.5%
a,b,c,d
Tempus
Labs,
Inc.,
F
...................................
United
States
504,854
25,604,215
a,b,c,d
Tempus
Labs,
Inc.,
G
..................................
United
States
126,131
6,413,412
32,017,627
IT
Services
0.4%
a,b,c,d
HashiCorp,
Inc.,
E
.....................................
United
States
415,102
22,111,823
b
Franklin
Strategic
Series
Statement
of
Investments
(unaudited)
Franklin
Growth
Opportunities
Fund
(continued)
Quarterly
Statement
of
Investments
See
Notes
to
Statements
of
Investments.
10
a
a
Country
Shares
a
Value
a
a
a
a
a
a
Preferred
Stocks
(continued)
Software
1.1%
a,b,c,d
ClearMotion,
Inc.,
C
...................................
United
States
2,610,594
$
8,281,031
a,b,c,d
ClearMotion,
Inc.,
D
...................................
United
States
3,698,772
12,293,635
a,b,d
Gitlab,
Inc.,
E
........................................
United
States
201,294
8,958,943
a,b,c,d
Talkdesk,
Inc.,
C
......................................
United
States
1,753,060
29,444,829
a,b,d
Tanium,
Inc.,
G
.......................................
United
States
805,800
8,815,248
67,793,686
Total
Preferred
Stocks
(Cost
$89,273,916)
......................................
152,583,290
Warrants
Warrants
0.0%
Food
&
Staples
Retailing
0.0%
a,b,d
Sweetgreen,
Inc.,
1/20/26
...............................
United
States
23,001
22,165
Total
Warrants
(Cost
$—)
.....................................................
22,165
Shares
Escrows
and
Litigation
Trusts
0.0%
a,b
Proterra,
Inc.,
Escrow
Account
...........................
United
States
127,452
a,b
Proterra,
Inc.,
Escrow
Account
...........................
United
States
127,452
a,b,c
Wheels
Up
Experience,
Inc.,
Escrow
Account
................
Singapore
34,260
a,b,c
Wheels
Up
Experience,
Inc.,
Escrow
Account
................
Singapore
34,260
a,b,c
Wheels
Up
Experience,
Inc.,
Escrow
Account
................
Singapore
34,260
Total
Escrows
and
Litigation
Trusts
(Cost
$–)
...................................
Total
Long
Term
Investments
(Cost
$2,158,857,057)
.............................
6,174,033,897
a
Short
Term
Investments
1.6%
a
a
Country
Shares
a
Value
a
Money
Market
Funds
0.2%
h,i
Institutional
Fiduciary
Trust
-
Money
Market
Portfolio,
0.01%
.....
United
States
13,591,131
13,591,131
Total
Money
Market
Funds
(Cost
$13,591,131)
..................................
13,591,131
a
a
a
a
a
Investments
from
Cash
Collateral
Received
for
Loaned
Securities
1.4%
Money
Market
Funds
1.4%
h,i
Institutional
Fiduciary
Trust
-
Money
Market
Portfolio,
0.01%
.....
United
States
82,534,897
82,534,897
Total
Investments
from
Cash
Collateral
Received
for
Loaned
Securities
(Cost
$82,534,897)
...........................................................
82,534,897
Total
Short
Term
Investments
(Cost
$96,126,028
)
................................
96,126,028
a
Total
Investments
(Cost
$2,254,983,085)
101.7%
................................
$6,270,159,925
Other
Assets,
less
Liabilities
(1.7)%
...........................................
(102,643,314)
Net
Assets
100.0%
...........................................................
$6,167,516,611
Franklin
Strategic
Series
Statement
of
Investments
(unaudited)
Franklin
Growth
Opportunities
Fund
(continued)
See
Notes
to
Statements
of
Investments.
Quarterly
Statement
of
Investments
11
See
Abbreviations
on
page
79
.
Rounds
to
less
than
0.1%
of
net
assets.
a
Fair
valued
using
significant
unobservable
inputs.
See
Note
10
regarding
fair
value
measurements.
b
Non-income
producing.
c
See
Note
8
regarding
holdings
of
5%
voting
securities.
d
See
Note
7
regarding
restricted
securities.
e
A
portion
or
all
of
the
security
purchased
on
a
delayed
delivery
basis.
f
A
portion
or
all
of
the
security
is
on
loan
at
July
31,
2021.
g
Security
was
purchased
pursuant
to
Rule
144A
or
Regulation
S
under
the
Securities
Act
of
1933.
144A
securities
may
be
sold
in
transactions
exempt
from
registration
only
to
qualified
institutional
buyers
or
in
a
public
offering
registered
under
the
Securities
Act
of
1933.
Regulation
S
securities
cannot
be
sold
in
the
United
States
without
either
an
effective
registration
statement
filed
pursuant
to
the
Securities
Act
of
1933,
or
pursuant
to
an
exemption
from
registration.
At
July
31,
2021,
the
aggregate
value
of
these
securities
was
$42,678,781,
representing
0.7%
of
net
assets.
h
See
Note
9
regarding
investments
in
affiliated
management
investment
companies.
i
The
rate
shown
is
the
annualized
seven-day
effective
yield
at
period
end.
Franklin
Strategic
Series
Statement
of
Investments
(unaudited),
July
31,
2021
Franklin
Natural
Resources
Fund
Quarterly
Statement
of
Investments
See
Notes
to
Statements
of
Investments.
12
a
a
Country
Shares
a
Value
a
Common
Stocks
98.9%
Agricultural
Products
0.9%
Bunge
Ltd.
..........................................
United
States
15,700
$
1,218,791
a
Darling
Ingredients,
Inc.
................................
United
States
15,000
1,036,050
2,254,841
Construction
Machinery
&
Heavy
Trucks
0.4%
a,b
Proterra
,
Inc.
.........................................
United
States
72,700
801,881
a
Proterra
,
Inc.
.........................................
United
States
18,500
204,055
1,005,936
Construction
Materials
1.1%
Martin
Marietta
Materials,
Inc.
............................
United
States
7,400
2,688,420
Consumer
Finance
0.2%
a,c,d
Sunlight
Financial
Holdings,
Inc.,
A
........................
United
States
74,343
610,356
a
Copper
6.4%
Antofagasta
plc
.......................................
Chile
108,900
2,260,792
a
ERO
Copper
Corp.
....................................
Canada
92,400
1,859,106
First
Quantum
Minerals
Ltd.
.............................
Zambia
147,800
3,164,436
Freeport-McMoRan,
Inc.
................................
United
States
157,600
6,004,560
a
Imperial
Metals
Corp.
..................................
Canada
122,760
465,268
Lundin
Mining
Corp.
...................................
Chile
259,300
2,362,373
16,116,535
Diversified
Chemicals
0.8%
Huntsman
Corp.
......................................
United
States
77,000
2,033,570
Diversified
Metals
&
Mining
6.7%
a
29Metals
Ltd.
........................................
Australia
1,091,100
1,825,480
Anglo
American
plc
....................................
South
Africa
102,600
4,545,960
BHP
Group
plc,
ADR
...................................
Australia
80,000
5,223,200
a
Glencore
plc
.........................................
Australia
364,400
1,636,339
Rio
Tinto
plc,
ADR
.....................................
Australia
27,500
2,373,525
Teck
Resources
Ltd.,
B
.................................
Canada
69,100
1,578,244
17,182,748
Electrical
Components
&
Equipment
0.5%
a
Shoals
Technologies
Group,
Inc.,
A
........................
United
States
44,100
1,282,869
a
Environmental
&
Facilities
Services
1.0%
a,c,d,e
Li-Cycle
Holdings
Corp.
.................................
Canada
173,800
1,738,000
a
US
Ecology,
Inc.
......................................
United
States
23,700
829,500
2,567,500
Fertilizers
&
Agricultural
Chemicals
1.4%
Corteva
,
Inc.
.........................................
United
States
44,000
1,882,320
Nutrien
Ltd.
..........................................
Canada
30,500
1,811,700
3,694,020
Food
Distributors
0.6%
a
Performance
Food
Group
Co.
............................
United
States
33,300
1,525,806
a
Gold
8.6%
Agnico
Eagle
Mines
Ltd.
................................
Canada
35,600
2,302,304
Alamos
Gold,
Inc.,
A
...................................
Canada
270,000
2,193,750
B2Gold
Corp.
........................................
Canada
330,800
1,386,285
Barrick
Gold
Corp.
....................................
Canada
280,791
6,112,820
Newcrest
Mining
Ltd.
...................................
Australia
26,800
517,943
Newmont
Corp.
.......................................
United
States
111,015
6,973,962
Franklin
Strategic
Series
Statement
of
Investments
(unaudited)
Franklin
Natural
Resources
Fund
(continued)
See
Notes
to
Statements
of
Investments.
Quarterly
Statement
of
Investments
13
a
a
Country
Shares
a
Value
a
Common
Stocks
(continued)
Gold
(continued)
SSR
Mining,
Inc.
......................................
Canada
131,400
$
2,136,564
21,623,628
Heavy
Electrical
Equipment
0.5%
a
TPI
Composites,
Inc.
...................................
United
States
33,400
1,307,276
a
Industrial
Gases
2.9%
Air
Products
and
Chemicals,
Inc.
..........................
United
States
11,900
3,463,257
Linde
plc
............................................
United
Kingdom
12,200
3,750,158
7,213,415
Integrated
Oil
&
Gas
15.8%
Chevron
Corp.
.......................................
United
States
103,800
10,567,878
Exxon
Mobil
Corp.
.....................................
United
States
150,800
8,681,556
Occidental
Petroleum
Corp.
.............................
United
States
117,200
3,058,920
Royal
Dutch
Shell
plc,
ADR,
A
............................
Netherlands
128,621
5,224,585
Suncor
Energy,
Inc.
....................................
Canada
359,500
7,074,776
TotalEnergies
SE,
ADR
.................................
France
120,310
5,249,125
39,856,840
Investment
Banking
&
Brokerage
2.3%
a,c,d
Alussa
Energy
Acquisition
Corp.
..........................
United
States
138,200
1,228,598
a,c,d,e
Ivanhoe
Capital
Acquisition
Corp.,
A
.......................
Singapore
150,000
1,500,000
a,c,d,e
Lucid
Group,
Inc.
.....................................
United
States
141,414
3,029,718
5,758,316
Metal
&
Glass
Containers
0.9%
Ball
Corp.
...........................................
United
States
16,700
1,350,696
Crown
Holdings,
Inc.
...................................
United
States
9,500
947,720
2,298,416
Oil
&
Gas
Drilling
1.0%
Helmerich
&
Payne,
Inc.
................................
United
States
40,600
1,164,002
Patterson-UTI
Energy,
Inc.
..............................
United
States
141,800
1,137,236
2,301,238
Oil
&
Gas
Equipment
&
Services
9.3%
Baker
Hughes
Co.
.....................................
United
States
163,300
3,468,492
Cactus,
Inc.,
A
........................................
United
States
29,100
1,048,764
a
ChampionX
Corp.
.....................................
United
States
78,500
1,824,340
Halliburton
Co.
.......................................
United
States
136,635
2,825,612
a
Liberty
Oilfield
Services,
Inc.,
A
...........................
United
States
83,600
851,884
a
NexTier
Oilfield
Solutions,
Inc.
............................
United
States
251,322
960,050
a
Nine
Energy
Service,
Inc.
...............................
United
States
277,692
730,330
a
Oceaneering
International,
Inc.
...........................
United
States
77,900
1,032,954
a
Oil
States
International,
Inc.
.............................
United
States
101,966
577,127
a
Ranger
Energy
Services,
Inc.
............................
United
States
169,957
1,368,154
Schlumberger
NV
.....................................
United
States
160,547
4,628,570
a
Schoeller-Bleckmann
Oilfield
Equipment
AG
.................
Austria
30,200
1,101,474
a
Select
Energy
Services,
Inc.,
A
...........................
United
States
193,119
1,149,058
a,b
Technip
Energies
NV
...................................
France
40,899
554,324
a
TechnipFMC
plc
......................................
United
Kingdom
228,300
1,648,326
23,769,459
Oil
&
Gas
Exploration
&
Production
21.7%
Aker
BP
ASA
.........................................
Norway
75,500
2,033,777
Cabot
Oil
&
Gas
Corp.
.................................
United
States
429,016
6,864,256
Cairn
Energy
plc
......................................
United
Kingdom
592,328
1,050,105
Franklin
Strategic
Series
Statement
of
Investments
(unaudited)
Franklin
Natural
Resources
Fund
(continued)
Quarterly
Statement
of
Investments
See
Notes
to
Statements
of
Investments.
14
a
a
Country
Shares
a
Value
a
Common
Stocks
(continued)
Oil
&
Gas
Exploration
&
Production
(continued)
Canadian
Natural
Resources
Ltd.
.........................
Canada
176,200
$
5,812,623
ConocoPhillips
.......................................
United
States
190,891
10,701,350
Devon
Energy
Corp.
...................................
United
States
343,282
8,870,407
EOG
Resources,
Inc.
..................................
United
States
104,900
7,643,014
a
EQT
Corp.
..........................................
United
States
108,500
1,995,315
Hess
Corp.
..........................................
United
States
52,100
3,982,524
Pioneer
Natural
Resources
Co.
...........................
United
States
42,101
6,120,222
55,073,593
Oil
&
Gas
Refining
&
Marketing
5.8%
Marathon
Petroleum
Corp.
..............................
United
States
97,800
5,400,516
New
Fortress
Energy,
Inc.
...............................
United
States
18,100
548,611
Phillips
66
...........................................
United
States
62,900
4,618,747
Valero
Energy
Corp.
...................................
United
States
61,900
4,145,443
14,713,317
Oil
&
Gas
Storage
&
Transportation
6.9%
Enbridge,
Inc.
........................................
Canada
69,647
2,740,609
Kinder
Morgan,
Inc.
....................................
United
States
98,100
1,704,978
Targa
Resources
Corp.
.................................
United
States
59,300
2,497,123
TC
Energy
Corp.
......................................
Canada
106,300
5,179,999
Williams
Cos.,
Inc.
(The)
................................
United
States
197,400
4,944,870
17,067,579
Paper
Packaging
0.4%
Packaging
Corp.
of
America
.............................
United
States
7,200
1,018,800
Semiconductor
Equipment
0.4%
a
SolarEdge
Technologies,
Inc.
............................
United
States
3,500
908,180
a
Steel
1.4%
Vale
SA,
ADR
........................................
Brazil
168,500
3,541,870
Trading
Companies
&
Distributors
1.0%
a
Univar
Solutions,
Inc.
..................................
United
States
101,600
2,493,264
a
Total
Common
Stocks
(Cost
$186,809,688)
.....................................
249,907,792
Warrants
a
a
a
a
a
Warrants
0.1%
Integrated
Oil
&
Gas
0.1%
a
Occidental
Petroleum
Corp.
,
8/03/27
.......................
United
States
17,900
192,067
Total
Warrants
(Cost
$88,605)
.................................................
192,067
Principal
Amount
*
Convertible
Bonds
0.4%
Oil
&
Gas
Equipment
&
Services
0.4%
f
Oil
States
International,
Inc.,
Senior
Note,
144A,
4.75%,
4/01/26
..
United
States
1,200,000
1,124,740
Total
Convertible
Bonds
(Cost
$1,200,000)
.....................................
1,124,740
Total
Long
Term
Investments
(Cost
$188,098,293)
...............................
251,224,599
a
Franklin
Strategic
Series
Statement
of
Investments
(unaudited)
Franklin
Natural
Resources
Fund
(continued)
See
Notes
to
Statements
of
Investments.
Quarterly
Statement
of
Investments
15
See
Abbreviations
on
page
79
.
Short
Term
Investments
2.2%
a
a
Country
Shares
a
Value
a
a
a
a
a
a
Money
Market
Funds
1.7%
g,h
Institutional
Fiduciary
Trust
-
Money
Market
Portfolio,
0.01%
.....
United
States
4,258,471
$
4,258,471
Total
Money
Market
Funds
(Cost
$4,258,471)
...................................
4,258,471
Investments
from
Cash
Collateral
Received
for
Loaned
Securities
0.5%
Money
Market
Funds
0.5%
g,h
Institutional
Fiduciary
Trust
-
Money
Market
Portfolio,
0.01%
.....
United
States
1,327,229
1,327,229
Total
Investments
from
Cash
Collateral
Received
for
Loaned
Securities
(Cost
$1,327,229)
.................................................................
1,327,229
Total
Short
Term
Investments
(Cost
$5,585,700
)
.................................
5,585,700
a
Total
Investments
(Cost
$193,683,993)
101.6%
..................................
$256,810,299
Other
Assets,
less
Liabilities
(1.6)%
...........................................
(4,183,615)
Net
Assets
100.0%
...........................................................
$252,626,684
*
The
principal
amount
is
stated
in
U.S.
dollars
unless
otherwise
indicated.
a
Non-income
producing.
b
A
portion
or
all
of
the
security
is
on
loan
at
July
31,
2021.
c
Fair
valued
using
significant
unobservable
inputs.
See
Note
10
regarding
fair
value
measurements.
d
See
Note
7
regarding
restricted
securities.
e
A
portion
or
all
of
the
security
purchased
on
a
delayed
delivery
basis.
f
Security
was
purchased
pursuant
to
Rule
144A
or
Regulation
S
under
the
Securities
Act
of
1933.
144A
securities
may
be
sold
in
transactions
exempt
from
registration
only
to
qualified
institutional
buyers
or
in
a
public
offering
registered
under
the
Securities
Act
of
1933.
Regulation
S
securities
cannot
be
sold
in
the
United
States
without
either
an
effective
registration
statement
filed
pursuant
to
the
Securities
Act
of
1933,
or
pursuant
to
an
exemption
from
registration.
At
July
31,
2021,
the
value
of
this
security
was
$1,124,740,
representing
0.4%
of
net
assets.
g
See
Note
9
regarding
investments
in
affiliated
management
investment
companies.
h
The
rate
shown
is
the
annualized
seven-day
effective
yield
at
period
end.
Franklin
Strategic
Series
Statement
of
Investments
(unaudited),
July
31,
2021
Franklin
Small
Cap
Growth
Fund
Quarterly
Statement
of
Investments
See
Notes
to
Statements
of
Investments.
16
a
a
Country
Shares
a
Value
a
a
a
a
a
a
Common
Stocks
94.9%
Aerospace
&
Defense
2.5%
a
Axon
Enterprise,
Inc.
...................................
United
States
82,100
$
15,272,242
BWX
Technologies,
Inc.
................................
United
States
800,600
45,978,458
a
Kratos
Defense
&
Security
Solutions,
Inc.
...................
United
States
587,564
15,981,741
a
Mercury
Systems,
Inc.
..................................
United
States
401,116
26,473,656
103,706,097
Airlines
2.3%
a
Allegiant
Travel
Co.
....................................
United
States
337,748
64,212,650
a,b,c
Wheels
Up
Experience,
Inc.
.............................
Singapore
2,000,000
16,000,000
a,b,c,d
Wheels
Up
Experience,
Inc.,
A
...........................
Singapore
1,984,450
13,976,052
94,188,702
Banks
2.7%
Pinnacle
Financial
Partners,
Inc.
..........................
United
States
659,804
59,125,036
Western
Alliance
Bancorp
...............................
United
States
569,500
52,860,990
111,986,026
Biotechnology
9.5%
a
Alector
,
Inc.
..........................................
United
States
773,200
18,583,862
a
Arcutis
Biotherapeutics
,
Inc.
.............................
United
States
226,300
5,279,579
a
Ascendis
Pharma
A/S,
ADR
.............................
Denmark
178,900
21,144,191
a
Blueprint
Medicines
Corp.
...............................
United
States
203,800
17,907,906
a
Centessa
Pharmaceuticals
plc,
ADR
.......................
United
States
349,300
7,209,552
a,e
Cullinan
Oncology,
Inc.
.................................
United
States
422,200
9,681,046
a
Cytokinetics,
Inc.
......................................
United
States
268,300
7,963,144
a,e
Day
One
Biopharmaceuticals,
Inc.
.........................
United
States
385,922
9,154,070
a
Deciphera
Pharmaceuticals,
Inc.
..........................
United
States
598,200
18,239,118
a
Dyne
Therapeutics,
Inc.
................................
United
States
508,100
9,181,367
a
Global
Blood
Therapeutics,
Inc.
...........................
United
States
551,300
15,067,029
a
Harpoon
Therapeutics,
Inc.
..............................
United
States
493,300
4,829,407
a
Heron
Therapeutics,
Inc.
................................
United
States
1,775,508
21,945,279
a
Insmed
,
Inc.
.........................................
United
States
937,300
23,057,580
a
Intellia
Therapeutics,
Inc.
................................
United
States
174,000
24,681,900
a
Iovance
Biotherapeutics
,
Inc.
.............................
United
States
1,165,300
25,951,231
a
KalVista
Pharmaceuticals,
Inc.
...........................
United
States
448,700
9,036,818
a
Karuna
Therapeutics,
Inc.
...............................
United
States
88,900
10,154,158
a
Kura
Oncology,
Inc.
....................................
United
States
564,700
10,695,418
a
Mirati
Therapeutics,
Inc.
................................
United
States
212,600
34,028,756
a
PTC
Therapeutics,
Inc.
.................................
United
States
973,400
37,310,422
a
Rocket
Pharmaceuticals,
Inc.
............................
United
States
319,000
11,426,580
a
Sutro
Biopharma,
Inc.
..................................
United
States
956,549
16,290,029
a,e
Taysha
Gene
Therapies,
Inc.
.............................
United
States
457,800
7,915,362
a
Trillium
Therapeutics,
Inc.
...............................
Canada
717,900
4,687,887
a
Twist
Bioscience
Corp.
.................................
United
States
118,362
14,564,444
395,986,135
Building
Products
0.9%
a
Masonite
International
Corp.
.............................
United
States
344,200
38,949,672
Capital
Markets
4.1%
Ares
Management
Corp.
................................
United
States
120,900
8,657,649
Artisan
Partners
Asset
Management,
Inc.,
A
.................
United
States
266,772
12,829,065
a,c
Bridge
Investment
Group
Holdings,
Inc.,
A
...................
United
States
1,501,000
23,655,760
Evercore
,
Inc.,
A
......................................
United
States
301,000
39,792,200
Houlihan
Lokey
,
Inc.
...................................
United
States
545,000
48,559,500
a,b,c,d
TPG
Pace
Governance
LLC,
A
...........................
United
States
2,500,000
25,000,000
Franklin
Strategic
Series
Statement
of
Investments
(unaudited)
Franklin
Small
Cap
Growth
Fund
(continued)
See
Notes
to
Statements
of
Investments.
Quarterly
Statement
of
Investments
17
a
a
Country
Shares
a
Value
a
a
a
a
a
a
Common
Stocks
(continued)
Capital
Markets
(continued)
a
TPG
Pace
Solutions
Corp.
..............................
United
States
1,230,000
$
12,213,900
170,708,074
Commercial
Services
&
Supplies
0.7%
Healthcare
Services
Group,
Inc.
..........................
United
States
131,819
3,440,476
a
US
Ecology,
Inc.
......................................
United
States
729,376
25,528,160
28,968,636
Communications
Equipment
1.9%
a
Viasat
,
Inc.
..........................................
United
States
807,612
40,089,860
a
Viavi
Solutions,
Inc.
....................................
United
States
2,253,900
37,617,591
77,707,451
Construction
&
Engineering
2.0%
Arcosa
,
Inc.
.........................................
United
States
903,800
49,492,088
Granite
Construction,
Inc.
...............................
United
States
875,643
33,642,204
83,134,292
Consumer
Finance
0.3%
a
PRA
Group,
Inc.
......................................
United
States
159,339
6,180,760
a,b,d
Sunlight
Financial
Holdings,
Inc.,
A
........................
United
States
714,286
5,864,288
12,045,048
Diversified
Consumer
Services
1.0%
a
Duolingo
,
Inc.
........................................
United
States
9,400
1,318,350
a
Grand
Canyon
Education,
Inc.
............................
United
States
460,600
42,545,622
43,863,972
Electronic
Equipment,
Instruments
&
Components
0.8%
Vontier
Corp.
.........................................
United
States
1,077,800
34,866,830
Equity
Real
Estate
Investment
Trusts
(REITs)
1.9%
Pebblebrook
Hotel
Trust
................................
United
States
1,160,400
26,097,396
Rexford
Industrial
Realty,
Inc.
............................
United
States
897,100
55,189,592
81,286,988
Food
&
Staples
Retailing
1.9%
a
Grocery
Outlet
Holding
Corp.
............................
United
States
1,125,394
37,273,049
a
Performance
Food
Group
Co.
............................
United
States
942,800
43,199,096
80,472,145
Food
Products
2.9%
a
Freshpet
,
Inc.
........................................
United
States
175,100
25,643,395
a
Hostess
Brands,
Inc.
...................................
United
States
863,774
13,898,124
a
Nomad
Foods
Ltd.
....................................
United
Kingdom
1,212,000
31,657,440
a
Simply
Good
Foods
Co.
(The)
............................
United
States
1,334,300
50,009,564
121,208,523
Health
Care
Equipment
&
Supplies
4.4%
a,e
CryoPort
,
Inc.
........................................
United
States
217,800
13,442,616
a
Figs,
Inc.,
A
..........................................
United
States
633,800
23,070,320
a
Haemonetics
Corp.
....................................
United
States
338,400
20,571,336
a
Inari
Medical,
Inc.
.....................................
United
States
182,400
16,377,696
a
Integer
Holdings
Corp.
.................................
United
States
521,400
51,039,846
a
iRhythm
Technologies,
Inc.
..............................
United
States
12,446
636,239
a
Neogen
Corp.
........................................
United
States
330,932
14,415,398
a
Nevro
Corp.
.........................................
United
States
204,300
31,666,500
Franklin
Strategic
Series
Statement
of
Investments
(unaudited)
Franklin
Small
Cap
Growth
Fund
(continued)
Quarterly
Statement
of
Investments
See
Notes
to
Statements
of
Investments.
18
a
a
Country
Shares
a
Value
a
a
a
a
a
a
Common
Stocks
(continued)
Health
Care
Equipment
&
Supplies
(continued)
a
Pulmonx
Corp.
.......................................
United
States
375,116
$
14,877,101
186,097,052
Health
Care
Providers
&
Services
3.5%
a
1Life
Healthcare,
Inc.
..................................
United
States
1,053,000
28,473,120
a
Accolade,
Inc.
........................................
United
States
650,500
30,449,905
a
HealthEquity
,
Inc.
.....................................
United
States
473,016
34,993,723
a,e
Hims
&
Hers
Health,
Inc.
................................
United
States
1,826,147
14,444,823
a
Privia
Health
Group,
Inc.
................................
United
States
551,200
22,874,800
a
Signify
Health,
Inc.,
A
..................................
United
States
505,809
13,312,893
144,549,264
Health
Care
Technology
3.2%
a
Certara
,
Inc.
.........................................
United
States
903,200
24,576,072
a
Inspire
Medical
Systems,
Inc.
............................
United
States
278,844
51,073,067
a
Phreesia
,
Inc.
........................................
United
States
846,182
57,836,540
133,485,679
Hotels,
Restaurants
&
Leisure
3.3%
a
Red
Rock
Resorts,
Inc.,
A
...............................
United
States
1,335,800
52,630,520
Texas
Roadhouse,
Inc.
.................................
United
States
428,100
39,457,977
Wingstop
,
Inc.
........................................
United
States
257,829
44,168,686
136,257,183
Household
Durables
2.5%
a
M/I
Homes,
Inc.
.......................................
United
States
976,546
63,192,292
a
Tri
Pointe
Homes,
Inc.
..................................
United
States
1,670,300
40,287,636
103,479,928
Insurance
0.1%
a
Selectquote
,
Inc.
......................................
United
States
337,309
6,004,100
IT
Services
6.4%
a
BigCommerce
Holdings,
Inc.,
1
...........................
United
States
396,600
25,683,816
a
Cantaloupe,
Inc.
......................................
United
States
2,469,265
25,532,200
a,e
Flywire
Corp.
........................................
United
States
453,410
14,400,302
a
LiveRamp
Holdings,
Inc.
................................
United
States
1,018,500
40,750,185
a,b,d
Marqeta
,
Inc.
.........................................
United
States
1,199,415
31,005,663
a
Paya
Holdings,
Inc.,
A
..................................
United
States
2,784,700
31,996,203
a,e
Paymentus
Holdings,
Inc.,
A
.............................
United
States
460,800
13,363,200
a
Repay
Holdings
Corp.
..................................
United
States
1,756,100
43,744,451
a
Shift4
Payments,
Inc.,
A
................................
United
States
460,200
41,045,238
267,521,258
Life
Sciences
Tools
&
Services
2.1%
a
Akoya
Biosciences,
Inc.
................................
United
States
156,009
2,705,196
a
Berkeley
Lights,
Inc.
...................................
United
States
622,200
28,359,876
a
Codex
DNA,
Inc.
......................................
United
States
525,185
8,292,671
a
NeoGenomics
,
Inc.
....................................
United
States
1,017,300
46,897,530
86,255,273
Machinery
2.7%
Kennametal,
Inc.
......................................
United
States
1,256,200
45,537,250
a,b,d
Proterra
,
Inc.
.........................................
United
States
3,243,564
31,803,775
a,e
Proterra
,
Inc.
.........................................
United
States
428,376
4,724,987
a,b
Proterra
,
Inc.
.........................................
United
States
114,973
Franklin
Strategic
Series
Statement
of
Investments
(unaudited)
Franklin
Small
Cap
Growth
Fund
(continued)
See
Notes
to
Statements
of
Investments.
Quarterly
Statement
of
Investments
19
a
a
Country
Shares
a
Value
a
a
a
a
a
a
Common
Stocks
(continued)
Machinery
(continued)
a
RBC
Bearings,
Inc.
....................................
United
States
136,600
$
32,101,000
114,167,012
Personal
Products
1.0%
a
BellRing
Brands,
Inc.,
A
.................................
United
States
1,261,200
41,707,884
Pharmaceuticals
1.5%
a,e
EyePoint
Pharmaceuticals,
Inc.
...........................
United
States
750,000
6,165,000
a
Reata
Pharmaceuticals,
Inc.,
A
...........................
United
States
236,574
29,645,088
a
Revance
Therapeutics,
Inc.
..............................
United
States
971,692
28,256,803
64,066,891
Professional
Services
2.8%
a,b,d
Legalzoom.com,
Inc.
...................................
United
States
1,431,280
50,386,482
ManTech
International
Corp.,
A
...........................
United
States
371,219
32,466,814
Science
Applications
International
Corp.
....................
United
States
413,000
36,054,900
118,908,196
Road
&
Rail
0.2%
a,b,d
New
Starship
Parent,
Inc.
...............................
United
States
750,000
7,080,000
Semiconductors
&
Semiconductor
Equipment
6.4%
a
Allegro
MicroSystems
,
Inc.
..............................
Japan
1,012,700
27,758,107
a
Lattice
Semiconductor
Corp.
.............................
United
States
1,073,000
60,892,750
a
Onto
Innovation,
Inc.
...................................
United
States
823,652
57,721,532
a
Semtech
Corp.
.......................................
United
States
717,500
44,420,425
a
Silicon
Laboratories,
Inc.
................................
United
States
203,100
30,259,869
a
SiTime
Corp.
.........................................
United
States
352,500
47,813,100
268,865,783
Software
7.6%
a,b,d
Alkami
Technology,
Inc.
.................................
United
States
292,188
8,884,866
a
Alkami
Technology,
Inc.
.................................
United
States
484,962
15,174,461
a
Alteryx
,
Inc.,
A
........................................
United
States
258,200
19,984,680
a
Asana,
Inc.,
A
........................................
United
States
182,276
12,952,532
a
Avalara,
Inc.
.........................................
United
States
200,546
33,525,275
a,e
BTRS
Holdings,
Inc.
...................................
United
States
2,373,100
27,789,001
a
Couchbase
,
Inc.
......................................
United
States
186,600
5,627,856
a
CS
Disco,
Inc.
........................................
United
States
34,700
1,434,151
a,e
Datto
Holding
Corp.
...................................
United
States
1,363,262
35,567,506
a
Duck
Creek
Technologies,
Inc.
...........................
United
States
813,769
35,748,872
a
Envestnet
,
Inc.
.......................................
United
States
395,922
29,785,212
a
Paycor
HCM,
Inc.
.....................................
United
States
1,407,200
38,698,000
a
Paylocity
Holding
Corp.
.................................
United
States
50,932
10,566,353
a
Q2
Holdings,
Inc.
.....................................
United
States
274,400
28,348,264
a
Zendesk
,
Inc.
........................................
United
States
119,214
15,561,003
319,648,032
Specialty
Retail
7.9%
e
American
Eagle
Outfitters,
Inc.
...........................
United
States
2,219,700
76,513,059
a
Boot
Barn
Holdings,
Inc.
................................
United
States
523,860
45,271,981
a
Five
Below,
Inc.
.......................................
United
States
277,200
53,893,224
Lithia
Motors,
Inc.,
A
...................................
United
States
109,626
41,353,120
a,e
MYT
Netherlands
Parent
BV,
ADR
.........................
Germany
802,500
23,144,100
a,e
Petco
Health
&
Wellness
Co.,
Inc.
.........................
United
States
1,918,800
39,584,844
a
Torrid
Holdings,
Inc.
...................................
United
States
1,173,921
27,411,055
Franklin
Strategic
Series
Statement
of
Investments
(unaudited)
Franklin
Small
Cap
Growth
Fund
(continued)
Quarterly
Statement
of
Investments
See
Notes
to
Statements
of
Investments.
20
a
a
Country
Shares
a
Value
a
a
a
a
a
a
Common
Stocks
(continued)
Specialty
Retail
(continued)
a
Urban
Outfitters,
Inc.
...................................
United
States
623,000
$
23,163,140
330,334,523
Textiles,
Apparel
&
Luxury
Goods
1.1%
Steven
Madden
Ltd.
...................................
United
States
1,082,650
47,452,550
Trading
Companies
&
Distributors
2.8%
a
Beacon
Roofing
Supply,
Inc.
.............................
United
States
1,163,000
62,197,240
a
Univar
Solutions,
Inc.
..................................
United
States
2,179,032
53,473,445
115,670,685
Total
Common
Stocks
(Cost
$2,689,966,289)
....................................
3,970,629,884
Convertible
Preferred
Stocks
0.8%
Diversified
Consumer
Services
0.3%
a,b,d
Newsela
,
Inc.,
D
......................................
United
States
709,046
15,254,167
a
Specialty
Retail
0.5%
a,b,d
1661,
Inc.,
F
.........................................
United
States
3,436,485
19,999,999
a
Total
Convertible
Preferred
Stocks
(Cost
$35,000,009)
...........................
35,254,166
Preferred
Stocks
2.2%
Auto
Components
0.2%
a,b,d
Tula
eTechnology
,
Inc.
..................................
United
States
361,111
a,b,d
Tula
eTechnology
,
Inc.,
E
...............................
United
States
3,611,111
9,479,643
9,479,643
Commercial
Services
&
Supplies
0.3%
a,b,c,d
Optoro
,
Inc.,
E
.......................................
United
States
508,130
12,952,057
a
Food
&
Staples
Retailing
0.2%
a,b,d
Sweetgreen
,
Inc.,
H
...................................
United
States
383,435
6,012,976
a,b,d
Sweetgreen
,
Inc.,
I
....................................
United
States
41,641
732,124
a,b,d
Sweetgreen
,
Inc.,
J
....................................
United
States
113,300
1,992,019
8,737,119
Software
0.6%
a,b,c,d
ClearMotion
,
Inc.,
D
...................................
United
States
3,698,772
12,293,634
a,b,d
Smule
,
Inc.,
144A,
G
...................................
United
States
1,542,673
9,370,140
a,b,d
Smule
,
Inc.,
144A,
H
...................................
United
States
352,675
2,532,151
24,195,925
Specialty
Retail
0.5%
a,b,d
Rent
the
Runway,
Inc.,
144A,
F
...........................
United
States
596,471
13,036,414
a,b,d
Rent
the
Runway,
Inc.,
G
................................
United
States
508,787
9,037,653
22,074,067
Textiles,
Apparel
&
Luxury
Goods
0.4%
a,b,d
Allbirds
,
Inc.,
E
.......................................
United
States
1,297,305
15,800,122
a
Total
Preferred
Stocks
(Cost
$84,082,806)
......................................
93,238,933
Franklin
Strategic
Series
Statement
of
Investments
(unaudited)
Franklin
Small
Cap
Growth
Fund
(continued)
See
Notes
to
Statements
of
Investments.
Quarterly
Statement
of
Investments
21
See
Abbreviations
on
page
79
.
a
a
Country
Warrants
a
Value
a
a
a
a
a
a
Warrants
0.0%
Food
&
Staples
Retailing
0.0%
a,b,d
Sweetgreen
,
Inc.,
1/20/26
...............................
United
States
33,990
$
32,754
Total
Warrants
(Cost
$—)
.....................................................
32,754
Shares
Escrows
and
Litigation
Trusts
0.0%
a,b
Proterra
,
Inc.,
Escrow
Account
...........................
United
States
114,974
a,b
Proterra
,
Inc.,
Escrow
Account
...........................
United
States
114,974
a,b
Wheels
Up
Experience,
Inc.,
Escrow
Account
................
Singapore
29,366
a,b
Wheels
Up
Experience,
Inc.,
Escrow
Account
................
Singapore
29,366
a,b
Wheels
Up
Experience,
Inc.,
Escrow
Account
................
Singapore
29,366
Total
Escrows
and
Litigation
Trusts
(Cost
$–)
...................................
Total
Long
Term
Investments
(Cost
$2,809,049,104)
.............................
4,099,155,737
a
Short
Term
Investments
4.5%
a
a
Country
Shares
a
Value
a
Money
Market
Funds
2.2%
f,g
Institutional
Fiduciary
Trust
-
Money
Market
Portfolio,
0.01%
.....
United
States
91,683,952
91,683,952
Total
Money
Market
Funds
(Cost
$91,683,952)
..................................
91,683,952
a
a
a
a
a
Investments
from
Cash
Collateral
Received
for
Loaned
Securities
2.3%
Money
Market
Funds
2.3%
f,g
Institutional
Fiduciary
Trust
-
Money
Market
Portfolio,
0.01%
.....
United
States
95,679,832
95,679,832
Total
Investments
from
Cash
Collateral
Received
for
Loaned
Securities
(Cost
$95,679,832)
...........................................................
95,679,832
Total
Short
Term
Investments
(Cost
$187,363,784
)
...............................
187,363,784
a
Total
Investments
(Cost
$2,996,412,888)
102.4%
................................
$4,286,519,521
Other
Assets,
less
Liabilities
(2.4)%
...........................................
(100,410,598)
Net
Assets
100.0%
...........................................................
$4,186,108,923
Rounds
to
less
than
0.1%
of
net
assets.
a
Non-income
producing.
b
Fair
valued
using
significant
unobservable
inputs.
See
Note
10
regarding
fair
value
measurements.
c
See
Note
8
regarding
holdings
of
5%
voting
securities.
d
See
Note
7
regarding
restricted
securities.
e
A
portion
or
all
of
the
security
is
on
loan
at
July
31,
2021.
f
See
Note
9
regarding
investments
in
affiliated
management
investment
companies.
g
The
rate
shown
is
the
annualized
seven-day
effective
yield
at
period
end.
Franklin
Strategic
Series
Statement
of
Investments
(unaudited),
July
31,
2021
Franklin
Small-Mid
Cap
Growth
Fund
Quarterly
Statement
of
Investments
See
Notes
to
Statements
of
Investments.
22
a
a
Country
Shares
a
Value
a
a
a
a
a
a
Common
Stocks
94.0%
Aerospace
&
Defense
1.6%
a
Mercury
Systems,
Inc.
..................................
United
States
575,300
$
37,969,800
a
TransDigm
Group,
Inc.
.................................
United
States
88,700
56,864,683
94,834,483
Airlines
0.5%
a
Southwest
Airlines
Co.
.................................
United
States
576,800
29,139,936
Banks
0.5%
a
SVB
Financial
Group
...................................
United
States
53,100
29,202,876
Biotechnology
3.1%
a
Centessa
Pharmaceuticals
plc,
ADR
.......................
United
States
313,700
6,474,768
a
Global
Blood
Therapeutics,
Inc.
...........................
United
States
502,700
13,738,791
a
Heron
Therapeutics,
Inc.
................................
United
States
877,252
10,842,835
a
Horizon
Therapeutics
plc
................................
United
States
520,000
52,010,400
a
Iovance
Biotherapeutics
,
Inc.
.............................
United
States
913,565
20,345,092
a
Mirati
Therapeutics,
Inc.
................................
United
States
76,000
12,164,560
a
Novavax
,
Inc.
........................................
United
States
88,200
15,816,906
a
PTC
Therapeutics,
Inc.
.................................
United
States
433,000
16,596,890
a
Seagen
,
Inc.
.........................................
United
States
252,600
38,746,314
186,736,556
Capital
Markets
5.1%
Ares
Management
Corp.
................................
United
States
875,000
62,658,750
a,b,c,d
Lucid
Group,
Inc.
.....................................
United
States
728,215
15,601,612
MarketAxess
Holdings,
Inc.
..............................
United
States
118,700
56,402,679
MSCI,
Inc.
...........................................
United
States
187,900
111,980,884
a
Soaring
Eagle
Acquisition
Corp.
..........................
United
States
1,126,700
11,593,743
a,b,c,d
Soaring
Eagle
Acquisition
Corp.,
A
.........................
United
States
271,200
2,712,000
Tradeweb
Markets,
Inc.,
A
...............................
United
States
484,300
42,003,339
302,953,007
Commercial
Services
&
Supplies
1.1%
Republic
Services,
Inc.
.................................
United
States
566,000
66,991,760
Communications
Equipment
0.3%
a
Arista
Networks,
Inc.
...................................
United
States
40,400
15,367,756
Consumer
Finance
0.1%
a,b,c
Sunlight
Financial
Holdings,
Inc.,
A
........................
United
States
963,371
7,909,276
Containers
&
Packaging
1.0%
Ball
Corp.
...........................................
United
States
762,700
61,687,176
Electrical
Equipment
0.8%
Rockwell
Automation,
Inc.
...............................
United
States
150,000
46,113,000
Electronic
Equipment,
Instruments
&
Components
2.0%
Cognex
Corp.
........................................
United
States
454,800
41,118,468
a
Keysight
Technologies,
Inc.
..............................
United
States
473,100
77,848,605
118,967,073
Entertainment
2.6%
a
Roku,
Inc.
...........................................
United
States
243,478
104,284,062
a
Zynga,
Inc.,
A
........................................
United
States
5,190,000
52,419,000
156,703,062
Equity
Real
Estate
Investment
Trusts
(REITs)
2.5%
Equity
LifeStyle
Properties,
Inc.
...........................
United
States
187,400
15,704,120
SBA
Communications
Corp.
.............................
United
States
303,400
103,456,366
Franklin
Strategic
Series
Statement
of
Investments
(unaudited)
Franklin
Small-Mid
Cap
Growth
Fund
(continued)
See
Notes
to
Statements
of
Investments.
Quarterly
Statement
of
Investments
23
a
a
Country
Shares
a
Value
a
a
a
a
a
a
Common
Stocks
(continued)
Equity
Real
Estate
Investment
Trusts
(REITs)
(continued)
Terreno
Realty
Corp.
...................................
United
States
449,800
$
30,748,328
149,908,814
Food
&
Staples
Retailing
0.5%
a
Grocery
Outlet
Holding
Corp.
............................
United
States
860,000
28,483,200
Food
Products
0.6%
a
Freshpet
,
Inc.
........................................
United
States
179,800
26,331,710
a
Oatly
Group
AB,
ADR
..................................
United
States
576,700
10,236,425
36,568,135
Health
Care
Equipment
&
Supplies
6.4%
a
DexCom
,
Inc.
........................................
United
States
71,314
36,763,080
a,e
Figs,
Inc.,
A
..........................................
United
States
575,300
20,940,920
a
IDEXX
Laboratories,
Inc.
................................
United
States
211,100
143,237,683
a
Inari
Medical,
Inc.
.....................................
United
States
271,500
24,377,985
a
Insulet
Corp.
.........................................
United
States
211,900
59,266,311
a
Penumbra,
Inc.
.......................................
United
States
95,747
25,490,724
Teleflex,
Inc.
.........................................
United
States
176,600
70,186,138
380,262,841
Health
Care
Providers
&
Services
1.1%
a
Guardant
Health,
Inc.
..................................
United
States
383,700
42,130,260
a
HealthEquity
,
Inc.
.....................................
United
States
295,000
21,824,100
63,954,360
Health
Care
Technology
2.4%
a
Certara
,
Inc.
.........................................
United
States
385,500
10,489,455
a
Teladoc
Health,
Inc.
...................................
United
States
193,841
28,775,696
a
Veeva
Systems,
Inc.,
A
.................................
United
States
302,000
100,478,420
139,743,571
Hotels,
Restaurants
&
Leisure
4.2%
a
Chipotle
Mexican
Grill,
Inc.
..............................
United
States
51,300
95,594,472
Darden
Restaurants,
Inc.
...............................
United
States
149,100
21,750,708
a
DraftKings
,
Inc.,
A
.....................................
United
States
840,955
40,786,318
a
Vail
Resorts,
Inc.
......................................
United
States
127,600
38,943,520
a
Wynn
Resorts
Ltd.
....................................
United
States
539,700
53,068,701
250,143,719
Household
Durables
0.8%
a
NVR,
Inc.
...........................................
United
States
9,400
49,092,440
Interactive
Media
&
Services
2.4%
a,e
Bumble,
Inc.,
A
.......................................
United
States
412,500
20,988,000
a
Match
Group,
Inc.
.....................................
United
States
454,359
72,365,758
a
Pinterest,
Inc.,
A
......................................
United
States
792,300
46,666,470
140,020,228
Internet
&
Direct
Marketing
Retail
1.1%
a
Etsy,
Inc.
............................................
United
States
181,800
33,362,118
a
Wayfair,
Inc.,
A
.......................................
United
States
142,700
34,442,072
67,804,190
IT
Services
5.9%
a
BigCommerce
Holdings,
Inc.,
1
...........................
United
States
576,300
37,321,188
a
GoDaddy
,
Inc.,
A
......................................
United
States
669,300
56,120,805
a,b,c
Marqeta
,
Inc.
.........................................
United
States
1,070,236
27,666,302
Franklin
Strategic
Series
Statement
of
Investments
(unaudited)
Franklin
Small-Mid
Cap
Growth
Fund
(continued)
Quarterly
Statement
of
Investments
See
Notes
to
Statements
of
Investments.
24
a
a
Country
Shares
a
Value
a
a
a
a
a
a
Common
Stocks
(continued)
IT
Services
(continued)
a,e
Marqeta
,
Inc.,
A
.......................................
United
States
211,700
$
5,679,911
a
MongoDB,
Inc.
.......................................
United
States
225,900
81,080,028
a,f
Nuvei
Corp.,
144A,
Reg
S
...............................
Canada
178,600
14,645,200
a
Okta
,
Inc.
...........................................
United
States
371,500
92,053,985
a
Paymentus
Holdings,
Inc.,
A
.............................
United
States
94,800
2,749,200
a
Wix.com
Ltd.
.........................................
Israel
120,600
36,015,984
353,332,603
Life
Sciences
Tools
&
Services
4.7%
a
10X
Genomics,
Inc.,
A
..................................
United
States
260,000
47,639,800
a
Avantor
,
Inc.
.........................................
United
States
800,400
30,079,032
Bio-
Techne
Corp.
.....................................
United
States
172,300
83,089,952
a
Maravai
LifeSciences
Holdings,
Inc.,
A
.....................
United
States
761,700
33,491,949
a
Mettler
-Toledo
International,
Inc.
..........................
United
States
56,100
82,675,131
276,975,864
Machinery
2.1%
Fortive
Corp.
.........................................
United
States
650,500
47,265,330
IDEX
Corp.
..........................................
United
States
119,500
27,089,455
a,e
Proterra
,
Inc.
.........................................
United
States
60,000
661,800
a,b,c
Proterra
,
Inc.
.........................................
United
States
1,264,594
12,399,588
a
Proterra
,
Inc.
.........................................
United
States
499,260
5,506,838
a,b
Proterra
,
Inc.
.........................................
United
States
44,825
Stanley
Black
&
Decker,
Inc.
.............................
United
States
153,300
30,207,765
123,130,776
Personal
Products
0.7%
a
BellRing
Brands,
Inc.,
A
.................................
United
States
1,177,500
38,939,925
Pharmaceuticals
0.6%
a
Jazz
Pharmaceuticals
plc
...............................
United
States
87,500
14,833,000
a
Reata
Pharmaceuticals,
Inc.,
A
...........................
United
States
186,900
23,420,439
38,253,439
Professional
Services
4.7%
a
CoStar
Group,
Inc.
....................................
United
States
1,208,500
107,375,225
TransUnion
..........................................
United
States
662,900
79,587,774
Verisk
Analytics,
Inc.
...................................
United
States
474,900
90,202,506
277,165,505
Road
&
Rail
1.2%
a,b,c
New
Starship
Parent,
Inc.
...............................
United
States
675,200
6,373,888
Old
Dominion
Freight
Line,
Inc.
...........................
United
States
232,050
62,456,258
68,830,146
Semiconductors
&
Semiconductor
Equipment
5.4%
a
Allegro
MicroSystems
,
Inc.
..............................
Japan
983,800
26,965,958
a
Alphawave
IP
Group
plc
................................
United
Kingdom
1,958,300
11,605,095
Entegris
,
Inc.
.........................................
United
States
357,200
43,092,608
a
Lattice
Semiconductor
Corp.
.............................
United
States
895,214
50,803,395
Monolithic
Power
Systems,
Inc.
...........................
United
States
126,100
56,651,686
a
Semtech
Corp.
.......................................
United
States
550,463
34,079,164
a
SiTime
Corp.
.........................................
United
States
598,514
81,182,439
a
SolarEdge
Technologies,
Inc.
............................
United
States
73,000
18,942,040
323,322,385
Software
19.5%
a,b,c
Alkami
Technology,
Inc.
.................................
United
States
344,335
10,470,554
Franklin
Strategic
Series
Statement
of
Investments
(unaudited)
Franklin
Small-Mid
Cap
Growth
Fund
(continued)
See
Notes
to
Statements
of
Investments.
Quarterly
Statement
of
Investments
25
a
a
Country
Shares
a
Value
a
a
a
a
a
a
Common
Stocks
(continued)
Software
(continued)
a
Alkami
Technology,
Inc.
.................................
United
States
112,565
$
3,522,159
a
Alteryx
,
Inc.,
A
........................................
United
States
494,000
38,235,600
a
ANSYS,
Inc.
.........................................
United
States
255,300
94,067,838
a,e
AppLovin
Corp.,
A
.....................................
United
States
320,800
19,719,576
a
Avalara,
Inc.
.........................................
United
States
485,100
81,094,167
a
Bill.com
Holdings,
Inc.
..................................
United
States
271,133
56,075,727
a
Black
Knight,
Inc.
.....................................
United
States
1,007,500
83,431,075
a
BTRS
Holdings,
Inc.
...................................
United
States
1,333,700
15,617,627
a
Cloudflare
,
Inc.,
A
.....................................
United
States
518,200
61,474,066
a
Coupa
Software,
Inc.
...................................
United
States
267,100
57,960,700
a
Crowdstrike
Holdings,
Inc.,
A
.............................
United
States
89,000
22,571,290
a
DocuSign,
Inc.
.......................................
United
States
448,000
133,521,920
a
Duck
Creek
Technologies,
Inc.
...........................
United
States
493,416
21,675,765
a
HubSpot
,
Inc.
........................................
United
States
130,700
77,899,814
a
Lightspeed
POS,
Inc.
..................................
Canada
513,700
43,936,761
a
Monday.com
Ltd.
......................................
United
States
31,100
6,882,119
a
Paylocity
Holding
Corp.
.................................
United
States
418,100
86,739,026
a
Q2
Holdings,
Inc.
.....................................
United
States
316,964
32,745,551
a
Synopsys,
Inc.
.......................................
United
States
496,500
142,987,035
a
Zendesk
,
Inc.
........................................
United
States
506,800
66,152,604
1,156,780,974
Specialty
Retail
5.0%
a
Burlington
Stores,
Inc.
..................................
United
States
224,600
75,196,080
a
Five
Below,
Inc.
.......................................
United
States
320,700
62,350,494
a
O'Reilly
Automotive,
Inc.
................................
United
States
105,100
63,463,584
a,e
Petco
Health
&
Wellness
Co.,
Inc.
.........................
United
States
1,264,100
26,078,383
Tractor
Supply
Co.
....................................
United
States
384,600
69,585,678
296,674,219
Textiles,
Apparel
&
Luxury
Goods
2.4%
Levi
Strauss
&
Co.,
A
..................................
United
States
839,900
23,114,048
a
Lululemon
Athletica
,
Inc.
................................
United
States
178,900
71,590,413
VF
Corp.
............................................
United
States
583,300
46,780,660
141,485,121
Trading
Companies
&
Distributors
1.1%
Fastenal
Co.
.........................................
United
States
1,216,400
66,622,228
Total
Common
Stocks
(Cost
$3,397,731,273)
....................................
5,584,100,644
Convertible
Preferred
Stocks
1.1%
Diversified
Consumer
Services
0.1%
a,b,c
Newsela
,
Inc.,
D
......................................
United
States
423,782
9,117,097
a
Internet
&
Direct
Marketing
Retail
0.4%
a,b,c
Fanatics,
Inc.,
E
......................................
United
States
775,014
21,404,793
a,b,c
Fanatics,
Inc.,
F
......................................
United
States
18,700
652,328
22,057,121
Semiconductors
&
Semiconductor
Equipment
0.0%
a,b,c,g
Phononic
Devices,
Inc.
.................................
United
States
513,050
2,113,853
a
Software
0.6%
a,b,c
Databricks
,
Inc.,
G
....................................
United
States
75,943
16,733,812
Franklin
Strategic
Series
Statement
of
Investments
(unaudited)
Franklin
Small-Mid
Cap
Growth
Fund
(continued)
Quarterly
Statement
of
Investments
See
Notes
to
Statements
of
Investments.
26
a
a
Country
Shares
a
Value
a
a
a
a
a
a
Convertible
Preferred
Stocks
(continued)
Software
(continued)
a,b,c
OneTrust
LLC,
C
......................................
United
States
767,526
$
16,931,624
33,665,436
Total
Convertible
Preferred
Stocks
(Cost
$51,538,567)
...........................
66,953,507
Preferred
Stocks
0.6%
Semiconductors
&
Semiconductor
Equipment
0.2%
a,b,c,g
Phononic
Devices,
Inc.,
F
...............................
United
States
2,970,061
10,820,143
a
Software
0.2%
a,b,c,g
Blaize
,
Inc.,
D
........................................
United
States
1,294,805
13,521,001
a
Textiles,
Apparel
&
Luxury
Goods
0.2%
a,b,c
Allbirds
,
Inc.,
E
.......................................
United
States
772,477
9,408,143
a
Total
Preferred
Stocks
(Cost
$29,952,719)
......................................
33,749,287
Warrants
Warrants
0.0%
Software
0.0%
a,b,c,g
Blaize
,
Inc.
Ltd.,
2/28/24
................................
United
Kingdom
64,741
Total
Warrants
(Cost
$—)
.....................................................
Principal
Amount
*
h
Senior
Floating
Rate
Interests
0.0%
Semiconductors
&
Semiconductor
Equipment
0.0%
b,c,g,i
Phononic
,
Inc.
,
Advance
Term
Loan,
B,
12%,
PIK,
7/31/26
.................
United
States
117,795
105,809
Advance
Term
Loan,
D,
12%,
PIK,
12/01/25
................
United
States
281,258
252,243
Term
Loan,
A,
12%,
PIK,
1/17/24
........................
United
States
572,775
526,138
Term
Loan,
C,
12%,
PIK,
8/25/24
........................
United
States
114,103
102,774
986,964
a
a
a
a
a
a
Total
Senior
Floating
Rate
Interests
(Cost
$1,073,242)
...........................
986,964
Shares
Escrows
and
Litigation
Trusts
0.0%
a,b
Proterra
,
Inc.,
Escrow
Account
...........................
United
States
44,826
a,b
Proterra
,
Inc.,
Escrow
Account
...........................
United
States
44,826
Total
Escrows
and
Litigation
Trusts
(Cost
$–)
...................................
Total
Long
Term
Investments
(Cost
$3,480,295,801)
.............................
5,685,790,402
a
Short
Term
Investments
5.7%
a
a
Country
Shares
a
Value
a
Money
Market
Funds
4.7%
j,k
Institutional
Fiduciary
Trust
-
Money
Market
Portfolio,
0.01%
.....
United
States
278,040,455
278,040,455
Total
Money
Market
Funds
(Cost
$278,040,455)
.................................
278,040,455
Franklin
Strategic
Series
Statement
of
Investments
(unaudited)
Franklin
Small-Mid
Cap
Growth
Fund
(continued)
See
Notes
to
Statements
of
Investments.
Quarterly
Statement
of
Investments
27
See
Abbreviations
on
page
79
.
Short
Term
Investments
(continued)
a
a
Country
Shares
a
Value
a
a
a
a
a
a
Investments
from
Cash
Collateral
Received
for
Loaned
Securities
1.0%
Money
Market
Funds
1.0%
j,k
Institutional
Fiduciary
Trust
-
Money
Market
Portfolio,
0.01%
.....
United
States
63,086,855
$
63,086,855
Total
Investments
from
Cash
Collateral
Received
for
Loaned
Securities
(Cost
$63,086,855)
...........................................................
63,086,855
Total
Short
Term
Investments
(Cost
$341,127,310
)
...............................
341,127,310
a
Total
Investments
(Cost
$3,821,423,111)
101.4%
.................................
$6,026,917,712
Other
Assets,
less
Liabilities
(1.4)%
...........................................
(86,217,601)
Net
Assets
100.0%
...........................................................
$5,940,700,111
*
The
principal
amount
is
stated
in
U.S.
dollars
unless
otherwise
indicated.
Rounds
to
less
than
0.1%
of
net
assets.
a
Non-income
producing.
b
Fair
valued
using
significant
unobservable
inputs.
See
Note
10
regarding
fair
value
measurements.
c
See
Note
7
regarding
restricted
securities.
d
A
portion
or
all
of
the
security
purchased
on
a
delayed
delivery
basis.
e
A
portion
or
all
of
the
security
is
on
loan
at
July
31,
2021.
f
Security
was
purchased
pursuant
to
Rule
144A
or
Regulation
S
under
the
Securities
Act
of
1933.
144A
securities
may
be
sold
in
transactions
exempt
from
registration
only
to
qualified
institutional
buyers
or
in
a
public
offering
registered
under
the
Securities
Act
of
1933.
Regulation
S
securities
cannot
be
sold
in
the
United
States
without
either
an
effective
registration
statement
filed
pursuant
to
the
Securities
Act
of
1933,
or
pursuant
to
an
exemption
from
registration.
At
July
31,
2021,
the
aggregate
value
of
these
securities
was
$14,645,200,
representing
0.2%
of
net
assets.
g
See
Note
8
regarding
holdings
of
5%
voting
securities.
h
The
coupon
rate
shown
represents
the
rate
at
period
end.
i
Income
may
be
received
in
additional
securities
and/or
cash.
j
See
Note
9
regarding
investments
in
affiliated
management
investment
companies.
k
The
rate
shown
is
the
annualized
seven-day
effective
yield
at
period
end.
Franklin
Strategic
Series
Statement
of
Investments
(unaudited),
July
31,
2021
Franklin
Strategic
Income
Fund
Quarterly
Statement
of
Investments
See
Notes
to
Statements
of
Investments.
28
a
a
Country
Shares
a
Value
a
a
a
a
a
a
Common
Stocks
0.3%
Energy
Equipment
&
Services
0.1%
a
Weatherford
International
plc
.............................
United
States
151,545
$
2,642,945
Machinery
0.1%
a
Birch
Permian
Holdings,
Inc.
.............................
United
States
46,176
692,640
a
Birch
Permian
Holdings,
Inc.
.............................
United
States
359,948
5,354,226
6,046,866
Media
0.1%
a
Clear
Channel
Outdoor
Holdings,
Inc.
......................
United
States
285,564
759,600
a
iHeartMedia
,
Inc.,
A
....................................
United
States
115,085
2,974,947
a,b
iHeartMedia
,
Inc.,
B
...................................
United
States
1,941
46,663
3,781,210
Multiline
Retail
0.0%
a,b,c
K2016470219
South
Africa
Ltd.,
A
.........................
South
Africa
125,940,079
a,b,c
K2016470219
South
Africa
Ltd.,
B
.........................
South
Africa
12,532,821
Oil,
Gas
&
Consumable
Fuels
0.0%
a
Amplify
Energy
Corp.
..................................
United
States
5,288
17,397
a,b
Riviera
Resources,
Inc.
.................................
United
States
84,462
21,817
39,214
Specialty
Retail
0.0%
a
Party
City
Holdco,
Inc.
..................................
United
States
1
8
Total
Common
Stocks
(Cost
$23,885,831)
......................................
12,510,243
Management
Investment
Companies
7.9%
Capital
Markets
7.9%
d
Franklin
Floating
Rate
Income
Fund
.......................
United
States
34,705,988
274,524,367
Invesco
Senior
Loan
ETF
...............................
United
States
1,562,500
34,421,875
308,946,242
Total
Management
Investment
Companies
(Cost
$376,927,715)
...................
308,946,242
Warrants
Warrants
0.0%
Oil,
Gas
&
Consumable
Fuels
0.0%
a,b
Battalion
Oil
Corp.,
A,
10/08/22
...........................
United
States
10,639
2,514
a,b
Battalion
Oil
Corp.,
B,
10/08/22
...........................
United
States
13,300
1,736
a,b
Battalion
Oil
Corp.,
C,
10/08/22
...........................
United
States
17,100
1,002
a,b
Chaparral
Energy,
Inc.,
10/01/24
..........................
United
States
9
a,b
Chaparral
Energy,
Inc.,
10/01/25
..........................
United
States
9
5,252
Paper
&
Forest
Products
0.0%
a
Verso
Corp.,
7/25/23
...................................
United
States
4,095
8,601
Software
0.0%
a,b,c
WorkCapital
BSD
SARL,
2/13/26
..........................
Luxembourg
6,000,000
Total
Warrants
(Cost
$750,000)
................................................
13,853
Franklin
Strategic
Series
Statement
of
Investments
(unaudited)
Franklin
Strategic
Income
Fund
(continued)
See
Notes
to
Statements
of
Investments.
Quarterly
Statement
of
Investments
29
a
a
Country
Principal
Amount
*
a
Value
a
a
a
a
a
Convertible
Bonds
0.0%
Wireless
Telecommunication
Services
0.0%
e,f,g
Digicel
Group
Holdings
Ltd.
,
Sub.
Bond
,
144A,
PIK,
7
%
,
Perpetual
Bermuda
620,300
$
472,447
Total
Convertible
Bonds
(Cost
$132,279)
.......................................
472,447
Corporate
Bonds
52.1%
Aerospace
&
Defense
0.7%
Boeing
Co.
(The)
,
Senior
Note
,
2.196
%
,
2/04/26
..............
United
States
9,500,000
9,588,084
Teledyne
FLIR
LLC
,
Senior
Note
,
2.5
%
,
8/01/30
..............
United
States
2,100,000
2,166,258
g
TransDigm
,
Inc.
,
Senior
Secured
Note
,
144A,
6.25
%
,
3/15/26
....
United
States
15,000,000
15,750,000
27,504,342
Air
Freight
&
Logistics
0.5%
g
DAE
Funding
LLC
,
Senior
Note,
144A,
4.5%,
8/01/22
.......................
United
Arab
Emirates
2,000,000
2,000,000
Senior
Note,
144A,
1.55%,
8/01/24
......................
United
Arab
Emirates
2,300,000
2,302,910
Senior
Note,
144A,
5%,
8/01/24
........................
United
Arab
Emirates
14,000,000
14,350,000
FedEx
Corp.
,
Senior
Bond
,
4.05
%
,
2/15/48
..................
United
States
1,200,000
1,402,642
20,055,552
Airlines
0.7%
g
American
Airlines
Inc
/
AAdvantage
Loyalty
IP
Ltd.
,
Senior
Secured
Note
,
144A,
5.75
%
,
4/20/29
............................
United
States
5,900,000
6,371,587
g
Delta
Air
Lines,
Inc.
/
SkyMiles
IP
Ltd.
,
Senior
Secured
Note
,
144A,
4.5
%
,
10/20/25
.....................................
United
States
10,400,000
11,185,963
g
Hawaiian
Brand
Intellectual
Property
Ltd.
/
HawaiianMiles
Loyalty
Ltd.
,
Senior
Secured
Note
,
144A,
5.75
%
,
1/20/26
............
United
States
9,100,000
9,550,359
g
United
Airlines,
Inc.
,
Senior
Secured
Note
,
144A,
4.375
%
,
4/15/26
.
United
States
1,700,000
1,751,221
28,859,130
Auto
Components
1.1%
g
Allison
Transmission,
Inc.
,
Senior
Bond,
144A,
5.875%,
6/01/29
.....................
United
States
7,000,000
7,668,465
Senior
Bond,
144A,
3.75%,
1/30/31
......................
United
States
6,700,000
6,684,422
Dana,
Inc.
,
Senior
Note
,
5.625
%
,
6/15/28
...................
United
States
12,400,000
13,369,742
Goodyear
Tire
&
Rubber
Co.
(The)
,
Senior
Bond
,
4.875
%
,
3/15/27
United
States
13,000,000
13,828,750
41,551,379
Automobiles
0.3%
g
Jaguar
Land
Rover
Automotive
plc
,
Senior
Note
,
144A,
5.5
%
,
7/15/29
...........................................
United
Kingdom
11,800,000
11,816,638
Banks
2.3%
g
Akbank
TAS
,
Senior
Bond,
144A,
5.125%,
3/31/25
.....................
Turkey
12,400,000
12,540,120
Senior
Note,
144A,
6.8%,
2/06/26
.......................
Turkey
3,200,000
3,397,680
Banco
Santander
SA
,
Sub.
Bond
,
2.749
%
,
12/03/30
...........
Spain
3,000,000
3,029,942
Bank
of
America
Corp.
,
Senior
Bond,
3.248%,
10/21/27
.........................
United
States
5,000,000
5,454,441
Senior
Bond,
2.676%
to
6/19/40,
FRN
thereafter,
6/19/41
.....
United
States
4,000,000
3,954,824
g
China
Construction
Bank
Corp.
,
Sub.
Bond
,
Reg
S,
4.25%
to
2/27/24,
FRN
thereafter
,
2/27/29
........................
China
8,000,000
8,582,311
f
Comerica,
Inc.
,
Junior
Sub.
Bond
,
5.625%
to
10/01/25,
FRN
thereafter
,
Perpetual
.................................
United
States
3,000,000
3,345,000
Franklin
Strategic
Series
Statement
of
Investments
(unaudited)
Franklin
Strategic
Income
Fund
(continued)
Quarterly
Statement
of
Investments
See
Notes
to
Statements
of
Investments.
30
a
a
Country
Principal
Amount
*
a
Value
a
a
a
a
a
Corporate
Bonds
(continued)
Banks
(continued)
HSBC
Holdings
plc
,
Senior
Bond
,
2.848%
to
6/04/30,
FRN
thereafter
,
6/04/31
...........................................
United
Kingdom
8,300,000
$
8,757,996
Industrial
&
Commercial
Bank
of
China
Ltd.
,
Senior
Bond
,
3.538
%
,
11/08/27
..........................................
China
8,500,000
9,493,323
JPMorgan
Chase
&
Co.
,
Senior
Bond,
2.522%
to
4/22/30,
FRN
thereafter,
4/22/31
.....
United
States
9,400,000
9,784,373
Senior
Bond,
2.525%
to
11/19/40,
FRN
thereafter,
11/19/41
....
United
States
4,000,000
3,919,247
g
Societe
Generale
SA
,
Senior
Bond
,
144A,
2.889%
to
6/09/31,
FRN
thereafter
,
6/09/32
...................................
France
7,500,000
7,678,021
SVB
Financial
Group
,
Senior
Bond
,
3.125
%
,
6/05/30
...........
United
States
2,700,000
2,952,432
g
UniCredit
SpA
,
Senior
Bond
,
144A,
3.127%
to
6/03/31,
FRN
thereafter
,
6/03/32
...................................
Italy
5,300,000
5,413,567
88,303,277
Beverages
0.5%
Anheuser-Busch
InBev
Worldwide,
Inc.
,
Senior
Bond
,
3.5
%
,
6/01/30
Belgium
10,000,000
11,267,313
g
Primo
Water
Holdings,
Inc.
,
Senior
Note
,
144A,
4.375
%
,
4/30/29
..
Canada
9,000,000
9,011,250
20,278,563
Biotechnology
0.2%
AbbVie,
Inc.
,
Senior
Note
,
3.2
%
,
11/21/29
...................
United
States
6,000,000
6,593,811
Building
Products
0.7%
Carrier
Global
Corp.
,
Senior
Note
,
2.722
%
,
2/15/30
............
United
States
16,000,000
16,970,779
Owens
Corning
,
Senior
Bond
,
4.3
%
,
7/15/47
.................
United
States
2,000,000
2,383,909
g
Standard
Industries,
Inc.
,
Senior
Bond,
144A,
4.75%,
1/15/28
......................
United
States
4,800,000
5,002,896
Senior
Bond,
144A,
4.375%,
7/15/30
.....................
United
States
1,600,000
1,650,176
Senior
Bond,
144A,
3.375%,
1/15/31
.....................
United
States
1,400,000
1,359,393
27,367,153
Capital
Markets
0.5%
Goldman
Sachs
Group,
Inc.
(The)
,
Senior
Bond
,
3.21%
to
4/22/41,
FRN
thereafter
,
4/22/42
...............................
United
States
7,000,000
7,423,666
Morgan
Stanley
,
Senior
Bond
,
3.591%
to
7/22/27,
FRN
thereafter
,
7/22/28
...........................................
United
States
10,000,000
11,149,755
18,573,421
Chemicals
3.0%
g
Alpek
SAB
de
CV
,
Senior
Bond
,
144A,
4.25
%
,
9/18/29
.........
Mexico
8,000,000
8,808,320
g
Axalta
Coating
Systems
LLC
,
Senior
Note
,
144A,
3.375
%
,
2/15/29
United
States
10,150,000
9,999,222
g
Braskem
Netherlands
Finance
BV
,
Senior
Bond
,
144A,
4.5
%
,
1/31/30
...........................................
Brazil
15,600,000
16,487,796
CF
Industries,
Inc.
,
Senior
Bond
,
5.15
%
,
3/15/34
..............
United
States
3,400,000
4,226,591
g
CNAC
HK
Finbridge
Co.
Ltd.
,
Senior
Note
,
Reg
S,
4.875
%
,
3/14/25
China
7,800,000
8,557,444
g
CVR
Partners
LP
/
CVR
Nitrogen
Finance
Corp.
,
Senior
Secured
Note
,
144A,
6.125
%
,
6/15/28
...........................
United
States
3,000,000
3,129,030
g
Element
Solutions,
Inc.
,
Senior
Note
,
144A,
3.875
%
,
9/01/28
.....
United
States
10,000,000
10,223,443
g
Gates
Global
LLC
/
Gates
Corp.
,
Senior
Note
,
144A,
6.25
%
,
1/15/26
United
States
12,500,000
13,021,750
g
GPD
Cos.,
Inc.
,
Senior
Secured
Note
,
144A,
10.125
%
,
4/01/26
...
United
States
5,000,000
5,430,575
HB
Fuller
Co.
,
Senior
Note
,
4.25
%
,
10/15/28
.................
United
States
2,500,000
2,559,500
g
Ingevity
Corp.
,
Senior
Note
,
144A,
3.875
%
,
11/01/28
...........
United
States
3,900,000
3,905,596
Methanex
Corp.
,
Senior
Note
,
5.125
%
,
10/15/27
..............
Canada
5,000,000
5,428,075
g
SABIC
Capital
II
BV
,
Senior
Bond
,
144A,
4.5
%
,
10/10/28
........
Saudi
Arabia
5,500,000
6,362,829
Franklin
Strategic
Series
Statement
of
Investments
(unaudited)
Franklin
Strategic
Income
Fund
(continued)
See
Notes
to
Statements
of
Investments.
Quarterly
Statement
of
Investments
31
a
a
Country
Principal
Amount
*
a
Value
a
a
a
a
a
Corporate
Bonds
(continued)
Chemicals
(continued)
g
SCIH
Salt
Holdings,
Inc.
,
Senior
Note,
144A,
6.625%,
5/01/29
.....................
United
States
4,200,000
$
4,163,523
Senior
Secured
Note,
144A,
4.875%,
5/01/28
..............
United
States
3,100,000
3,105,084
g
Syngenta
Finance
NV
,
Senior
Note
,
144A,
4.892
%
,
4/24/25
......
Switzerland
8,000,000
8,867,387
Westlake
Chemical
Corp.
,
Senior
Bond
,
3.375
%
,
6/15/30
.......
United
States
2,500,000
2,738,541
g
Yara
International
ASA
,
Senior
Bond
,
144A,
3.148
%
,
6/04/30
.....
Brazil
1,400,000
1,522,190
118,536,896
Commercial
Services
&
Supplies
1.0%
g
Allied
Universal
Holdco
LLC
/
Allied
Universal
Finance
Corp.
,
Senior
Note
,
144A,
6
%
,
6/01/29
..............................
United
States
10,100,000
10,125,553
g
Allied
Universal
Holdco
LLC
/
Allied
Universal
Finance
Corp.
/
Atlas
LuxCo
4
SARL
,
Senior
Secured
Note
,
144A,
4.625
%
,
6/01/28
..
United
States
4,100,000
4,105,125
g
APCOA
Parking
Holdings
GmbH
,
Senior
Secured
Note
,
144A,
4.625
%
,
1/15/27
.....................................
Germany
1,700,000
EUR
2,034,088
g
APX
Group,
Inc.
,
Senior
Note
,
144A,
5.75
%
,
7/15/29
...........
United
States
7,200,000
7,238,268
g
Nielsen
Finance
LLC
/
Nielsen
Finance
Co.
,
Senior
Bond
,
144A,
4.75
%
,
7/15/31
.....................................
United
States
3,000,000
3,029,640
g
Prime
Security
Services
Borrower
LLC
/
Prime
Finance,
Inc.
,
Senior
Secured
Note
,
144A,
3.375
%
,
8/31/27
....................
United
States
13,000,000
12,662,000
39,194,674
Communications
Equipment
0.3%
g
CommScope
Technologies
LLC
,
Senior
Bond
,
144A,
6
%
,
6/15/25
.
United
States
12,652,000
12,857,595
Construction
&
Engineering
0.1%
g
Arcosa
,
Inc.
,
Senior
Note
,
144A,
4.375
%
,
4/15/29
.............
United
States
2,600,000
2,665,000
g
Rutas
2
and
7
Finance
Ltd.
,
Senior
Secured
Bond
,
144A,
Zero
Cpn
.,
9/30/36
...........................................
United
States
1,200,000
912,810
3,577,810
Consumer
Finance
0.6%
g
FirstCash
,
Inc.
,
Senior
Note
,
144A,
4.625
%
,
9/01/28
...........
United
States
12,700,000
13,220,446
OneMain
Finance
Corp.
,
Senior
Bond,
5.375%,
11/15/29
.........................
United
States
3,300,000
3,631,881
Senior
Note,
4%,
9/15/30
.............................
United
States
5,000,000
4,987,500
21,839,827
Containers
&
Packaging
1.7%
g
Ardagh
Metal
Packaging
Finance
USA
LLC
/
Ardagh
Metal
Packaging
Finance
plc
,
Senior
Note
,
144A,
4
%
,
9/01/29
.......
United
States
5,800,000
5,821,750
g
Ardagh
Packaging
Finance
plc
/
Ardagh
Holdings
USA,
Inc.
,
Senior
Note,
144A,
6%,
2/15/25
........................
United
States
3,167,000
3,273,094
Senior
Note,
144A,
5.25%,
8/15/27
......................
United
States
3,700,000
3,782,834
Crown
Americas
LLC
/
Crown
Americas
Capital
Corp.
VI
,
Senior
Note
,
4.75
%
,
2/01/26
.................................
United
States
7,100,000
7,366,250
g
Mauser
Packaging
Solutions
Holding
Co.
,
Senior
Note
,
144A,
7.25
%
,
4/15/25
...........................................
United
States
15,000,000
14,672,775
g
Owens-Brockway
Glass
Container,
Inc.
,
Senior
Note
,
144A,
5.875
%
,
8/15/23
...........................................
United
States
10,000,000
10,745,400
g
Reynolds
Group
Issuer,
Inc.
/
Reynolds
Group
Issuer
LLC
/
Reynolds
Group
Issuer
Luxembourg
SA
,
Senior
Secured
Note
,
144A,
4
%
,
10/15/27
..........................................
United
States
4,600,000
4,600,000
g
Sealed
Air
Corp.
,
Senior
Bond
,
144A,
5.125
%
,
12/01/24
........
United
States
11,300,000
12,295,587
WRKCo
,
Inc.
,
Senior
Bond
,
3
%
,
6/15/33
....................
United
States
3,600,000
3,860,310
66,418,000
Franklin
Strategic
Series
Statement
of
Investments
(unaudited)
Franklin
Strategic
Income
Fund
(continued)
Quarterly
Statement
of
Investments
See
Notes
to
Statements
of
Investments.
32
a
a
Country
Principal
Amount
*
a
Value
a
a
a
a
a
Corporate
Bonds
(continued)
Diversified
Financial
Services
0.6%
h
Cia
Securitizadora
de
Creditos
Financeiros
Vert
-Fintech
,
12
,
Senior
Secured
Note
,
FRN
,
Zero
Cpn
.,
(
BZDIOVRA
+
5.75
%
),
2/14/24
.
Brazil
11,513,000
BRL
$
2,648,789
g,i
Jefferson
Capital
Holdings
LLC
,
Senior
Note
,
144A,
6
%
,
8/15/26
..
United
States
7,000,000
7,096,250
g
MPH
Acquisition
Holdings
LLC
,
Senior
Note
,
144A,
5.75
%
,
11/01/28
United
States
13,000,000
12,640,550
22,385,589
Diversified
Telecommunication
Services
1.1%
g
Altice
France
Holding
SA
,
Senior
Note
,
144A,
6
%
,
2/15/28
......
Luxembourg
9,100,000
8,986,250
g
Altice
France
SA
,
Senior
Secured
Note
,
144A,
5.5
%
,
1/15/28
....
France
2,500,000
2,565,913
g
AT&T,
Inc.
,
Senior
Bond
,
144A,
3.65
%
,
9/15/59
...............
United
States
4,000,000
4,143,125
CCO
Holdings
LLC
/
CCO
Holdings
Capital
Corp.
,
g
Senior
Bond,
144A,
4.5%,
8/15/30
.......................
United
States
2,000,000
2,102,500
Senior
Bond,
4.5%,
5/01/32
............................
United
States
13,000,000
13,646,295
g
Virgin
Media
Secured
Finance
plc
,
Senior
Secured
Bond
,
144A,
4.5
%
,
8/15/30
......................................
United
Kingdom
10,600,000
10,691,584
42,135,667
Electric
Utilities
2.1%
g
CGNPC
International
Ltd.
,
Senior
Bond
,
Reg
S,
3.75
%
,
12/11/27
..
China
3,289,000
3,587,468
Duke
Energy
Corp.
,
Senior
Bond,
2.45%,
6/01/30
...........................
United
States
3,800,000
3,943,501
Senior
Bond,
3.75%,
9/01/46
...........................
United
States
1,600,000
1,762,583
Exelon
Corp.
,
Senior
Bond,
4.05%,
4/15/30
...........................
United
States
13,400,000
15,499,366
Senior
Bond,
4.45%,
4/15/46
...........................
United
States
1,400,000
1,745,151
Southern
Co.
(The)
,
Senior
Bond
,
4.4
%
,
7/01/46
..............
United
States
5,000,000
6,039,614
g
State
Grid
Overseas
Investment
2016
Ltd.
,
Senior
Bond
,
144A,
3.5
%
,
5/04/27
......................................
China
15,800,000
17,584,446
g
Three
Gorges
Finance
I
Cayman
Islands
Ltd.
,
Senior
Bond
,
144A,
3.15
%
,
6/02/26
.....................................
China
12,800,000
13,813,577
Virginia
Electric
and
Power
Co.
,
Senior
Bond
,
6.35
%
,
11/30/37
...
United
States
820,000
1,214,406
g
Vistra
Operations
Co.
LLC
,
Senior
Note,
144A,
4.375%,
5/01/29
.....................
United
States
11,000,000
11,300,740
Senior
Secured
Bond,
144A,
4.3%,
7/15/29
................
United
States
6,000,000
6,571,616
83,062,468
Electrical
Equipment
0.3%
g
Sensata
Technologies
BV
,
Senior
Note
,
144A,
4
%
,
4/15/29
......
United
States
9,600,000
9,878,640
Electronic
Equipment,
Instruments
&
Components
0.3%
CDW
LLC
/
CDW
Finance
Corp.
,
Senior
Note
,
3.25
%
,
2/15/29
....
United
States
5,000,000
5,030,499
Flex
Ltd.
,
Senior
Bond
,
4.875
%
,
5/12/30
....................
United
States
7,100,000
8,308,978
13,339,477
Energy
Equipment
&
Services
0.4%
g
Nabors
Industries
Ltd.
,
Senior
Note
,
144A,
7.25
%
,
1/15/26
......
United
States
6,000,000
5,619,750
g
Schlumberger
Holdings
Corp.
,
Senior
Note
,
144A,
3.9
%
,
5/17/28
..
United
States
3,800,000
4,276,065
g
Weatherford
International
Ltd.
,
Senior
Note
,
144A,
11
%
,
12/01/24
.
United
States
4,591,000
4,759,329
14,655,144
Entertainment
0.6%
g
Live
Nation
Entertainment,
Inc.
,
Senior
Secured
Note
,
144A,
3.75
%
,
1/15/28
...........................................
United
States
5,800,000
5,821,576
Franklin
Strategic
Series
Statement
of
Investments
(unaudited)
Franklin
Strategic
Income
Fund
(continued)
See
Notes
to
Statements
of
Investments.
Quarterly
Statement
of
Investments
33
a
a
Country
Principal
Amount
*
a
Value
a
a
a
a
a
Corporate
Bonds
(continued)
Entertainment
(continued)
Netflix,
Inc.
,
Senior
Bond,
4.375%,
11/15/26
.........................
United
States
11,800,000
$
13,404,328
g
Senior
Bond,
144A,
4.875%,
6/15/30
.....................
United
States
2,000,000
2,412,270
21,638,174
Equity
Real
Estate
Investment
Trusts
(REITs)
1.6%
g
Global
Net
Lease,
Inc.
/
Global
Net
Lease
Operating
Partnership
LP
,
Senior
Note
,
144A,
3.75
%
,
12/15/27
......................
United
States
7,700,000
7,664,933
g
MGM
Growth
Properties
Operating
Partnership
LP
/
MGP
Finance
Co-Issuer,
Inc.
,
Senior
Note
,
144A,
3.875
%
,
2/15/29
..........
United
States
3,300,000
3,389,463
MPT
Operating
Partnership
LP
/
MPT
Finance
Corp.
,
Senior
Bond,
5.25%,
8/01/26
...........................
United
States
4,200,000
4,316,781
Senior
Bond,
5%,
10/15/27
............................
United
States
5,700,000
6,041,173
Senior
Bond,
3.5%,
3/15/31
............................
United
States
4,000,000
4,110,000
g
Park
Intermediate
Holdings
LLC
/
PK
Domestic
Property
LLC
/
PK
Finance
Co-Issuer
,
Senior
Secured
Note,
144A,
5.875%,
10/01/28
.............
United
States
10,200,000
10,922,466
Senior
Secured
Note,
144A,
4.875%,
5/15/29
..............
United
States
1,700,000
1,740,724
SBA
Communications
Corp.
,
Senior
Note
,
3.875
%
,
2/15/27
......
United
States
9,000,000
9,293,130
Simon
Property
Group
LP
,
Senior
Bond
,
4.25
%
,
11/30/46
.......
United
States
3,000,000
3,607,161
g
VICI
Properties
LP
/
VICI
Note
Co.,
Inc.
,
Senior
Bond,
144A,
4.125%,
8/15/30
.....................
United
States
1,300,000
1,369,466
Senior
Note,
144A,
3.75%,
2/15/27
......................
United
States
7,500,000
7,734,375
g
XHR
LP
,
Senior
Secured
Note
,
144A,
4.875
%
,
6/01/29
.........
United
States
3,500,000
3,587,010
63,776,682
Food
&
Staples
Retailing
0.2%
g
Cencosud
SA
,
Senior
Bond
,
144A,
4.375
%
,
7/17/27
...........
Chile
6,900,000
7,570,542
Food
Products
1.6%
B&G
Foods,
Inc.
,
Senior
Note
,
5.25
%
,
9/15/27
...............
United
States
9,000,000
9,382,500
g
Bimbo
Bakeries
USA,
Inc.
,
Senior
Bond
,
144A,
4
%
,
5/17/51
.....
Mexico
2,000,000
2,231,707
g
Chobani
LLC
/
Chobani
Finance
Corp.,
Inc.
,
Senior
Secured
Note
,
144A,
4.625
%
,
11/15/28
...............................
United
States
7,000,000
7,307,265
g
JBS
Finance
Luxembourg
SARL
,
Senior
Bond
,
144A,
3.625
%
,
1/15/32
...........................................
United
States
3,500,000
3,528,000
Kraft
Heinz
Foods
Co.
,
Senior
Bond,
4.25%,
3/01/31
...........................
United
States
2,000,000
2,310,143
Senior
Note,
3.875%,
5/15/27
..........................
United
States
11,500,000
12,745,193
g
MHP
Lux
SA
,
Senior
Note
,
144A,
6.95
%
,
4/03/26
.............
Ukraine
10,500,000
11,079,023
g
Post
Holdings,
Inc.
,
Senior
Bond
,
144A,
4.5
%
,
9/15/31
.........
United
States
13,000,000
13,172,770
61,756,601
Gas
Utilities
0.1%
Piedmont
Natural
Gas
Co.,
Inc.
,
Senior
Bond
,
3.35
%
,
6/01/50
....
United
States
2,800,000
2,997,529
Health
Care
Providers
&
Services
2.0%
Anthem,
Inc.
,
Senior
Bond
,
3.7
%
,
9/15/49
...................
United
States
1,400,000
1,603,378
Centene
Corp.
,
g
Senior
Note,
144A,
5.375%,
6/01/26
.....................
United
States
7,600,000
7,926,420
Senior
Note,
4.25%,
12/15/27
..........................
United
States
3,000,000
3,168,750
i
Senior
Note,
2.45%,
7/15/28
...........................
United
States
2,300,000
2,334,684
Senior
Note,
4.625%,
12/15/29
.........................
United
States
2,300,000
2,523,560
Senior
Note,
3.375%,
2/15/30
..........................
United
States
1,400,000
1,462,671
i
Senior
Note,
2.625%,
8/01/31
..........................
United
States
5,300,000
5,346,375
Franklin
Strategic
Series
Statement
of
Investments
(unaudited)
Franklin
Strategic
Income
Fund
(continued)
Quarterly
Statement
of
Investments
See
Notes
to
Statements
of
Investments.
34
a
a
Country
Principal
Amount
*
a
Value
a
a
a
a
a
Corporate
Bonds
(continued)
Health
Care
Providers
&
Services
(continued)
g
CHS/Community
Health
Systems,
Inc.
,
Secured
Note,
144A,
6.875%,
4/15/29
....................
United
States
8,000,000
$
8,446,720
Senior
Secured
Note,
144A,
5.625%,
3/15/27
..............
United
States
3,700,000
3,922,166
Senior
Secured
Note,
144A,
6%,
1/15/29
..................
United
States
3,600,000
3,834,396
CVS
Health
Corp.
,
Senior
Bond,
4.3%,
3/25/28
............................
United
States
3,272,000
3,791,613
Senior
Bond,
1.75%,
8/21/30
...........................
United
States
4,000,000
3,923,222
g
DaVita,
Inc.
,
Senior
Note
,
144A,
4.625
%
,
6/01/30
.............
United
States
9,500,000
9,832,500
Orlando
Health
Obligated
Group
,
3.777
%
,
10/01/28
............
United
States
3,870,000
4,384,075
Quest
Diagnostics,
Inc.
,
Senior
Bond
,
2.8
%
,
6/30/31
...........
United
States
2,100,000
2,236,211
g
Tenet
Healthcare
Corp.
,
Senior
Secured
Note
,
144A,
4.25
%
,
6/01/29
United
States
11,500,000
11,744,375
76,481,116
Hotels,
Restaurants
&
Leisure
3.1%
g
Boyd
Gaming
Corp.
,
Senior
Bond
,
144A,
4.75
%
,
6/15/31
........
United
States
8,600,000
8,908,351
g
Caesars
Entertainment,
Inc.
,
Senior
Secured
Note
,
144A,
6.25
%
,
7/01/25
...........................................
United
States
3,700,000
3,911,936
g
Caesars
Resort
Collection
LLC
/
CRC
Finco
,
Inc.
,
Senior
Secured
Note
,
144A,
5.75
%
,
7/01/25
............................
United
States
8,800,000
9,262,000
g
Carnival
Corp.
,
Senior
Note
,
144A,
5.75
%
,
3/01/27
............
United
States
4,100,000
4,171,750
g
Genting
New
York
LLC
/
GENNY
Capital,
Inc.
,
Senior
Note
,
144A,
3.3
%
,
2/15/26
......................................
United
States
2,200,000
2,216,961
g
Golden
Nugget,
Inc.
,
Senior
Note
,
144A,
6.75
%
,
10/15/24
.......
United
States
13,200,000
13,249,500
g
International
Game
Technology
plc
,
Senior
Secured
Note
,
144A,
5.25
%
,
1/15/29
.....................................
United
States
13,000,000
13,894,140
Las
Vegas
Sands
Corp.
,
Senior
Bond
,
3.9
%
,
8/08/29
...........
United
States
8,300,000
8,843,906
MGM
Resorts
International
,
Senior
Note
,
4.75
%
,
10/15/28
.......
United
States
10,000,000
10,539,250
g
Motion
Bondco
DAC
,
Senior
Note
,
144A,
6.625
%
,
11/15/27
......
United
Kingdom
2,000,000
2,037,730
g
NCL
Corp.
Ltd.
,
Senior
Note
,
144A,
5.875
%
,
3/15/26
...........
United
States
17,700,000
17,854,875
g
Penn
National
Gaming,
Inc.
,
Senior
Note
,
144A,
4.125
%
,
7/01/29
.
United
States
6,000,000
5,923,260
g
Studio
City
Finance
Ltd.
,
Senior
Note
,
144A,
5
%
,
1/15/29
.......
Macau
11,700,000
11,543,922
g
TUI
Cruises
GmbH
,
Senior
Note
,
144A,
6.5
%
,
5/15/26
..........
Germany
1,300,000
EUR
1,583,919
g
Wynn
Macau
Ltd.
,
Senior
Note
,
144A,
5.625
%
,
8/26/28
.........
Macau
5,800,000
5,953,120
119,894,620
Household
Durables
0.6%
Mohawk
Industries,
Inc.
,
Senior
Bond
,
3.625
%
,
5/15/30
.........
United
States
14,300,000
16,007,811
g
Williams
Scotsman
International,
Inc.
,
Senior
Secured
Note
,
144A,
4.625
%
,
8/15/28
.....................................
United
States
7,500,000
7,743,750
23,751,561
Household
Products
0.9%
g
Central
Garden
&
Pet
Co.
,
Senior
Bond
,
144A,
4.125
%
,
4/30/31
..
United
States
11,000,000
11,253,715
g
Energizer
Holdings,
Inc.
,
Senior
Note
,
144A,
4.375
%
,
3/31/29
....
United
States
13,500,000
13,610,430
g
Kimberly-Clark
de
Mexico
SAB
de
CV
,
Senior
Bond
,
144A,
2.431
%
,
7/01/31
...........................................
Mexico
2,200,000
2,220,537
g
Spectrum
Brands,
Inc.
,
Senior
Bond,
144A,
5.5%,
7/15/30
.......................
United
States
2,300,000
2,495,419
Senior
Bond,
144A,
3.875%,
3/15/31
.....................
United
States
4,800,000
4,814,136
34,394,237
Independent
Power
and
Renewable
Electricity
Producers
1.6%
g
Atlantica
Sustainable
Infrastructure
plc
,
Senior
Note
,
144A,
4.125
%
,
6/15/28
...........................................
Spain
3,400,000
3,534,470
Franklin
Strategic
Series
Statement
of
Investments
(unaudited)
Franklin
Strategic
Income
Fund
(continued)
See
Notes
to
Statements
of
Investments.
Quarterly
Statement
of
Investments
35
a
a
Country
Principal
Amount
*
a
Value
a
a
a
a
a
Corporate
Bonds
(continued)
Independent
Power
and
Renewable
Electricity
Producers
(continued)
g
Calpine
Corp.
,
Senior
Bond,
144A,
5%,
2/01/31
........................
United
States
4,300,000
$
4,357,985
Senior
Note,
144A,
5.125%,
3/15/28
.....................
United
States
4,000,000
4,055,260
Senior
Note,
144A,
4.625%,
2/01/29
.....................
United
States
6,500,000
6,425,835
g
Clearway
Energy
Operating
LLC
,
Senior
Note
,
144A,
3.75
%
,
2/15/31
United
States
7,800,000
7,810,881
g
Colbun
SA
,
Senior
Bond,
144A,
3.95%,
10/11/27
.....................
Chile
7,500,000
8,224,838
Senior
Bond,
144A,
3.15%,
3/06/30
......................
Chile
2,900,000
3,028,281
g
InterGen
NV
,
Senior
Secured
Bond
,
144A,
7
%
,
6/30/23
.........
Netherlands
11,900,000
11,824,614
g
Talen
Energy
Supply
LLC
,
Senior
Note,
144A,
10.5%,
1/15/26
......................
United
States
3,000,000
2,002,500
Senior
Secured
Note,
144A,
7.25%,
5/15/27
...............
United
States
10,800,000
9,866,664
61,131,328
Insurance
0.3%
Arch
Capital
Group
Ltd.
,
Senior
Bond
,
3.635
%
,
6/30/50
.........
United
States
10,000,000
11,153,816
Interactive
Media
&
Services
0.4%
g
Tencent
Holdings
Ltd.
,
Senior
Bond
,
144A,
2.39
%
,
6/03/30
......
China
17,100,000
17,218,417
Internet
&
Direct
Marketing
Retail
0.4%
Alibaba
Group
Holding
Ltd.
,
Senior
Bond
,
4
%
,
12/06/37
.........
China
4,000,000
4,497,172
JD.com,
Inc.
,
Senior
Bond
,
3.375
%
,
1/14/30
.................
China
12,200,000
13,113,464
17,610,636
IT
Services
0.8%
g
Cablevision
Lightpath
LLC
,
Senior
Secured
Note
,
144A,
3.875
%
,
9/15/27
...........................................
United
States
9,200,000
9,162,096
g
Gartner,
Inc.
,
Senior
Note,
144A,
4.5%,
7/01/28
.......................
United
States
7,000,000
7,411,250
Senior
Note,
144A,
3.625%,
6/15/29
.....................
United
States
2,200,000
2,255,000
g
Presidio
Holdings,
Inc.
,
Senior
Secured
Note
,
144A,
4.875
%
,
2/01/27
United
States
12,000,000
12,393,540
31,221,886
Life
Sciences
Tools
&
Services
0.1%
g
Charles
River
Laboratories
International,
Inc.
,
Senior
Note
,
144A,
3.75
%
,
3/15/29
.....................................
United
States
2,100,000
2,160,375
Machinery
0.4%
g
Manitowoc
Co.,
Inc.
(The)
,
Secured
Note
,
144A,
9
%
,
4/01/26
....
United
States
7,000,000
7,579,250
g
TK
Elevator
U.S.
Newco
,
Inc.
,
Senior
Secured
Note
,
144A,
5.25
%
,
7/15/27
...........................................
Germany
9,000,000
9,515,700
17,094,950
Marine
0.3%
g
ICTSI
Treasury
BV
,
Senior
Bond
,
Reg
S,
4.625
%
,
1/16/23
.......
Philippines
12,000,000
12,750,000
Media
2.6%
Charter
Communications
Operating
LLC
/
Charter
Communications
Operating
Capital
,
Senior
Secured
Bond
,
2.8
%
,
4/01/31
.......
United
States
15,900,000
16,506,890
g
Clear
Channel
Outdoor
Holdings,
Inc.
,
Senior
Note,
144A,
7.75%,
4/15/28
......................
United
States
5,200,000
5,429,736
Senior
Note,
144A,
7.5%,
6/01/29
.......................
United
States
3,500,000
3,637,760
g
Clear
Channel
Worldwide
Holdings,
Inc.
,
Senior
Secured
Note
,
144A,
5.125
%
,
8/15/27
................................
United
States
3,200,000
3,290,720
Franklin
Strategic
Series
Statement
of
Investments
(unaudited)
Franklin
Strategic
Income
Fund
(continued)
Quarterly
Statement
of
Investments
See
Notes
to
Statements
of
Investments.
36
a
a
Country
Principal
Amount
*
a
Value
a
a
a
a
a
Corporate
Bonds
(continued)
Media
(continued)
g
Diamond
Sports
Group
LLC
/
Diamond
Sports
Finance
Co.
,
Senior
Note,
144A,
6.625%,
8/15/27
.....................
United
States
4,500,000
$
1,791,788
Senior
Secured
Note,
144A,
5.375%,
8/15/26
..............
United
States
4,300,000
2,499,375
g,i
DIRECTV
Holdings
LLC
/
DIRECTV
Financing
Co.,
Inc.
,
Senior
Secured
Note
,
144A,
5.875
%
,
8/15/27
....................
United
States
2,300,000
2,380,845
Fox
Corp.
,
Senior
Bond
,
3.5
%
,
4/08/30
.....................
United
States
1,400,000
1,563,948
g
Gray
Television,
Inc.
,
Senior
Note
,
144A,
4.75
%
,
10/15/30
.......
United
States
10,300,000
10,229,754
g
News
Corp.
,
Senior
Note
,
144A,
3.875
%
,
5/15/29
.............
United
States
2,000,000
2,038,850
g
Nexstar
Media,
Inc.
,
Senior
Note
,
144A,
4.75
%
,
11/01/28
........
United
States
8,000,000
8,259,960
g
Outfront
Media
Capital
LLC
/
Outfront
Media
Capital
Corp.
,
Senior
Note
,
144A,
4.25
%
,
1/15/29
............................
United
States
11,000,000
11,055,880
g
Sinclair
Television
Group,
Inc.
,
Senior
Bond,
144A,
5.5%,
3/01/30
.......................
United
States
3,900,000
3,900,097
Senior
Secured
Note,
144A,
4.125%,
12/01/30
.............
United
States
7,600,000
7,384,654
g
Sirius
XM
Radio,
Inc.
,
Senior
Note
,
144A,
4
%
,
7/15/28
.........
United
States
6,000,000
6,197,550
g
Univision
Communications,
Inc.
,
Senior
Secured
Note
,
144A,
5.125
%
,
2/15/25
.....................................
United
States
16,000,000
16,279,040
102,446,847
Metals
&
Mining
1.5%
g
Constellium
SE
,
Senior
Note
,
144A,
3.75
%
,
4/15/29
...........
United
States
10,200,000
10,188,576
g
CSN
Inova
Ventures
,
Senior
Note
,
144A,
6.75
%
,
1/28/28
........
Brazil
8,000,000
8,844,760
g
FMG
Resources
August
2006
Pty.
Ltd.
,
Senior
Bond
,
144A,
4.375
%
,
4/01/31
...........................................
Australia
13,300,000
14,480,841
g
Novelis
Corp.
,
Senior
Bond,
144A,
5.875%,
9/30/26
.....................
United
States
14,000,000
14,545,650
i
Senior
Bond,
144A,
3.875%,
8/15/31
.....................
United
States
2,200,000
2,227,588
i
Senior
Note,
144A,
3.25%,
11/15/26
.....................
United
States
1,700,000
1,727,684
g
SunCoke
Energy,
Inc.
,
Senior
Secured
Note
,
144A,
4.875
%
,
6/30/29
United
States
6,100,000
6,154,229
58,169,328
Mortgage
Real
Estate
Investment
Trusts
(REITs)
0.0%
g
Apollo
Commercial
Real
Estate
Finance,
Inc.
,
Senior
Secured
Note
,
144A,
4.625
%
,
6/15/29
................................
United
States
1,400,000
1,375,640
Multiline
Retail
0.0%
b,e,g
K2016470219
South
Africa
Ltd.
,
Senior
Secured
Note
,
144A,
PIK,
3
%
,
12/31/22
.......................................
South
Africa
10,594,042
b,e,g
K2016470260
South
Africa
Ltd.
,
Senior
Secured
Note
,
144A,
PIK,
25
%
,
12/31/22
......................................
South
Africa
3,798,736
Multi-Utilities
0.2%
Dominion
Energy,
Inc.
,
C
,
Senior
Note
,
3.375
%
,
4/01/30
........
United
States
7,800,000
8,657,974
Oil,
Gas
&
Consumable
Fuels
5.3%
g
Antero
Resources
Corp.
,
Senior
Note,
144A,
8.375%,
7/15/26
.....................
United
States
1,106,000
1,252,678
Senior
Note,
144A,
7.625%,
2/01/29
.....................
United
States
2,600,000
2,853,487
Apache
Corp.
,
Senior
Note,
4.625%,
11/15/25
.........................
United
States
5,600,000
6,027,000
Senior
Note,
4.875%,
11/15/27
.........................
United
States
5,000,000
5,380,775
Canadian
Natural
Resources
Ltd.
,
Senior
Bond
,
2.95
%
,
7/15/30
..
Canada
3,700,000
3,875,832
Cheniere
Corpus
Christi
Holdings
LLC
,
Senior
Secured
Note
,
5.875
%
,
3/31/25
.....................................
United
States
6,400,000
7,318,748
g
Cheniere
Energy
Partners
LP
,
Senior
Note
,
144A,
4
%
,
3/01/31
...
United
States
12,000,000
12,708,600
Franklin
Strategic
Series
Statement
of
Investments
(unaudited)
Franklin
Strategic
Income
Fund
(continued)
See
Notes
to
Statements
of
Investments.
Quarterly
Statement
of
Investments
37
a
a
Country
Principal
Amount
*
a
Value
a
a
a
a
a
Corporate
Bonds
(continued)
Oil,
Gas
&
Consumable
Fuels
(continued)
g
Continental
Resources,
Inc.
,
Senior
Bond
,
144A,
5.75
%
,
1/15/31
..
United
States
6,000,000
$
7,241,070
g
Crestwood
Midstream
Partners
LP
/
Crestwood
Midstream
Finance
Corp.
,
Senior
Note
,
144A,
6
%
,
2/01/29
....................
United
States
15,200,000
15,828,900
g
CrownRock
LP
/
CrownRock
Finance,
Inc.
,
Senior
Note
,
144A,
5
%
,
5/01/29
...........................................
United
States
3,100,000
3,245,700
g
CVR
Energy,
Inc.
,
Senior
Note
,
144A,
5.25
%
,
2/15/25
..........
United
States
5,000,000
4,868,800
g
DT
Midstream,
Inc.
,
Senior
Bond
,
144A,
4.375
%
,
6/15/31
.......
United
States
4,600,000
4,778,595
Energy
Transfer
LP
,
Senior
Bond
,
4.05
%
,
3/15/25
.............
United
States
1,300,000
1,413,068
EnLink
Midstream
LLC
,
Senior
Bond,
5.375%,
6/01/29
..........................
United
States
10,900,000
11,352,459
g
Senior
Note,
144A,
5.625%,
1/15/28
.....................
United
States
1,700,000
1,803,190
e,g
EnQuest
plc
,
Senior
Note
,
144A,
Reg
S,
PIK,
7
%
,
10/15/23
......
United
Kingdom
11,037,421
10,145,708
g
Hilcorp
Energy
I
LP
/
Hilcorp
Finance
Co.
,
Senior
Bond,
144A,
6%,
2/01/31
........................
United
States
6,500,000
6,804,655
Senior
Note,
144A,
5.75%,
2/01/29
......................
United
States
2,000,000
2,043,210
g
Martin
Midstream
Partners
LP
/
Martin
Midstream
Finance
Corp.
,
Secured
Note,
144A,
10%,
2/29/24
......................
United
States
3,608,495
3,712,239
Secured
Note,
144A,
11.5%,
2/28/25
.....................
United
States
16,387,122
16,983,368
MPLX
LP
,
Senior
Note
,
2.65
%
,
8/15/30
.....................
United
States
15,000,000
15,421,057
Occidental
Petroleum
Corp.
,
Senior
Bond,
8.875%,
7/15/30
..........................
United
States
6,800,000
9,185,134
Senior
Bond,
6.125%,
1/01/31
..........................
United
States
5,900,000
6,977,930
Senior
Bond,
6.45%,
9/15/36
...........................
United
States
5,000,000
6,044,250
g
Rattler
Midstream
LP
,
Senior
Note
,
144A,
5.625
%
,
7/15/25
......
United
States
8,200,000
8,569,984
Sabine
Pass
Liquefaction
LLC
,
Senior
Secured
Note
,
4.5
%
,
5/15/30
United
States
10,000,000
11,710,167
Sunoco
LP
/
Sunoco
Finance
Corp.
,
Senior
Note
,
4.5
%
,
5/15/29
..
United
States
12,000,000
12,300,000
g
Venture
Global
Calcasieu
LLC
,
144A,
4.125%,
8/15/31
...............................
United
States
2,600,000
2,694,250
Senior
Secured
Note
,
144A,
3.875%,
8/15/29
..............
United
States
2,600,000
2,661,750
205,202,604
Paper
&
Forest
Products
0.3%
Suzano
Austria
GmbH
,
Senior
Bond,
3.75%,
1/15/31
...........................
Brazil
7,100,000
7,405,655
Senior
Bond,
3.125%,
1/15/32
..........................
Brazil
4,400,000
4,365,900
11,771,555
Personal
Products
0.4%
g
Oriflame
Investment
Holding
plc
,
Senior
Secured
Note
,
144A,
5.125
%
,
5/04/26
.....................................
Switzerland
9,600,000
9,883,200
g
Prestige
Brands,
Inc.
,
Senior
Bond
,
144A,
3.75
%
,
4/01/31
.......
United
States
5,900,000
5,845,779
15,728,979
Pharmaceuticals
1.6%
g
Bausch
Health
Cos.,
Inc.
,
Senior
Bond,
144A,
5.25%,
2/15/31
......................
United
States
4,000,000
3,755,180
Senior
Note,
144A,
5%,
2/15/29
........................
United
States
4,000,000
3,785,160
Senior
Secured
Note,
144A,
4.875%,
6/01/28
..............
United
States
6,300,000
6,508,466
g
Bayer
US
Finance
II
LLC
,
Senior
Bond
,
144A,
4.375
%
,
12/15/28
..
Germany
11,700,000
13,576,730
g
Endo
Dac
/
Endo
Finance
LLC
/
Endo
Finco
,
Inc.
,
Secured
Note,
144A,
9.5%,
7/31/27
......................
United
States
6,580,000
6,609,281
Senior
Note,
144A,
6%,
6/30/28
........................
United
States
6,537,000
4,421,006
g
Organon
&
Co.
/
Organon
Foreign
Debt
Co-Issuer
BV
,
Senior
Bond,
144A,
5.125%,
4/30/31
.....................
United
States
7,300,000
7,528,125
Senior
Secured
Note,
144A,
4.125%,
4/30/28
..............
United
States
10,100,000
10,369,822
Franklin
Strategic
Series
Statement
of
Investments
(unaudited)
Franklin
Strategic
Income
Fund
(continued)
Quarterly
Statement
of
Investments
See
Notes
to
Statements
of
Investments.
38
a
a
Country
Principal
Amount
*
a
Value
a
a
a
a
a
Corporate
Bonds
(continued)
Pharmaceuticals
(continued)
g
Par
Pharmaceutical,
Inc.
,
Senior
Secured
Note
,
144A,
7.5
%
,
4/01/27
United
States
1,716,000
$
1,752,722
g
Royalty
Pharma
plc
,
Senior
Bond
,
144A,
3.3
%
,
9/02/40
.........
United
States
5,300,000
5,409,266
63,715,758
Real
Estate
Management
&
Development
0.9%
g
China
Overseas
Finance
Cayman
VI
Ltd.
,
Senior
Bond
,
Reg
S,
5.95
%
,
5/08/24
.....................................
China
7,500,000
8,402,042
g
Five
Point
Operating
Co.
LP
/
Five
Point
Capital
Corp.
,
Senior
Note
,
144A,
7.875
%
,
11/15/25
...............................
United
States
8,000,000
8,390,560
g
Forestar
Group,
Inc.
,
Senior
Note
,
144A,
3.85
%
,
5/15/26
........
United
States
5,300,000
5,370,066
g
Howard
Hughes
Corp.
(The)
,
Senior
Note
,
144A,
5.375
%
,
8/01/28
.
United
States
10,000,000
10,600,000
g
Vivion
Investments
SARL
,
Senior
Note
,
Reg
S,
3
%
,
8/08/24
.....
Luxembourg
1,800,000
EUR
2,132,415
34,895,083
Road
&
Rail
0.8%
CSX
Corp.
,
Senior
Bond
,
4.1
%
,
3/15/44
....................
United
States
1,600,000
1,921,499
g
First
Student
Bidco
,
Inc.
/
First
Transit
Parent,
Inc.
,
Senior
Secured
Note
,
144A,
4
%
,
7/31/29
..............................
United
States
8,300,000
8,320,750
g
Kazakhstan
Temir
Zholy
Finance
BV
,
Senior
Bond
,
144A,
6.95
%
,
7/10/42
...........................................
Kazakhstan
14,900,000
20,785,500
31,027,749
Software
0.5%
Anagram,
Inc.
,
Secured
Note
,
10
%
,
8/15/26
.................
United
States
640,432
601,117
g
Blackboard,
Inc.
,
Secured
Note
,
144A,
10.375
%
,
11/15/24
.......
United
States
4,200,000
4,402,125
g
NortonLifeLock
,
Inc.
,
Senior
Note
,
144A,
5
%
,
4/15/25
..........
United
States
4,000,000
4,060,520
g
Rocket
Software,
Inc.
,
Senior
Note
,
144A,
6.5
%
,
2/15/29
........
United
States
10,000,000
9,962,950
19,026,712
Specialty
Retail
1.2%
AutoNation,
Inc.
,
Senior
Bond
,
4.75
%
,
6/01/30
...............
United
States
1,900,000
2,274,097
L
Brands,
Inc.
,
Senior
Bond,
5.25%,
2/01/28
...........................
United
States
5,500,000
6,196,960
g
Senior
Bond,
144A,
6.625%,
10/01/30
....................
United
States
1,600,000
1,848,000
g
Lithia
Motors,
Inc.
,
Senior
Bond,
144A,
4.375%,
1/15/31
.....................
United
States
5,000,000
5,459,325
Senior
Note,
144A,
3.875%,
6/01/29
.....................
United
States
6,100,000
6,432,267
g
Michaels
Cos.,
Inc.
(The)
,
Senior
Note,
144A,
7.875%,
5/01/29
.....................
United
States
6,100,000
6,338,022
Senior
Secured
Note,
144A,
5.25%,
5/01/28
...............
United
States
2,700,000
2,797,970
g
Park
River
Holdings,
Inc.
,
Senior
Note
,
144A,
6.75
%
,
8/01/29
....
United
States
11,400,000
11,529,675
g
Party
City
Holdings,
Inc.
,
Senior
Secured
Note
,
144A,
5.75
%
,
(
6-month
USD
LIBOR
+
5
%
),
7/15/25
.....................
United
States
1,153,545
1,094,783
g
Victoria's
Secret
&
Co.
,
Senior
Note
,
144A,
4.625
%
,
7/15/29
.....
United
States
4,100,000
4,110,804
48,081,903
Thrifts
&
Mortgage
Finance
0.8%
g
Ladder
Capital
Finance
Holdings
LLLP
/
Ladder
Capital
Finance
Corp.
,
Senior
Note
,
144A,
4.75
%
,
6/15/29
.................
United
States
2,700,000
2,693,250
MGIC
Investment
Corp.
,
Senior
Note
,
5.25
%
,
8/15/28
..........
United
States
7,000,000
7,455,390
g
PennyMac
Financial
Services,
Inc.
,
Senior
Note
,
144A,
5.375
%
,
10/15/25
..........................................
United
States
9,000,000
9,471,195
g
United
Wholesale
Mortgage
LLC
,
Senior
Note
,
144A,
5.5
%
,
11/15/25
United
States
9,500,000
9,781,675
29,401,510
Franklin
Strategic
Series
Statement
of
Investments
(unaudited)
Franklin
Strategic
Income
Fund
(continued)
See
Notes
to
Statements
of
Investments.
Quarterly
Statement
of
Investments
39
a
a
Country
Principal
Amount
*
a
Value
a
a
a
a
a
Corporate
Bonds
(continued)
Tobacco
0.4%
Altria
Group,
Inc.
,
Senior
Bond
,
3.4
%
,
5/06/30
................
United
States
12,400,000
$
13,362,531
g
Imperial
Brands
Finance
plc
,
Senior
Bond
,
144A,
3.875
%
,
7/26/29
.
United
Kingdom
2,200,000
2,416,099
15,778,630
Trading
Companies
&
Distributors
0.6%
g
H&E
Equipment
Services,
Inc.
,
Senior
Note
,
144A,
3.875
%
,
12/15/28
United
States
13,600,000
13,500,584
g
Herc
Holdings,
Inc.
,
Senior
Note
,
144A,
5.5
%
,
7/15/27
..........
United
States
5,300,000
5,565,000
g
WESCO
Distribution,
Inc.
,
Senior
Note
,
144A,
7.25
%
,
6/15/28
....
United
States
5,500,000
6,129,337
25,194,921
Wireless
Telecommunication
Services
1.0%
e,g
Digicel
Group
Holdings
Ltd.
,
Senior
Note
,
144A,
PIK,
8
%
,
4/01/25
.
Bermuda
1,151,888
995,224
Hughes
Satellite
Systems
Corp.
,
Senior
Note
,
6.625
%
,
8/01/26
...
United
States
8,000,000
9,015,720
Sprint
Communications,
Inc.
,
Senior
Note
,
6
%
,
11/15/22
........
United
States
7,000,000
7,424,900
T-Mobile
USA,
Inc.
,
Senior
Secured
Bond,
3.3%,
2/15/51
.....................
United
States
4,800,000
4,901,160
Senior
Secured
Note,
3.875%,
4/15/30
...................
United
States
13,400,000
15,175,768
37,512,772
Total
Corporate
Bonds
(Cost
$1,986,810,257)
...................................
2,029,375,488
a
h
Senior
Floating
Rate
Interests
1.5%
Aerospace
&
Defense
0.2%
Dynasty
Acquisition
Co.,
Inc.
,
2020
Term
Loan,
B1,
3.647%,
(3-month
USD
LIBOR
+
3.5%),
4/06/26
...........................................
United
States
5,138,131
4,977,565
2020
Term
Loan,
B2,
3.647%,
(3-month
USD
LIBOR
+
3.5%),
4/06/26
...........................................
United
States
2,762,436
2,676,110
7,653,675
a
a
a
a
a
a
Airlines
0.3%
i,j
Air
Canada
,
Term
Loan,
B
,
TBD,
7/27/28
....................
Canada
9,800,000
9,828,616
Diversified
Consumer
Services
0.2%
KUEHG
Corp.
,
Term
Loan,
B3
,
4.75
%
,
(
3-month
USD
LIBOR
+
3.75
%
),
2/21/25
.....................................
United
States
7,100,068
6,967,439
Entertainment
0.2%
Diamond
Sports
Group
LLC
,
Term
Loan
,
3.35
%
,
(
1-month
USD
LIBOR
+
3.25
%
),
8/24/26
..............................
United
States
2,947,500
1,629,835
William
Morris
Endeavor
Entertainment
LLC
(IMG
Worldwide
Holdings
LLC)
,
First
Lien,
Term
Loan,
B1
,
2.85
%
,
(
1-month
USD
LIBOR
+
2.75
%
),
5/18/25
..............................
United
States
7,223,783
7,038,060
8,667,895
a
a
a
a
a
a
Leisure
Products
0.2%
Hercules
Achievement,
Inc.
(Varsity
Brands
Holding
Co.,
Inc.)
,
First
Lien,
Initial
Term
Loan
,
4.5
%
,
(
1-month
USD
LIBOR
+
3.5
%
),
12/16/24
..........................................
United
States
7,952,892
7,756,297
Franklin
Strategic
Series
Statement
of
Investments
(unaudited)
Franklin
Strategic
Income
Fund
(continued)
Quarterly
Statement
of
Investments
See
Notes
to
Statements
of
Investments.
40
a
a
Country
Principal
Amount
*
a
Value
a
a
a
a
a
a
h
Senior
Floating
Rate
Interests
(continued)
Media
0.2%
i
Cengage
Learning,
Inc.
,
First
Lien,
Term
Loan,
B
,
5.75
%
,
(
3-month
USD
LIBOR
+
4.75
%
),
7/14/26
..........................
United
States
7,089,812
7,096,654
i
Clear
Channel
Outdoor
Holdings,
Inc.
,
Term
Loan,
B
,
3.628
%
,
(
2-month
USD
LIBOR
+
3.5%;
3-month
USD
LIBOR
+
3.5%
),
8/21/26
...........................................
United
States
1,400,000
1,361,647
8,458,301
a
a
a
a
a
a
Personal
Products
0.2%
Coty,
Inc.
,
USD
Term
Loan,
B
,
2.352
%
,
(
1-month
USD
LIBOR
+
2.25
%
),
4/07/25
.....................................
United
States
8,043,562
7,749,127
Software
0.0%
b,c,k
WorkCapital
BSD
SARL
,
Term
Loan
,
6.5
%
,
11/02/22
...........
Luxembourg
20,000,000
Total
Senior
Floating
Rate
Interests
(Cost
$77,334,548)
..........................
57,081,350
Marketplace
Loans
0.2%
Diversified
Financial
Services
0.2%
b
Lending
Club
-
LCX
PM,
6.74%
-
23.99%,
9/04/23
-
2/01/26
.....
United
States
3,329,360
3,230,842
b
Lending
Club
-
LCX,
5%
-
25.65%,
5/31/22
-
3/17/25
...........
United
States
2,547,144
2,388,898
b
Prosper,
14.24%
-
16.6%,
7/23/24
-
7/23/26
..................
United
States
29,800
29,748
b
Prosper,
8.7%
-
25.75%,
11/12/23
-
10/12/26
.................
United
States
205,353
197,439
b
Upgrade,
14.19%
-
30.51%,
11/05/22
-
1/22/25
...............
United
States
1,131,689
1,033,571
6,880,498
a
a
a
a
a
a
Total
Marketplace
Loans
(Cost
$7,243,346)
.....................................
6,880,498
Loan
Participations
and
Assignments
0.4%
g
Russian
Railways
Via
RZD
Capital
plc,
Senior
Bond,
Reg
S,
5.7%,
4/05/22
...........................................
Russia
14,600,000
15,107,350
Total
Loan
Participations
and
Assignments
(Cost
$14,819,554)
...................
15,107,350
Foreign
Government
and
Agency
Securities
14.8%
g
African
Export-Import
Bank
(The),
Senior
Bond,
144A,
3.994%,
9/21/29
...........................................
Supranational
l
19,100,000
20,308,075
g
Angola
Government
Bond,
Senior
Bond,
144A,
8.25%,
5/09/28
...
Angola
26,800,000
28,257,652
g
Banque
Centrale
de
Tunisie
,
Senior
Note,
Reg
S,
5.625%,
2/17/24
Tunisia
24,800,000
EUR
25,251,244
g
Banque
Ouest
Africaine
de
Developpement
,
Senior
Bond,
144A,
5%,
7/27/27
...........................................
Supranational
l
11,500,000
12,837,588
g
Belarus
Government
Bond
,
Senior
Bond,
144A,
7.625%,
6/29/27
.....................
Belarus
11,400,000
11,223,015
Senior
Bond,
144A,
6.2%,
2/28/30
.......................
Belarus
12,300,000
10,907,148
Brazil
Notas
do
Tesouro
Nacional
,
10%,
1/01/23
.......................................
Brazil
34,402,000
BRL
6,806,355
m
Index
Linked,
6%,
5/15/23
.............................
Brazil
70,027,822
BRL
14,254,576
Colombia
Government
Bond
,
Senior
Bond,
3.875%,
4/25/27
..........................
Colombia
14,000,000
14,836,780
Senior
Bond,
9.85%,
6/28/27
...........................
Colombia
55,750,000,000
COP
17,142,766
Senior
Bond,
4.5%,
3/15/29
............................
Colombia
2,800,000
3,050,348
Senior
Bond,
5%,
6/15/45
.............................
Colombia
20,700,000
21,719,061
g
Dominican
Republic
Government
Bond,
Senior
Note,
144A,
8.9%,
2/15/23
...........................................
Dominican
Republic
838,300,000
DOP
15,518,672
Ecopetrol
SA,
Senior
Bond,
4.125%,
1/16/25
.................
Colombia
8,200,000
8,597,946
f,g
Electricite
de
France
SA
,
Junior
Sub.
Bond,
144A,
5.25%
to
1/29/23,
FRN
thereafter,
Perpetual
..........................................
France
25,000,000
26,300,000
Franklin
Strategic
Series
Statement
of
Investments
(unaudited)
Franklin
Strategic
Income
Fund
(continued)
See
Notes
to
Statements
of
Investments.
Quarterly
Statement
of
Investments
41
a
a
Country
Principal
Amount
*
a
Value
a
a
a
a
a
a
Foreign
Government
and
Agency
Securities
(continued)
f,g
Electricite
de
France
SA,
(continued)
Junior
Sub.
Bond,
144A,
5.625%
to
1/22/24,
FRN
thereafter,
Perpetual
..........................................
France
5,000,000
$
5,385,000
Equinor
ASA,
Senior
Bond,
2.375%,
5/22/30
.................
Norway
7,000,000
7,332,011
g
Export-Import
Bank
of
India,
Senior
Bond,
144A,
3.875%,
2/01/28
.
India
16,000,000
17,395,353
g
Gabon
Government
Bond
,
144A,
6.375%,
12/12/24
...............................
Gabon
8,243,918
8,778,783
Senior
Bond,
144A,
6.625%,
2/06/31
.....................
Gabon
17,150,000
17,240,895
g
Indonesia
Asahan
Aluminium
Persero
PT,
Senior
Bond,
144A,
5.45%,
5/15/30
.....................................
Indonesia
13,800,000
16,113,294
Indonesia
Government
Bond
,
FR39,
11.75%,
8/15/23
...............................
Indonesia
29,150,000,000
IDR
2,309,123
FR44,
10%,
9/15/24
..................................
Indonesia
8,340,000,000
IDR
664,530
FR56,
8.375%,
9/15/26
...............................
Indonesia
215,988,000,000
IDR
16,987,820
g
Senior
Bond,
144A,
4.35%,
1/08/27
......................
Indonesia
8,100,000
9,207,909
g
Senior
Bond,
144A,
3.85%,
7/18/27
......................
Indonesia
22,000,000
24,571,458
g
Senior
Bond,
144A,
4.625%,
4/15/43
.....................
Indonesia
7,000,000
8,224,253
g
Iraq
Government
Bond,
Senior
Bond,
144A,
5.8%,
1/15/28
......
Iraq
22,262,500
21,350,294
g
Israel
Electric
Corp.
Ltd.,
Senior
Secured
Bond,
144A,
Reg
S,
4.25%,
8/14/28
...........................................
Israel
9,200,000
10,332,060
g
Kazakhstan
Government
Bond,
Senior
Bond,
144A,
4.875%,
10/14/44
..........................................
Kazakhstan
17,700,000
22,476,274
Mexico
Government
Bond
,
Senior
Bond,
4.15%,
3/28/27
...........................
Mexico
28,700,000
32,699,776
Senior
Bond,
3.75%,
1/11/28
...........................
Mexico
4,000,000
4,401,820
Senior
Bond,
4.75%,
4/27/32
...........................
Mexico
6,400,000
7,359,744
Peru
Government
Bond,
Senior
Bond,
6.55%,
3/14/37
..........
Peru
8,600,000
11,722,273
Petroleos
Mexicanos
,
Senior
Bond,
6.625%,
6/15/35
...........
Mexico
6,500,000
6,291,317
g
Russia
Government
Bond
,
Senior
Bond,
Reg
S,
4.75%,
5/27/26
.....................
Russia
12,000,000
13,684,872
Senior
Bond,
144A,
5.625%,
4/04/42
.....................
Russia
5,800,000
7,554,616
n
South
Africa
Government
Bond,
Senior
Bond,
5.875%,
6/22/30
...
South
Africa
6,500,000
7,393,750
Turkey
Government
Bond,
Senior
Bond,
4.875%,
10/09/26
......
Turkey
8,000,000
7,903,432
g
Ukraine
Government
Bond
,
Senior
Note,
144A,
7.75%,
9/01/23
.......................
Ukraine
4,355,000
4,676,025
Senior
Note,
144A,
7.75%,
9/01/24
.......................
Ukraine
4,355,000
4,738,379
Senior
Bond,
144A,
7.375%,
9/25/32
.....................
Ukraine
6,000,000
6,258,480
o
VRI,
GDP
Linked
Security,
Senior
Bond,
144A,
5/31/40
.......
Ukraine
9,990,000
11,668,270
m
Uruguay
Government
Bond,
Index
Linked,
Senior
Bond,
3.7%,
6/26/37
...........................................
Uruguay
968,653,618
UYU
24,910,311
Total
Foreign
Government
and
Agency
Securities
(Cost
$580,353,691)
............
576,643,348
U.S.
Government
and
Agency
Securities
2.9%
U.S.
Treasury
Bonds
,
7.125%,
2/15/23
.....................................
United
States
3,000,000
3,323,203
6.25%,
8/15/23
.....................................
United
States
4,000,000
4,493,906
6.875%,
8/15/25
.....................................
United
States
1,000,000
1,253,438
U.S.
Treasury
Notes
,
1.5%,
11/30/21
......................................
United
States
30,000,000
30,142,884
m
0.125%,
7/15/24
.....................................
United
States
10,340,000
12,687,736
m
0.375%,
7/15/25
.....................................
United
States
17,700,000
22,305,594
1.125%,
2/28/27
.....................................
United
States
40,000,000
40,750,000
Total
U.S.
Government
and
Agency
Securities
(Cost
$110,114,369)
................
114,956,761
Franklin
Strategic
Series
Statement
of
Investments
(unaudited)
Franklin
Strategic
Income
Fund
(continued)
Quarterly
Statement
of
Investments
See
Notes
to
Statements
of
Investments.
42
a
a
Country
Principal
Amount
*
a
Value
a
a
a
a
a
a
Asset-Backed
Securities
6.8%
Airlines
0.0%
United
Airlines
Pass-Through
Trust
,
2020-1
,
B
,
4.875
%
,
7/15/27
..
United
States
1,121,100
$
1,178,009
Consumer
Finance
0.5%
p
Citibank
Credit
Card
Issuance
Trust
,
2017-A7
,
A7
,
FRN
,
0.472
%
,
(
1-month
USD
LIBOR
+
0.37
%
),
8/08/24
..................
United
States
20,069,000
20,145,643
Diversified
Financial
Services
6.3%
g,p
AMMC
CLO
XI
Ltd.
,
2012-11A
,
CR2
,
144A,
FRN
,
2.028
%
,
(
3-month
USD
LIBOR
+
1.9
%
),
4/30/31
...........................
United
States
1,000,000
996,722
g,p
Antares
CLO
Ltd.
,
2018-1A
,
B
,
144A,
FRN
,
1.784
%
,
(
3-month
USD
LIBOR
+
1.65
%
),
4/20/31
..............................
United
States
17,500,000
17,259,375
g,p
BCC
Middle
Market
CLO
LLC
,
2018-1A
,
A2
,
144A,
FRN
,
2.284
%
,
(
3-month
USD
LIBOR
+
2.15
%
),
10/20/30
.................
United
States
6,300,000
6,233,473
g,p
BlueMountain
CLO
Ltd.
,
2012-2A,
BR2,
144A,
FRN,
1.605%,
(3-month
USD
LIBOR
+
1.45%),
11/20/28
....................................
United
States
6,710,000
6,718,231
2012-2A,
CR2,
144A,
FRN,
2.155%,
(3-month
USD
LIBOR
+
2%),
11/20/28
..........................................
United
States
2,730,000
2,710,187
2014-2A,
CR2,
144A,
FRN,
2.334%,
(3-month
USD
LIBOR
+
2.2%),
10/20/30
.....................................
United
States
3,800,000
3,809,146
2016-3A,
CR,
144A,
FRN,
2.356%,
(3-month
USD
LIBOR
+
2.2%),
11/15/30
..........................................
United
States
300,000
300,759
2018-1A,
D,
144A,
FRN,
3.179%,
(3-month
USD
LIBOR
+
3.05%),
7/30/30
...........................................
United
States
5,000,000
4,787,683
g,p
BlueMountain
Fuji
EUR
CLO
V
DAC
,
5A
,
B
,
144A,
FRN
,
1.55
%
,
(
3-month
EURIBOR
+
1.55
%
),
1/15/33
....................
Ireland
6,200,000
EUR
7,366,078
g,p
BlueMountain
Fuji
US
CLO
III
Ltd.
,
2017-3A
,
C
,
144A,
FRN
,
1.826
%
,
(
3-month
USD
LIBOR
+
1.7
%
),
1/15/30
...................
United
States
1,250,000
1,241,068
g,p
Burnham
Park
CLO
Ltd.
,
2016-1A
,
BR
,
144A,
FRN
,
1.634
%
,
(
3-month
USD
LIBOR
+
1.5
%
),
10/20/29
..................
United
States
3,500,000
3,490,344
g,p
Buttermilk
Park
CLO
Ltd.
,
2018-1A
,
C
,
144A,
FRN
,
2.226
%
,
(
3-month
USD
LIBOR
+
2.1
%
),
10/15/31
..................
United
States
9,730,950
9,758,177
g,p
Carlyle
Global
Market
Strategies
CLO
Ltd.
,
2013-3A,
BR,
144A,
FRN,
1.826%,
(3-month
USD
LIBOR
+
1.7%),
10/15/30
..........................................
United
States
300,000
294,099
2014-2RA,
B,
144A,
FRN,
1.981%,
(3-month
USD
LIBOR
+
1.825%),
5/15/31
....................................
United
States
580,000
572,737
2014-4RA,
C,
144A,
FRN,
3.026%,
(3-month
USD
LIBOR
+
2.9%),
7/15/30
...........................................
United
States
3,000,000
2,888,649
g,p
Carlyle
GMS
Finance
MM
CLO
LLC
,
2015-1A
,
A2R
,
144A,
FRN
,
2.326
%
,
(
3-month
USD
LIBOR
+
2.2
%
),
10/15/31
............
United
States
12,000,000
11,793,815
g,q
Consumer
Loan
Underlying
Bond
Certificate
Issuer
Trust
I
,
2018-14,
PT,
144A,
FRN,
7.893%,
9/16/41
.................
United
States
185,708
179,576
b
2018-29,
PT,
144A,
FRN,
30.891%,
12/15/43
...............
United
States
778,925
776,285
2019-26,
PT,
144A,
FRN,
20.753%,
8/15/44
................
United
States
2,977,710
2,979,812
2019-31,
PT,
144A,
FRN,
22.416%,
9/15/44
................
United
States
2,661,709
2,641,665
2019-37,
PT,
144A,
FRN,
22.443%,
10/17/44
...............
United
States
2,780,284
2,744,774
2019-42,
PT,
144A,
FRN,
21.204%,
11/15/44
...............
United
States
3,130,796
3,131,555
2019-51,
PT,
144A,
FRN,
17.225%,
1/15/45
................
United
States
3,441,972
3,444,089
2019-52,
PT,
144A,
FRN,
16.627%,
1/15/45
................
United
States
3,446,554
3,474,959
2019-S1,
PT,
144A,
FRN,
18.465%,
4/15/44
................
United
States
1,697,612
1,669,119
2019-S2,
PT,
144A,
FRN,
15.051%,
5/16/44
................
United
States
1,342,435
1,336,624
2019-S3,
PT,
144A,
FRN,
15.166%,
6/15/44
................
United
States
1,885,308
1,878,306
2019-S4,
PT,
144A,
FRN,
14.24%,
8/15/44
.................
United
States
2,202,595
2,204,348
2019-S5,
PT,
144A,
FRN,
13.929%,
9/15/44
................
United
States
2,261,840
2,262,030
2019-S6,
PT,
144A,
FRN,
12.466%,
10/17/44
...............
United
States
2,179,232
2,142,675
2019-S7,
PT,
144A,
FRN,
11.254%,
12/15/44
...............
United
States
1,905,855
1,882,959
Franklin
Strategic
Series
Statement
of
Investments
(unaudited)
Franklin
Strategic
Income
Fund
(continued)
See
Notes
to
Statements
of
Investments.
Quarterly
Statement
of
Investments
43
a
a
Country
Principal
Amount
*
a
Value
a
a
a
a
a
a
Asset-Backed
Securities
(continued)
Diversified
Financial
Services
(continued)
g,q
Consumer
Loan
Underlying
Bond
Certificate
Issuer
Trust
I,
(continued)
2019-S8,
PT,
144A,
FRN,
11.978%,
1/15/45
................
United
States
2,499,292
$
2,461,878
2020-2,
PT,
144A,
FRN,
17.112%,
3/15/45
.................
United
States
3,306,535
3,317,767
2020-7,
PT,
144A,
FRN,
16.993%,
4/17/45
.................
United
States
2,014,033
1,996,355
g,p
Dryden
38
Senior
Loan
Fund
,
2015-38A
,
CR
,
144A,
FRN
,
2.126
%
,
(
3-month
USD
LIBOR
+
2
%
),
7/15/30
.....................
United
States
7,186,000
7,199,412
g,p
Dryden
55
CLO
Ltd.
,
2018-55A
,
D
,
144A,
FRN
,
2.976
%
,
(
3-month
USD
LIBOR
+
2.85
%
),
4/15/31
..........................
United
States
3,000,000
2,970,000
g,p
Galaxy
XVIII
CLO
Ltd.
,
2018-28A
,
C
,
144A,
FRN
,
2.076
%
,
(
3-month
USD
LIBOR
+
1.95
%
),
7/15/31
..........................
United
States
3,070,000
3,066,095
g,p
Galaxy
XXVII
CLO
Ltd.
,
2018-27A
,
C
,
144A,
FRN
,
1.956
%
,
(
3-month
USD
LIBOR
+
1.8
%
),
5/16/31
...........................
United
States
3,600,000
3,599,998
g,p
HPS
Loan
Management
Ltd.
,
13A-18
,
C
,
144A,
FRN
,
2.276
%
,
(
3-month
USD
LIBOR
+
2.15
%
),
10/15/30
.................
United
States
4,950,000
4,954,185
g,p
LCM
XVII
LP
,
17A,
BRR,
144A,
FRN,
1.726%,
(3-month
USD
LIBOR
+
1.6%),
10/15/31
..........................................
United
States
4,590,000
4,595,040
17A,
CRR,
144A,
FRN,
2.226%,
(3-month
USD
LIBOR
+
2.1%),
10/15/31
..........................................
United
States
4,240,000
4,229,713
g,p
LCM
XVIII
LP
,
18A
,
DR
,
144A,
FRN
,
2.934
%
,
(
3-month
USD
LIBOR
+
2.8
%
),
4/20/31
....................................
United
States
6,860,000
6,586,344
g,p
Madison
Park
Euro
Funding
VIII
DAC
,
8A
,
BRN
,
144A,
FRN
,
1.7
%
,
(
3-month
EURIBOR
+
1.7
%
),
4/15/32
.....................
Ireland
4,100,000
EUR
4,875,724
g,q
Mill
City
Mortgage
Loan
Trust
,
2018-4
,
A1B
,
144A,
FRN
,
3.5
%
,
4/25/66
...........................................
United
States
11,986,139
12,515,955
g,p
Neuberger
Berman
CLO
XXII
Ltd.
,
2016-22A
,
CR
,
144A,
FRN
,
2.334
%
,
(
3-month
USD
LIBOR
+
2.2
%
),
10/17/30
............
United
States
2,129,630
2,132,561
g,p
Octagon
Investment
Partners
28
Ltd.
,
2016-1A
,
BR
,
144A,
FRN
,
1.925
%
,
(
3-month
USD
LIBOR
+
1.8
%
),
10/24/30
............
United
States
3,914,730
3,924,722
g,p
Octagon
Investment
Partners
36
Ltd.
,
2018-1A
,
A1
,
144A,
FRN
,
1.096
%
,
(
3-month
USD
LIBOR
+
0.97
%
),
4/15/31
............
United
States
7,475,000
7,473,332
g,p
Octagon
Investment
Partners
37
Ltd.
,
2018-2A
,
C
,
144A,
FRN
,
2.975
%
,
(
3-month
USD
LIBOR
+
2.85
%
),
7/25/30
............
United
States
4,000,000
3,970,000
g,p
Octagon
Investment
Partners
38
Ltd.
,
2018-1A
,
C
,
144A,
FRN
,
3.084
%
,
(
3-month
USD
LIBOR
+
2.95
%
),
7/20/30
............
United
States
5,000,000
4,875,310
g,q
Prosper
Pass-Thru
Trust
III
,
2020-PT1,
A,
144A,
FRN,
8.796%,
3/15/26
.................
United
States
2,095,306
2,078,020
2020-PT2,
A,
144A,
FRN,
9.444%,
4/15/26
.................
United
States
2,391,608
2,349,755
2020-PT3,
A,
144A,
FRN,
7.183%,
5/15/26
.................
United
States
678,930
681,183
g,p
Strata
CLO
I
Ltd.
,
2018-1A
,
B
,
144A,
FRN
,
2.326
%
,
(
3-month
USD
LIBOR
+
2.2
%
),
1/15/31
...............................
United
States
14,100,000
14,075,906
g,q
Upgrade
Master
Pass-Thru
Trust
,
2019-PT1,
A,
144A,
FRN,
15.567%,
6/15/25
................
United
States
1,047,494
939,043
2019-PT2,
A,
144A,
FRN,
13.977%,
2/15/26
................
United
States
1,829,203
1,848,099
g,p
Voya
CLO
Ltd.
,
2013-2A,
A2AR,
144A,
FRN,
1.525%,
(3-month
USD
LIBOR
+
1.4%),
4/25/31
......................................
United
States
2,200,000
2,189,000
2013-2A,
BR,
144A,
FRN,
1.975%,
(3-month
USD
LIBOR
+
1.85%),
4/25/31
.....................................
United
States
5,770,000
5,692,814
2014-1A,
CR2,
144A,
FRN,
2.934%,
(3-month
USD
LIBOR
+
2.8%),
4/18/31
......................................
United
States
8,000,000
7,737,504
2015-2A,
BR,
144A,
FRN,
1.638%,
(3-month
USD
LIBOR
+
1.5%),
7/23/27
...........................................
United
States
9,290,000
9,292,380
Franklin
Strategic
Series
Statement
of
Investments
(unaudited)
Franklin
Strategic
Income
Fund
(continued)
Quarterly
Statement
of
Investments
See
Notes
to
Statements
of
Investments.
44
a
a
Country
Principal
Amount
*
a
Value
a
a
a
a
a
a
Asset-Backed
Securities
(continued)
Diversified
Financial
Services
(continued)
g,p
Voya
CLO
Ltd.,
(continued)
2016-1A,
BR,
144A,
FRN,
1.934%,
(3-month
USD
LIBOR
+
1.8%),
1/20/31
...........................................
United
States
590,000
$
580,862
245,178,276
a
a
a
a
a
a
Total
Asset-Backed
Securities
(Cost
$264,874,571)
..............................
266,501,928
Commercial
Mortgage-Backed
Securities
0.1%
Diversified
Financial
Services
0.1%
q
Commercial
Mortgage
Trust
,
2006-GG7
,
AJ
,
FRN
,
6.012
%
,
7/10/38
United
States
2,336,688
2,103,603
Total
Commercial
Mortgage-Backed
Securities
(Cost
$2,251,544)
.................
2,103,603
Mortgage-Backed
Securities
3.0%
r
Federal
Home
Loan
Mortgage
Corp.
(FHLMC)
Adjustable
Rate
0.0%
FHLMC,
2.348%,
(1-year
CMT
T-Note
+/-
MBS
Margin),
1/01/33
..
United
States
9,924
9,892
Federal
Home
Loan
Mortgage
Corp.
(FHLMC)
Fixed
Rate
0.0%
FHLMC
Gold
Pools,
15
Year,
5%,
7/01/22
...................
United
States
6,365
6,630
FHLMC
Gold
Pools,
20
Year,
5%,
5/01/27
-
5/01/30
............
United
States
193,610
213,095
FHLMC
Gold
Pools,
20
Year,
6.5%,
10/01/21
.................
United
States
121
136
FHLMC
Gold
Pools,
20
Year,
7%,
9/01/21
...................
United
States
50
50
FHLMC
Gold
Pools,
30
Year,
4.5%,
10/01/40
.................
United
States
81,757
91,417
FHLMC
Gold
Pools,
30
Year,
5%,
3/01/34
-
2/01/38
............
United
States
441,395
497,433
FHLMC
Gold
Pools,
30
Year,
5.5%,
6/01/33
-
6/01/36
..........
United
States
522,845
597,912
FHLMC
Gold
Pools,
30
Year,
6%,
6/01/33
-
6/01/37
............
United
States
196,557
224,262
FHLMC
Gold
Pools,
30
Year,
6.5%,
12/01/25
-
6/01/36
.........
United
States
62,059
71,791
FHLMC
Gold
Pools,
30
Year,
7%,
4/01/28
-
8/01/32
............
United
States
11,190
11,735
FHLMC
Gold
Pools,
30
Year,
7.5%,
1/01/26
-
1/01/31
..........
United
States
3,151
3,730
FHLMC
Gold
Pools,
30
Year,
8%,
11/01/25
-
1/01/26
...........
United
States
49
49
FHLMC
Gold
Pools,
30
Year,
9%,
12/01/24
..................
United
States
29
32
1,718,272
r
Federal
National
Mortgage
Association
(FNMA)
Adjustable
Rate
0.0%
FNMA,
2.331%,
(1-year
CMT
T-Note
+/-
MBS
Margin),
12/01/34
..
United
States
78,214
79,912
Federal
National
Mortgage
Association
(FNMA)
Fixed
Rate
2.6%
FNMA,
15
Year,
2.5%,
7/01/27
...........................
United
States
131,593
138,507
FNMA,
15
Year,
5.5%,
4/01/22
...........................
United
States
794
798
FNMA,
20
Year,
4.5%,
3/01/28
...........................
United
States
35,867
38,650
FNMA,
20
Year,
5%,
9/01/23
-
6/01/31
......................
United
States
241,984
266,278
FNMA,
30
Year,
3%,
9/01/48
-
4/01/51
......................
United
States
23,762,852
25,110,451
FNMA,
30
Year,
4.5%,
2/01/41
...........................
United
States
202,439
226,301
FNMA,
30
Year,
5%,
10/01/35
............................
United
States
443,926
505,587
FNMA,
30
Year,
5.5%,
9/01/33
-
12/01/35
...................
United
States
675,142
773,938
FNMA,
30
Year,
6%,
6/01/34
-
5/01/38
......................
United
States
1,110,937
1,274,445
FNMA,
30
Year,
6.5%,
3/01/28
-
10/01/37
...................
United
States
204,610
238,503
FNMA,
30
Year,
7.5%,
10/01/29
...........................
United
States
3,495
4,070
FNMA,
30
Year,
8%,
1/01/25
-
5/01/26
......................
United
States
1,413
1,552
s
FNMA,
Single-family,
15
Year,
2%,
8/25/36
..................
United
States
14,514,000
15,063,378
s
FNMA,
Single-family,
30
Year,
2%,
8/25/51
..................
United
States
19,610,000
20,002,966
s
FNMA,
Single-family,
30
Year,
2.5%,
8/25/51
.................
United
States
34,852,000
36,307,343
99,952,767
Government
National
Mortgage
Association
(GNMA)
Fixed
Rate
0.4%
GNMA
I,
30
Year,
8%,
2/15/25
............................
United
States
19
20
GNMA
I,
Single-family,
30
Year,
5%,
6/15/34
-
7/15/34
..........
United
States
70,707
80,341
Franklin
Strategic
Series
Statement
of
Investments
(unaudited)
Franklin
Strategic
Income
Fund
(continued)
See
Notes
to
Statements
of
Investments.
Quarterly
Statement
of
Investments
45
a
a
Country
Principal
Amount
*
a
Value
a
a
a
a
a
a
Mortgage-Backed
Securities
(continued)
Government
National
Mortgage
Association
(GNMA)
Fixed
Rate
(continued)
GNMA
I,
Single-family,
30
Year,
5.5%,
2/15/33
-
6/15/36
........
United
States
253,621
$
290,114
GNMA
I,
Single-family,
30
Year,
6%,
8/15/36
.................
United
States
15,561
18,374
GNMA
I,
Single-family,
30
Year,
6.5%,
2/15/29
-
3/15/32
........
United
States
4,138
4,627
GNMA
I,
Single-family,
30
Year,
7%,
11/15/27
-
5/15/28
.........
United
States
4,670
4,691
GNMA
I,
Single-family,
30
Year,
7.5%,
9/15/23
-
5/15/27
........
United
States
440
453
GNMA
I,
Single-family,
30
Year,
8%,
7/15/26
-
9/15/27
..........
United
States
2,301
2,384
GNMA
I,
Single-family,
30
Year,
8.5%,
8/15/24
................
United
States
30
30
GNMA
I,
Single-family,
30
Year,
9%,
1/15/25
.................
United
States
104
104
GNMA
I,
Single-family,
30
Year,
9.5%,
6/15/25
................
United
States
268
269
s
GNMA
II,
Single-family,
30
Year,
2%,
8/15/51
.................
United
States
7,714,000
7,901,125
s
GNMA
II,
Single-family,
30
Year,
2.5%,
8/15/51
...............
United
States
7,651,000
7,954,948
GNMA
II,
Single-family,
30
Year,
5%,
9/20/33
-
11/20/33
.........
United
States
119,462
134,335
GNMA
II,
Single-family,
30
Year,
5.5%,
6/20/34
...............
United
States
62,706
73,717
GNMA
II,
Single-family,
30
Year,
6%,
11/20/34
................
United
States
66,378
77,895
GNMA
II,
Single-family,
30
Year,
6.5%,
7/20/28
-
12/20/31
.......
United
States
36,692
42,447
GNMA
II,
Single-family,
30
Year,
7.5%,
4/20/32
...............
United
States
13,430
15,302
16,601,176
Total
Mortgage-Backed
Securities
(Cost
$116,665,901)
...........................
118,362,019
Municipal
Bonds
0.9%
California
0.1%
San
Bernardino
Community
College
District
,
GO
,
2019
A-1
,
3.271
%
,
8/01/39
...........................................
United
States
2,160,000
2,311,005
Illinois
0.2%
State
of
Illinois
,
GO
,
2003
,
5.1
%
,
6/01/33
...................
United
States
6,960,000
8,353,683
New
Jersey
0.1%
New
Jersey
Transportation
Trust
Fund
Authority
,
Revenue
,
2019
B
,
Refunding
,
4.131
%
,
6/15/42
............................
United
States
3,535,000
4,110,219
New
York
0.2%
Metropolitan
Transportation
Authority
,
Revenue
,
2020
E
,
Refunding
,
4
%
,
11/15/45
.......................................
United
States
5,340,000
6,265,335
New
York
State
Dormitory
Authority
,
State
University
of
New
York
,
Revenue
,
2019
B
,
Refunding
,
3.142
%
,
7/01/43
..............
United
States
3,145,000
3,335,444
9,600,779
Ohio
0.1%
State
of
Ohio
,
Cleveland
Clinic
Health
System
Obligated
Group
,
Revenue
,
2019
G
,
Refunding
,
3.276
%
,
1/01/42
.............
United
States
1,975,000
2,198,556
Pennsylvania
0.1%
University
of
Pittsburgh-of
the
Commonwealth
System
of
Higher
Education
,
Revenue
,
2017
C
,
Refunding
,
3.005
%
,
9/15/41
.....
United
States
5,500,000
5,920,998
Texas
0.1%
Texas
State
University
System
,
Revenue
,
2019
B
,
Refunding
,
3.289
%
,
3/15/40
.....................................
United
States
1,965,000
2,072,269
Total
Municipal
Bonds
(Cost
$30,511,182)
......................................
34,567,509
Residential
Mortgage-Backed
Securities
8.6%
Diversified
Financial
Services
0.6%
g
BRAVO
Residential
Funding
Trust
,
2019-1,
A1C,
144A,
3.5%,
3/25/58
.......................
United
States
4,079,335
4,179,740
q
2019-2,
A3,
144A,
FRN,
3.5%,
10/25/44
...................
United
States
6,183,335
6,458,681
Franklin
Strategic
Series
Statement
of
Investments
(unaudited)
Franklin
Strategic
Income
Fund
(continued)
Quarterly
Statement
of
Investments
See
Notes
to
Statements
of
Investments.
46
a
a
Country
Principal
Amount
*
a
Value
a
a
a
a
a
a
Residential
Mortgage-Backed
Securities
(continued)
Diversified
Financial
Services
(continued)
g,q
CIM
Trust
,
2019-INV1,
A1,
144A,
FRN,
4%,
2/25/49
..................
United
States
2,964,270
$
3,011,344
2019-INV2,
A3,
144A,
FRN,
4%,
5/25/49
..................
United
States
4,599,021
4,690,545
g,q
Provident
Funding
Mortgage
Trust
,
2019-1,
A2,
144A,
FRN,
3%,
12/25/49
....................
United
States
2,647,370
2,679,771
2020-1,
A3,
144A,
FRN,
3%,
2/25/50
.....................
United
States
777,572
779,552
21,799,633
a
a
a
a
a
a
Thrifts
&
Mortgage
Finance
8.0%
p
FHLMC
Structured
Agency
Credit
Risk
Debt
Notes
,
2013-DN2,
M2,
FRN,
4.339%,
(1-month
USD
LIBOR
+
4.25%),
11/25/23
..........................................
United
States
7,142,942
7,335,530
2014-DN2,
M3,
FRN,
3.689%,
(1-month
USD
LIBOR
+
3.6%),
4/25/24
...........................................
United
States
13,539,270
13,750,911
2014-DN3,
M3,
FRN,
4.089%,
(1-month
USD
LIBOR
+
4%),
8/25/24
...........................................
United
States
406,091
414,527
2014-DN4,
M3,
FRN,
4.639%,
(1-month
USD
LIBOR
+
4.55%),
10/25/24
..........................................
United
States
4,520,316
4,588,701
2014-HQ1,
M3,
FRN,
4.189%,
(1-month
USD
LIBOR
+
4.1%),
8/25/24
...........................................
United
States
555,985
559,872
2014-HQ3,
M3,
FRN,
4.839%,
(1-month
USD
LIBOR
+
4.75%),
10/25/24
..........................................
United
States
854,159
857,693
2015-DNA1,
M3,
FRN,
3.389%,
(1-month
USD
LIBOR
+
3.3%),
10/25/27
..........................................
United
States
1,397,995
1,419,370
2015-DNA3,
M3,
FRN,
4.789%,
(1-month
USD
LIBOR
+
4.7%),
4/25/28
...........................................
United
States
14,795,889
15,314,473
2015-HQA1,
M3,
FRN,
4.789%,
(1-month
USD
LIBOR
+
4.7%),
3/25/28
...........................................
United
States
13,406,934
13,766,937
2016-DNA2,
M3,
FRN,
4.739%,
(1-month
USD
LIBOR
+
4.65%),
10/25/28
..........................................
United
States
12,123,113
12,671,553
2017-DNA1,
M2,
FRN,
3.339%,
(1-month
USD
LIBOR
+
3.25%),
7/25/29
...........................................
United
States
6,850,246
7,041,090
2017-DNA2,
M2,
FRN,
3.539%,
(1-month
USD
LIBOR
+
3.45%),
10/25/29
..........................................
United
States
5,868,312
6,085,891
2017-DNA3,
M2,
FRN,
2.589%,
(1-month
USD
LIBOR
+
2.5%),
3/25/30
...........................................
United
States
26,312,269
26,907,229
2017-HQA1,
M2,
FRN,
3.639%,
(1-month
USD
LIBOR
+
3.55%),
8/25/29
...........................................
United
States
23,533,600
24,335,298
2017-HQA2,
M2,
FRN,
2.739%,
(1-month
USD
LIBOR
+
2.65%),
12/25/29
..........................................
United
States
2,619,843
2,664,411
p
FNMA
Connecticut
Avenue
Securities
,
2013-C01,
M2,
FRN,
5.339%,
(1-month
USD
LIBOR
+
5.25%),
10/25/23
..........................................
United
States
6,751,674
7,058,860
2014-C01,
M2,
FRN,
4.489%,
(1-month
USD
LIBOR
+
4.4%),
1/25/24
...........................................
United
States
8,393,949
8,678,665
2014-C02,
1M2,
FRN,
2.689%,
(1-month
USD
LIBOR
+
2.6%),
5/25/24
...........................................
United
States
7,549,515
7,605,264
2014-C03,
1M2,
FRN,
3.089%,
(1-month
USD
LIBOR
+
3%),
7/25/24
...........................................
United
States
16,086,538
16,220,562
2014-C03,
2M2,
FRN,
2.989%,
(1-month
USD
LIBOR
+
2.9%),
7/25/24
...........................................
United
States
1,528,357
1,549,444
2015-C01,
1M2,
FRN,
4.389%,
(1-month
USD
LIBOR
+
4.3%),
2/25/25
...........................................
United
States
3,241,551
3,321,216
2015-C01,
2M2,
FRN,
4.639%,
(1-month
USD
LIBOR
+
4.55%),
2/25/25
...........................................
United
States
292,409
292,922
2015-C02,
1M2,
FRN,
4.089%,
(1-month
USD
LIBOR
+
4%),
5/25/25
...........................................
United
States
10,021,662
10,228,118
Franklin
Strategic
Series
Statement
of
Investments
(unaudited)
Franklin
Strategic
Income
Fund
(continued)
See
Notes
to
Statements
of
Investments.
Quarterly
Statement
of
Investments
47
a
a
Country
Principal
Amount
*
a
Value
a
a
a
a
a
a
Residential
Mortgage-Backed
Securities
(continued)
Thrifts
&
Mortgage
Finance
(continued)
p
FNMA
Connecticut
Avenue
Securities,
(continued)
2015-C02,
2M2,
FRN,
4.089%,
(1-month
USD
LIBOR
+
4%),
5/25/25
...........................................
United
States
1,989,427
$
2,008,132
2015-C03,
1M2,
FRN,
5.089%,
(1-month
USD
LIBOR
+
5%),
7/25/25
...........................................
United
States
11,685,773
12,003,387
2015-C03,
2M2,
FRN,
5.089%,
(1-month
USD
LIBOR
+
5%),
7/25/25
...........................................
United
States
2,563,950
2,595,222
2016-C01,
1M2,
FRN,
6.839%,
(1-month
USD
LIBOR
+
6.75%),
8/25/28
...........................................
United
States
2,129,212
2,270,329
2016-C02,
1M2,
FRN,
6.089%,
(1-month
USD
LIBOR
+
6%),
9/25/28
...........................................
United
States
15,000,757
15,772,432
2016-C03,
1M2,
FRN,
5.389%,
(1-month
USD
LIBOR
+
5.3%),
10/25/28
..........................................
United
States
10,560,869
11,101,096
2016-C04,
1M2,
FRN,
4.339%,
(1-month
USD
LIBOR
+
4.25%),
1/25/29
...........................................
United
States
6,344,697
6,634,934
2016-C05,
2M2,
FRN,
4.539%,
(1-month
USD
LIBOR
+
4.45%),
1/25/29
...........................................
United
States
3,528,542
3,697,495
2016-C06,
1M2,
FRN,
4.339%,
(1-month
USD
LIBOR
+
4.25%),
4/25/29
...........................................
United
States
1,613,040
1,678,217
2016-C07,
2M2,
FRN,
4.439%,
(1-month
USD
LIBOR
+
4.35%),
5/25/29
...........................................
United
States
2,475,523
2,597,003
2017-C01,
1M2,
FRN,
3.639%,
(1-month
USD
LIBOR
+
3.55%),
7/25/29
...........................................
United
States
15,636,995
16,204,411
2017-C03,
1M2,
FRN,
3.089%,
(1-month
USD
LIBOR
+
3%),
10/25/29
..........................................
United
States
22,152,645
22,777,837
2017-C04,
2M2,
FRN,
2.939%,
(1-month
USD
LIBOR
+
2.85%),
11/25/29
..........................................
United
States
5,986,615
6,142,395
2017-C05,
1M2,
FRN,
2.289%,
(1-month
USD
LIBOR
+
2.2%),
1/25/30
...........................................
United
States
15,007,776
15,328,975
313,480,402
a
a
a
a
a
a
Total
Residential
Mortgage-Backed
Securities
(Cost
$351,761,760)
................
335,280,035
Shares
Escrows
and
Litigation
Trusts
0.0%
Mesquite
Energy,
Inc.,
Escrow
Account
.....................
United
States
6,000,000
165,000
a,b
Millennium
Corporate
Claim
Trust,
Escrow
Account
............
United
States
8,736,450
a,b
Millennium
Lender
Claim
Trust,
Escrow
Account
..............
United
States
8,736,450
Total
Escrows
and
Litigation
Trusts
(Cost
$5,707,489)
...........................
165,000
Total
Long
Term
Investments
(Cost
$3,950,144,037)
.............................
3,878,967,674
a
Number
of
Contracts
Notional
Amount
#
a
a
aa
Options
Purchased
0.0%
Calls
-
Over-the-Counter
Interest
Rate
Swaptions
0.0%
Receive
Fixed
0.9%,
Pay
Floating
3-month
USD
LIBOR,
Counterparty
CITI,
Expires
9/16/21
.......................
1
209,200,000
1,353,533
Total
Options
Purchased
(Cost
$1,103,530)
.....................................
1,353,533
Franklin
Strategic
Series
Statement
of
Investments
(unaudited)
Franklin
Strategic
Income
Fund
(continued)
Quarterly
Statement
of
Investments
See
Notes
to
Statements
of
Investments.
48
Short
Term
Investments
3.7%
a
a
Country
Shares
a
Value
a
Money
Market
Funds
1.3%
d,t
Institutional
Fiduciary
Trust
-
Money
Market
Portfolio,
0.01%
.....
United
States
50,697,250
$
50,697,250
Total
Money
Market
Funds
(Cost
$50,697,250)
..................................
50,697,250
Principal
Amount
*
a
a
a
a
a
Repurchase
Agreements
2.3%
u
Joint
Repurchase
Agreement,
0.026%,
8/02/21
(Maturity
Value
$88,181,666)
BNP
Paribas
Securities
Corp.
(Maturity
Value
$63,817,953)
Deutsche
Bank
Securities,
Inc.
(Maturity
Value
$8,864,903)
HSBC
Securities
(USA)
Inc.
(Maturity
Value
$15,498,810)
Collateralized
by
U.S.
Government
Agency
Securities,
3%
-
5%,
4/20/41
-
3/20/51;
U.S.
Treasury
Bond,
Index
Linked,
2.38%,
1/15/25;
and
U.S.
Treasury
Note,
2.25%,
4/30/24
(valued
at
$89,964,316)
.......................................
88,181,473
88,181,473
Total
Repurchase
Agreements
(Cost
$88,181,473)
...............................
88,181,473
Investments
from
Cash
Collateral
Received
for
Loaned
Securities
0.1%
Country
Shares
Money
Market
Funds
0.1%
d,t
Institutional
Fiduciary
Trust
-
Money
Market
Portfolio,
0.01%
.....
United
States
3,802,000
3,802,000
Principal
Amount
*
Repurchase
Agreements
0.0%
u
Joint
Repurchase
Agreement,
BofA
Securities,
Inc.,
0.05%,
8/02/21
(Maturity
Value
$950,600)
Collateralized
by
U.S.
Treasury
Note,
0.125%,
10/31/22
(valued
at
$969,608)
.........................................
950,596
950,596
Total
Investments
from
Cash
Collateral
Received
for
Loaned
Securities
(Cost
$4,752,596)
............................................................
4,752,596
Total
Short
Term
Investments
(Cost
$143,631,319
)
...............................
143,631,319
a
Total
Investments
(Cost
$4,094,878,886)
103.2%
................................
$4,023,952,526
Options
Written
(0.0)%
......................................................
(35,082)
Other
Assets,
less
Liabilities
(3.2)%
...........................................
(127,316,300)
Net
Assets
100.0%
...........................................................
$3,896,601,144
Number
of
Contracts
Notional
Amount
#
Options
Written
(0.0)%
Puts
-
Over-the-Counter
Interest
Rate
Swaptions
(0.0)%
Receive
Floating
3-month
USD
LIBOR,
Pay
Fixed
1.39%,
Counterparty
CITI,
Expires
9/16/21
.......................
1
(209,200,000)
(35,082)
(35,082)
Total
Options
Written
(Premiums
received
$1,082,610)
...........................
$
(35,082)
Franklin
Strategic
Series
Statement
of
Investments
(unaudited)
Franklin
Strategic
Income
Fund
(continued)
See
Notes
to
Statements
of
Investments.
Quarterly
Statement
of
Investments
49
#
Notional
amount
is
the
number
of
units
specified
in
the
contract,
and
can
include
currency
units,
bushels,
shares,
pounds,
barrels
or
other
units.
Currency
units
are
stated
in
U.S.
dollars
unless
otherwise
indicated.
*
The
principal
amount
is
stated
in
U.S.
dollars
unless
otherwise
indicated.
Rounds
to
less
than
0.1%
of
net
assets.
a
Non-income
producing.
b
Fair
valued
using
significant
unobservable
inputs.
See
Note
10
regarding
fair
value
measurements.
c
See
Note
7
regarding
restricted
securities.
d
See
Note
9
regarding
investments
in
affiliated
management
investment
companies.
e
Income
may
be
received
in
additional
securities
and/or
cash.
f
Perpetual
security
with
no
stated
maturity
date.
g
Security
was
purchased
pursuant
to
Rule
144A
or
Regulation
S
under
the
Securities
Act
of
1933.
144A
securities
may
be
sold
in
transactions
exempt
from
registration
only
to
qualified
institutional
buyers
or
in
a
public
offering
registered
under
the
Securities
Act
of
1933.
Regulation
S
securities
cannot
be
sold
in
the
United
States
without
either
an
effective
registration
statement
filed
pursuant
to
the
Securities
Act
of
1933,
or
pursuant
to
an
exemption
from
registration.
At
July
31,
2021,
the
aggregate
value
of
these
securities
was
$2,063,744,861,
representing
53.0%
of
net
assets.
h
The
coupon
rate
shown
represents
the
rate
at
period
end.
i
A
portion
or
all
of
the
security
purchased
on
a
delayed
delivery
basis.
j
A
portion
or
all
of
the
security
represents
an
unsettled
loan
commitment.
The
coupon
rate
is
to-be
determined
(TBD)
at
the
time
of
the
settlement
and
will
be
based
upon
a
reference
index/floor
plus
a
spread.
k
Defaulted
security
or
security
for
which
income
has
been
deemed
uncollectible.
l
A
supranational
organization
is
an
entity
formed
by
two
or
more
central
governments
through
international
treaties.
m
Principal
amount
of
security
is
adjusted
for
inflation.
n
A
portion
or
all
of
the
security
is
on
loan
at
July
31,
2021.
o
The
principal
represents
the
notional
amount.
See
Note
3
regarding
value
recovery
instruments.
p
The
coupon
rate
shown
represents
the
rate
inclusive
of
any
caps
or
floors,
if
applicable,
in
effect
at
period
end.
q
Adjustable
rate
security
with
an
interest
rate
that
is
not
based
on
a
published
reference
index
and
spread.  The
rate
is
based
on
the
structure
of
the
agreement
and
current
market
conditions.
The
coupon
rate
shown
represents
the
rate
at
period
end.
r
Adjustable
Rate
Mortgage-Backed
Security
(ARM);
the
rate
shown
is
the
effective
rate
at
period
end.
ARM
rates
are
not
based
on
a
published
reference
rate
and
spread,
but
instead
pass-through
weighted
average
interest
income
inclusive
of
any
caps
or
floors,
if
applicable,
from
the
underlying
mortgage
loans
in
which
the
majority
of
mortgages
pay
interest
based
on
the
index
shown
at
their
designated
reset
dates
plus
a
spread,
less
the
applicable
servicing
and
guaranty
fee
(MBS
margin).
s
Security
purchased
on
a
to-be-announced
(TBA)
basis.
t
The
rate
shown
is
the
annualized
seven-day
effective
yield
at
period
end.
u
Investment
is
through
participation
in
a
joint
account
with
other
funds
managed
by
the
investment
manager
or
an
affiliate
of
the
investment
manager.
At
July
31,
2021,
all
repurchase
agreements
had
been
entered
into
on
that
date.
Franklin
Strategic
Series
Statement
of
Investments
(unaudited)
Franklin
Strategic
Income
Fund
(continued)
Quarterly
Statement
of
Investments
See
Notes
to
Statements
of
Investments.
50
At
July
31,
2021,
the
Fund
had
the
following futures
contracts
outstanding.
See
Note
3. 
At
July
31,
2021,
the
Fund
had
the
following
forward
exchange
contracts
outstanding.
See
Note
3
At
July
31,
2021,
the
Fund
had
the
following credit
default
swap
contracts outstanding.
See
Note
3
Futures
Contracts
Description
Type
Number
of
Contracts
Notional
Amount
*
Expiration
Date
Value/
Unrealized
Appreciation
(Depreciation)
Interest
rate
contracts
U.S.
Treasury
10
Year
Notes
....................
Short
547
$
73,545,859
9/21/21
$
(166,296)
U.S.
Treasury
10
Year
Ultra
Notes
................
Short
524
78,731,000
9/21/21
(2,593,159)
U.S.
Treasury
2
Year
Notes
.....................
Long
808
178,290,250
9/30/21
(32,548)
U.S.
Treasury
5
Year
Notes
.....................
Long
1,006
125,191,985
9/30/21
631,121
U.S.
Treasury
Long
Bonds
.....................
Short
703
115,797,281
9/21/21
(4,628,456)
Total
Futures
Contracts
......................................................................
$(6,789,338)
*
As
of
period
end.
Forward
Exchange
Contracts
Currency
Counter-
party
a
Type
Quantity
Contract
Amount
*
Settlement
Date
Unrealized
Appreciation
Unrealized
Depreciation
a
a
a
a
a
a
a
a
OTC
Forward
Exchange
Contracts
Brazilian
Real
......
JPHQ
Buy
3,778,007
746,314
8/09/21
$
$
(21,502)
Brazilian
Real
......
JPHQ
Sell
3,778,007
689,480
8/09/21
(35,332)
Canadian
Dollar
....
JPHQ
Buy
15,500,000
12,457,459
8/09/21
(37,269)
Canadian
Dollar
....
JPHQ
Sell
15,500,000
12,763,033
8/09/21
342,843
Chinese
Yuan
......
JPHQ
Buy
64,000,000
9,736,950
8/17/21
149,751
Brazilian
Real
......
JPHQ
Sell
119,495,000
22,458,089
8/30/21
(399,358)
Turkish
Lira
........
JPHQ
Buy
61,000,000
6,827,085
9/07/21
276,417
Mexican
Peso
......
JPHQ
Buy
287,000,000
14,118,353
9/21/21
200,788
Australian
Dollar
....
JPHQ
Buy
11,000,000
8,339,375
9/27/21
(265,293)
South
Korean
Won
..
JPHQ
Buy
10,300,000,000
9,079,530
9/27/21
(154,384)
Euro
.............
JPHQ
Sell
39,200,000
46,343,886
10/18/21
(227,019)
Brazilian
Real
......
JPHQ
Sell
3,778,007
736,770
11/08/21
21,367
Canadian
Dollar
....
JPHQ
Sell
15,500,000
12,456,257
11/08/21
35,263
Total
Forward
Exchange
Contracts
...................................................
$1,026,429
$(1,140,157)
Net
unrealized
appreciation
(depreciation)
............................................
$(113,728)
*
In
U.S.
dollars
unless
otherwise
indicated.
a
May
be
comprised
of
multiple
contracts
with
the
same
counterparty,
currency
and
settlement
date.
Franklin
Strategic
Series
Statement
of
Investments
(unaudited)
Franklin
Strategic
Income
Fund
(continued)
See
Notes
to
Statements
of
Investments.
Quarterly
Statement
of
Investments
51
Credit
Default
Swap
Contracts
Description
Periodic
Payment
Rate
Received
(Paid)
Payment
Frequency
Counter-
party
Maturity
Date
Notional
Amount
(a)
Value
Unamortized
Upfront
Payments
(Receipts)
Unrealized
Appreciation
(Depreciation)
Rating
(b)
OTC
Swap
Contracts
Contracts
to
Sell
Protection
(c)(d)
Single
Name
Air
France-KLM
.
5.00%
Quarterly
BOFA
6/20/26
970,000
EUR
$
47,229
$
19,048
$
28,181
NR
Air
France-KLM
.
5.00%
Quarterly
JPHQ
6/20/26
2,310,000
EUR
112,473
39,628
72,845
NR
Air
France-KLM
.
5.00%
Quarterly
MSCO
12/20/25
6,680,000
EUR
322,361
6,994
315,367
NR
American
Airlines
Group,
Inc.
..
5.00%
Quarterly
CITI
12/20/21
8,100,000
176,813
(209,835)
386,648
CCC
American
Airlines
Group,
Inc.
..
5.00%
Quarterly
GSCO
6/20/22
2,000,000
34,089
(16,630)
50,719
CCC
Carnival
Corp.
..
1.00%
Quarterly
CITI
12/20/25
8,100,000
(1,037,501)
(1,111,338)
73,837
B-
Macy's
Retail
Holdings
LLC
.
1.00%
Quarterly
JPHQ
12/20/25
8,100,000
(685,651)
(1,323,742)
638,091
B
Nordstrom,
Inc.
.
1.00%
Quarterly
BNDP
6/20/26
4,700,000
(296,456)
(298,655)
2,199
BB+
Nordstrom,
Inc.
.
1.00%
Quarterly
JPHQ
6/20/26
4,700,000
(296,456)
(229,182)
(67,274)
BB+
Royal
Caribbean
Cruises
Ltd.
..
5.00%
Quarterly
BZWS
12/20/25
8,100,000
415,432
(211,684)
627,116
B
United
Airlines
Holdings,
Inc.
.
5.00%
Quarterly
FBCO
12/20/25
998,000
52,306
(1,854)
54,160
B
Traded
Index
(e)
Citibank
Bespoke
Franklin,
Equity
Tranche
0-5%
—%
Quarterly
CITI
12/20/22
9,500,000
(2,297,870)
(1,820,355)
(477,515)
Non-
Investment
Grade
(e)
Citibank
Bespoke
Palm
Beach
Index,
Mezzanine
Tranche
5-10%
1.97%
Quarterly
CITI
12/20/22
10,600,000
31,971
31,971
Non-
Investment
Grade
(e)
Citibank
Bespoke
Palm
Beach
Index,
Mezzanine
Tranche
5-10%
2.42%
Quarterly
CITI
12/20/22
7,900,000
15,506
15,506
Non-
Investment
Grade
(e)
Citibank
Bespoke
Phoenix
Index,
Mezzanine
Tranche
5-7%
2.90%
Quarterly
CITI
12/20/21
8,500,000
103,520
103,520
Non-
Investment
Grade
MCDX.
NA.MAIN.31
.
1.00%
Quarterly
CITI
12/20/23
23,060,000
292,057
111,406
180,651
Investment
Grade
(e)
Morgan
Stanley
Bespoke
Pecan
Index,
Mezzanine
Tranche
5-10%
4.10%
Quarterly
MSCO
12/20/21
9,000,000
8,554
8,554
Non-
Investment
Grade
(e)
Morgan
Stanley
Bespoke
Pecan
Index,
Mezzanine
Tranche
5-10%
3.98%
Quarterly
MSCO
12/20/21
9,000,000
3,105
3,105
Non-
Investment
Grade
Total
OTC
Swap
Contracts
..............................................
$(2,998,518)
$(5,046,199)
$2,047,681
Total
Credit
Default
Swap
Contracts
....................................
$(2,998,518)
$
(5,046,199)
$2,047,681
Franklin
Strategic
Series
Statement
of
Investments
(unaudited)
Franklin
Strategic
Income
Fund
(continued)
Quarterly
Statement
of
Investments
See
Notes
to
Statements
of
Investments.
52
At
July
31,
2021,
the
Fund
had
the
following inflation index
swap
contracts outstanding.
See
Note
3
See
abbreviations
on
page
79
.
(a)
In
U.S.
dollars
unless
otherwise
indicated.
For
contracts
to
sell
protection,
the
notional
amount
is
equal
to
the
maximum
potential
amount
of
the
future
payments
and
no
recourse
provisions
have
been
entered
into
in
association
with
the
contracts.
(b)
Based
on
Standard
and
Poor's
(S&P)
Rating
for
single
name
swaps
and
internal
ratings
for
index
swaps.
Internal
ratings
based
on
mapping
into
equivalent
ratings
from
external
vendors.
(c)
Performance
triggers
for
settlement
of
contract
include
default,
bankruptcy
or
restructuring
for
single
name
swaps,
and
failure
to
pay
or
bankruptcy
of
the
underlying
securities
for
traded
index
swaps.
(d)
The
fund
enters
contracts
to
sell
protection
to
create
a
long
credit
position.
(e)
Represents
a
custom
index
comprised
of
a
basket
of
underlying
instruments.
Inflation
Index
Swap
Contracts
Description
Payment
Frequency
Counter-
party
Maturity
Date
Notional
Amount
Value
Unamortized
Upfront
Payments
(Receipts)
Unrealized
Appreciation
(Depreciation)
Centrally
Cleared
Swap
Contracts
Receive
variable
change
  in
USA
CPI-U
........
At
Maturity
Pay
Fixed
1.913%
.....
At
Maturity
1/14/29
$
34,600,000
$
2,615,071
$
$
2,615,071
Receive
variable
change
  in
USA
CPI-U
........
At
Maturity
Pay
Fixed
1.943%
.....
At
Maturity
1/15/29
4,900,000
356,069
356,069
Total
Inflation
Index
Swap
Contracts
..................................
$2,971,140
$—
$2,971,140
Franklin
Strategic
Series
53
Quarterly
Statement
of
Investments
Notes
to
Statements
of
Investments
(unaudited)
1.
Organization
Franklin
Strategic
Series (Trust)
is
registered
under
the
Investment
Company
Act
of
1940
(1940
Act)
as
an
open-end
management
investment
company,
consisting
of ten
separate
funds,
six
of
which
are
included
in
this
report
(Funds)
and
applies
the
specialized
accounting
and
reporting
guidance
in
U.S.
Generally
Accepted
Accounting
Principles
(U.S.
GAAP). 
2. Financial
Instrument
Valuation
The
Funds’
investments
in
financial
instruments
are
carried
at
fair
value
daily.
Fair
value
is
the
price
that
would
be
received
to
sell
an
asset
or
paid
to
transfer
a
liability
in
an
orderly
transaction
between
market
participants
on
the
measurement
date.
The
Funds
calculate
the
net
asset
value
(NAV)
per
share
each
business
day
as
of
4
p.m.
Eastern
time
or
the
regularly
scheduled
close
of
the
New
York
Stock
Exchange
(NYSE),
whichever
is
earlier.
Under
compliance
policies
and
procedures
approved
by
the
Trust’s
Board
of
Trustees
(the
Board),
the
Funds’
administrator
has
responsibility
for
oversight
of
valuation,
including
leading
the
cross-functional
Valuation
Committee
(VC).
The
Funds
may
utilize
independent
pricing
services,
quotations
from
securities
and
financial
instrument
dealers,
and
other
market
sources
to
determine
fair
value. 
Equity
securities,
exchange
traded
funds,
and
derivative
financial
instruments
listed
on
an
exchange
or
on
the
NASDAQ
National
Market
System
are
valued
at
the
last
quoted
sale
price
or
the
official
closing
price
of
the
day,
respectively.
Foreign
equity
securities
are
valued
as
of
the
close
of
trading
on
the
foreign
stock
exchange
on
which
the
security
is
primarily
traded
or
as
of
4
p.m.
Eastern
time.
The
value
is
then
converted
into
its
U.S.
dollar
equivalent
at
the
foreign
exchange
rate
in
effect
at
4
p.m. Eastern
time
on
the
day
that
the
value
of
the
security
is
determined.
Over-the-counter
(OTC)
securities
are
valued
within
the
range
of
the
most
recent
quoted
bid
and
ask
prices.
Securities
that
trade
in
multiple
markets
or
on
multiple
exchanges
are
valued
according
to
the
broadest
and
most
representative
market.
Certain
equity
securities
are
valued
based
upon
fundamental
characteristics
or
relationships
to
similar
securities. 
Debt
and
certain
preferred
securities
generally
trade
in
the
OTC
market
rather
than
on
a
securities
exchange.
The
Funds’
pricing
services
use
multiple
valuation
techniques
to
determine
fair
value.
In
instances
where
sufficient
market
activity
exists,
the
pricing
services
may
utilize
a
market-based
approach
through
which
quotes
from
market
makers
are
used
to
determine
fair
value.
In
instances
where
sufficient
market
activity
may
not
exist
or
is
limited,
the
pricing
services
also
utilize
proprietary
valuation
models
which
may
consider
market
characteristics
such
as
benchmark
yield
curves,
credit
spreads,
estimated
default
rates,
anticipated
market
interest
rate
volatility,
coupon
rates,
anticipated
timing
of
principal
repayments,
underlying
collateral,
and
other
unique
security
features
in
order
to
estimate
the
relevant
cash
flows,
which
are
then
discounted
to
calculate
the
fair
value.
Securities
denominated
in
a
foreign
currency
are
converted
into
their
U.S.
dollar
equivalent
at
the
foreign
exchange
rate
in
effect
at
4
p.m.
Eastern
time
on
the
date
that
the
values
of
the
foreign
debt
securities
are
determined.
Investments
in
open-end
mutual
funds
are
valued
at
the
closing
NAV.
Investments
in
repurchase
agreements
are
valued
at
cost,
which
approximates
fair
value.
Certain
derivative
financial
instruments
are
centrally
cleared
or
trade
in
the
OTC
market.
The
Funds’
pricing
services
use
various
techniques
including
industry
standard
option
pricing
models
and
proprietary
discounted
cash
flow
models
to
determine
the
fair
value
of
those
instruments.
The
Funds’ net
benefit
or
obligation
under
the
derivative
contract,
as
measured
by
the
fair
value
of
the
contract,
is
included
in
net
assets. 
The
Funds
have procedures
to
determine
the
fair
value
of
financial
instruments
for
which
market
prices
are
not
reliable
or
readily
available.
Under
these
procedures,
the
Funds
primarily employ
a
market-based
approach
which
may
use
related
or
comparable
assets
or
liabilities,
recent
transactions,
market
multiples,
book
values,
and
other
relevant
information
for
the
investment
to
determine
the
fair
value
of
the
investment.
An
income-based
valuation
approach
may
also
be
used
in
which
the
anticipated
future
cash
flows
of
the
investment
are
discounted
to
calculate
fair
value.
Discounts
may
also
be
applied
due
to
the
nature
or
duration
of
any
restrictions
on
the
disposition
of
the
investments.
Due
to
the
inherent
uncertainty
of
valuations
of
such
investments,
the
fair
values
may
differ
significantly
from
the
values
that
would
have
been
used
had
an
active
market
existed. 
Franklin
Strategic
Series
Notes
to
Statements
of
Investments
(unaudited)
54
Quarterly
Statement
of
Investments
Trading
in
securities
on
foreign
securities
stock
exchanges
and
OTC
markets
may
be
completed
before
4
p.m.
Eastern
time.
In
addition,
trading
in
certain
foreign
markets
may
not
take
place
on
every
Funds’ business
day.
Events
can
occur
between
the
time
at
which
trading
in
a
foreign
security
is
completed
and
4
p.m.
Eastern
time
that
might
call
into
question
the
reliability
of
the
value
of
a
portfolio
security
held
by
the
Fund.
As
a
result,
differences
may
arise
between
the
value
of
the
Funds’
portfolio
securities
as
determined
at
the
foreign
market
close
and
the
latest
indications
of
value
at
4
p.m.
Eastern
time.
In
order
to
minimize
the
potential
for
these
differences,
an
independent
pricing
service
may
be
used
to
adjust
the
value
of
the
Funds'
portfolio
securities
to
the
latest
indications
of
fair
value
at 4
p.m.
Eastern
time.
At
July
31,
2021,
certain
securities
may
have
been
fair
valued
using
these
procedures,
in
which
case
the
securities
were
categorized
as
Level
2
inputs
within
the
fair
value
hierarchy.
See
the
Fair
Value
Measurements
note
for
more
information.
When
the
last
day
of
the
reporting
period
is
a
non-business
day,
certain
foreign
markets
may
be
open
on
those
days
that
the
Funds’
NAV
is
not
calculated,
which
could
result
in
differences
between
the
value
of
the
Funds’
portfolio securities
on
the
last
business
day
and
the
last
calendar
day
of
the
reporting
period.
Any
security
valuation
changes
due
to
an
open
foreign
market
are
adjusted
and
reflected
by
the
Funds for
financial
reporting
purposes.
3.
Derivative
Financial
Instruments
Certain
or
all
Funds
invested
in
derivative
financial
instruments
in
order
to
manage
risk
or
gain
exposure
to
various
other
investments
or
markets.
Derivatives
are
financial
contracts
based
on
an
underlying
or
notional
amount,
require
no
initial
investment
or
an
initial
net
investment
that
is
smaller
than
would
normally
be
required
to
have
a
similar
response
to
changes
in
market
factors,
and
require
or
permit
net
settlement.
Derivatives
contain
various
risks
including
the
potential
inability
of
the
counterparty
to
fulfill
their
obligations
under
the
terms
of
the
contract,
the
potential
for
an
illiquid
secondary
market,
and/or
the
potential
for
market
movements.
Derivative
counterparty
credit
risk
is
managed
through
a
formal
evaluation
of
the
creditworthiness
of
all
potential
counterparties.
Certain
or
all
Funds
attempt
to
reduce
their
exposure
to
counterparty
credit
risk
on
OTC
derivatives,
whenever
possible,
by
entering
into
International
Swaps
and
Derivatives
Association
(ISDA)
master
agreements
with
certain
counterparties.
These
agreements
contain
various
provisions,
including
but
not
limited
to
collateral
requirements,
events
of
default,
or
early
termination.
Termination
events
applicable
to
the
counterparty
include
certain
deteriorations
in
the
credit
quality
of
the
counterparty.
Termination
events
applicable
to
the
Funds include
failure
of
the
Funds
to
maintain
certain
net
asset
levels
and/or
limit
the
decline
in
net
assets
over
various
periods
of
time.
In
the
event
of
default
or
early
termination,
the
ISDA
master
agreement
gives
the
non-defaulting
party
the
right
to
net
and
close-out
all
transactions
traded,
whether
or
not
arising
under
the
ISDA
agreement,
to
one
net
amount
payable
by
one
counterparty
to
the
other.
Early
termination
by
the
counterparty
may
result
in
an
immediate
payment
by
the
Funds
of
any
net
liability
owed
to
that
counterparty
under
the
ISDA
agreement. 
Collateral
requirements
differ
by
type
of
derivative.
Collateral
or
initial
margin
requirements
are
set
by
the
broker
or
exchange
clearing
house
for
exchange
traded
and
centrally
cleared
derivatives.
Initial
margin
deposited
is
held
at
the
exchange
and
can
be
in
the
form
of
cash
and/or
securities.
For
OTC
derivatives
traded
under
an
ISDA
master
agreement,
posting
of
collateral
is
required
by
either
the
Fund
or
the
applicable
counterparty
if
the
total
net
exposure
of
all
OTC
derivatives
with
the
applicable
counterparty
exceeds
the
minimum
transfer
amount,
which
typically
ranges
from
$100,000
to
$250,000,
and
can
vary
depending
on
the
counterparty
and
the
type
of
the
agreement.
Generally,
collateral
is
determined
at
the
close
of
Fund
business
each
day
and
any
additional
collateral
required
due
to
changes
in
derivative
values
may
be
delivered
by
the
Fund
or
the
counterparty
the
next
business
day,
or
within
a
few
business
days.
Collateral
pledged
and/or
received
by
the
Fund
for
OTC
derivatives,
if
any,
is
held
in
segregated
accounts
with
the
Fund’s
custodian/counterparty
broker
and
can
be
in
the
form
of
cash
and/or
securities.
Unrestricted
cash
may
be
invested
according
to
the
Funds’ investment
objectives.
To
the
extent
that
the
amounts
due
to
the
Fund
from
its
counterparties
are
not
subject
to
collateralization
or
are
not
fully
collateralized,
the
Fund
bears
the
risk
of
loss
from
counterparty
non-performance.
2. Financial
Instrument
Valuation
(continued)
Franklin
Strategic
Series
Notes
to
Statements
of
Investments
(unaudited)
55
Quarterly
Statement
of
Investments
At
July
31,
2021,
the
Funds
received
U.S.
Treasury
Bills
as
collateral
for
derivatives,
as
follows:
Franklin
Strategic
Income Fund
-
$333,969
Certain
or
all
Funds entered
into
exchange
traded
futures
contracts
primarily
to
manage
and/or
gain
exposure
to
interest
rate
risk.
A
futures
contract
is
an
agreement
between
the
Fund
and
a
counterparty
to
buy
or
sell
an
asset
at
a
specified
price
on
a
future
date.
Required
initial
margins
are
pledged
by
the
Fund,
and
the
daily
change
in
fair
value
is
accounted
for
as
a
variation
margin
payable
or
receivable.
Certain
or
all
Funds
entered
into
OTC
forward
exchange
contracts
primarily
to
[manage
and/or
gain]
exposure
to
certain
foreign
currencies.
A
forward
exchange
contract
is
an
agreement
between
the
Funds
and
a
counterparty
to
buy
or
sell
a
foreign
currency
for
a
specific
exchange
rate
on
a
future
date.
Certain
or
all
Funds
entered
into
credit
default
swap
contracts
primarily
to
manage
and/or
gain
exposure
to
credit
risk.
A
credit
default
swap
is
an
agreement
between
the
Fund
and
a
counterparty
whereby
the
buyer
of
the
contract
receives
credit
protection
and
the
seller
of
the
contract
guarantees
the
credit
worthiness
of
a
referenced
debt
obligation.
These
agreements
may
be
privately
negotiated
in
the
over-the-counter
market
(OTC
credit
default
swaps)
or
may
be
executed
in
a
multilateral
trade
facility
platform,
such
as
a
registered
exchange
(centrally
cleared
credit
default
swaps).
The
underlying
referenced
debt
obligation
may
be
a
single
issuer
of
corporate
or
sovereign
debt,
a
credit
index,
a
basket
of
issuers
or
indices,
or
a
tranche
of
a
credit
index
or
basket
of
issuers
or
indices.
In
the
event
of
a
default
of
the
underlying
referenced
debt
obligation,
the
buyer
is
entitled
to
receive
the
notional
amount
of
the
credit
default
swap
contract
from
the
seller
in
exchange
for
the
referenced
debt
obligation,
a
net
settlement
amount
equal
to
the
notional
amount
of
the
credit
default
swap
less
the
recovery
value
of
the
referenced
debt
obligation,
or
other
agreed
upon
amount.
For
centrally
cleared
credit
default
swaps,
required
initial
margins
are
pledged
by
the
Fund,
and
the
daily
change
in
fair
value
is
accounted
for
as
a
variation
margin
payable
or
receivable.
Over
the
term
of
the
contract,
the
buyer
pays
the
seller
a
periodic
stream
of
payments,
provided
that
no
event
of
default
has
occurred.
Such
periodic
payments
are
accrued
daily
as
an
unrealized
appreciation
or
depreciation
until
the
payments
are
made,
at
which
time
they
are
realized.
Upfront
payments
and
receipts
represent
compensating
factors
between
stated
terms
of
the
credit
default
swap
agreement
and
prevailing
market
conditions
(credit
spreads
and
other
relevant
factors).
These
upfront
payments
and
receipts
are
amortized
over
the
term
of
the
contract
as
a
realized
gain
or
loss.
Certain
or
all
Funds
entered
into
OTC
cross
currency
swap
contracts
primarily
to
manage
and/or
gain
exposure
to
interest
rate
risk
and
certain
foreign
currencies.
A
cross
currency
swap
is
an
agreement
between
the
Fund
and
a
counterparty
to
exchange
cash
flows
(determined
using
either
a
fixed
or
floating
rate)
based
on
the
notional
amounts
of
two
different
currencies.
The
notional
amounts
are
typically
determined
based
on
the
spot
exchange
rates
at
the
opening
of
the
contract.
Cross
currency
swaps
may
require
the
exchange
of
notional
amounts
at
the
opening
and/or
closing
of
the
contract.
Over
the
term
of
the
contract,
contractually
required
payments
to
be
paid
and
to
be
received
are
accrued
daily
and
recorded
as
unrealized
depreciation
and
appreciation
until
the
payments
are
made,
at
which
time
they
are
realized.
Upfront
payments
and
receipts
represent
compensating
factors
between
stated
terms
of
the
cross
currency
swap
contract
and
prevailing
market
conditions
(interest
rate
spreads
and
other
relevant
factors).
These
upfront
payments
and
receipts
are
amortized
over
the
term
of
the
contract
as
a
realized
gain
or
loss.
Certain
or
all
Funds
entered
into
inflation
index
swap
contracts
primarily
to
manage
and/or
gain
exposure
to
inflation
risk.
An
inflation
index
swap
is
an
agreement
between
the
Fund
and
a
counterparty
to
exchange
cash
flows
whereby
one
party
makes
payments
based
on
the
percentage
change
in
an
index
that
serves
as
a
measure
of
inflation
and
the
other
party
makes
a
regular
payment
based
on
a
compounded
fixed
rate,
applied
to
a
notional
amount.
These
agreements
may
be
privately
negotiated
in
the
over-the-counter
market
(OTC
inflation
index
swap)
or
may
be
executed
on
a
registered
exchange
(centrally
cleared
inflation
index
swap).
For
centrally
cleared
inflation
index
swaps,
required
initial
margins
are
pledged
by
the
Fund,
and
the
daily
change
in
fair
value
is
accounted
for
as
a
variation
margin
payable
or
receivable.
Over
the
term
of
the
contract,
3.
Derivative
Financial
Instruments
(continued)
Franklin
Strategic
Series
Notes
to
Statements
of
Investments
(unaudited)
56
Quarterly
Statement
of
Investments
contractually
required
payments
to
be
paid
and
to
be
received
are
accrued
daily
and
recorded
as
unrealized
depreciation
and
appreciation
until
the
payments
are
made,
at
which
time
they
are
realized.
Typically,
an
inflation
index
swap
has
payment
obligations
netted
and
exchanged
upon
maturity. 
Certain
or
all
Funds
entered
into
interest
rate
swap
contracts
primarily
to
manage
interest
rate
risk.
An
interest
rate
swap
is
an
agreement
between
the
Fund
and
a
counterparty
to
exchange
cash
flows
based
on
the
difference
between
two
interest
rates,
applied
to
a
notional
amount.
These
agreements
may
be
privately
negotiated
in
the
over-the-counter
market
(OTC
interest
rate
swaps)
or
may
be
executed
on
a
registered
exchange
(centrally
cleared
interest
rate
swaps).
For
centrally
cleared
interest
rate
swaps,
required
initial
margins
are
pledged
by
the
Fund,
and
the
daily
change
in
fair
value
is
accounted
for
as
a
variation
margin
payable
or
receivable.
Over
the
term
of
the
contract,
contractually
required
payments
to
be
paid
and
to
be
received
are
accrued
daily
and
recorded
as
unrealized
depreciation
and
appreciation
until
the
payments
are
made,
at
which
time
they
are
realized.
Certain
or
all
Funds
entered
into
OTC
total
return
swap
contracts
primarily
to
manage
and/or
gain
exposure
to
credit
and
other
markets
risk
of
an
underlying
instrument
such
as
a
stock,
bond,
index
or
basket
of
securities
or
indices.
A
total
return
swap
is
an
agreement
between
the
Fund
and
a
counterparty
to
exchange
a
return
linked
to
an
underlying
instrument
for
a
floating
or
fixed
rate
payment,
both
based
upon
a
notional
amount.
Over
the
term
of
the
contract,
contractually
required
payments
to
be
paid
or
received
are
accrued
daily
and
recorded
as
unrealized
appreciation
or
depreciation
until
the
payments
are
made,
at
which
time
they
are
recognized
as
realized
gain
or
loss.
Certain
or
all
Funds purchased
or
wrote
OTC
option
contracts
primarily
to
manage
and/or
gain
exposure
to
foreign
exchange
rate
risk.
An
option
is
a
contract
entitling
the
holder
to
purchase
or
sell
a
specific
amount
of
shares
or
units
of
an
asset
or
notional
amount
of
a
swap
(swaption),
at
a
specified
price.
When
an
option
is
purchased
or
written,
an
amount
equal
to
the
premium
paid
or
received
is
recorded
as
an
asset
or
liability,
respectively.
Upon
exercise
of
an
option,
the
acquisition
cost
or
sales
proceeds
of
the
underlying
investment
is
adjusted
by
any
premium
received
or
paid.
Upon
expiration
of
an
option,
any
premium
received
or
paid
is
recorded
as
a
realized
gain
or
loss.
Upon
closing
an
option
other
than
through
expiration
or
exercise,
the
difference
between
the
premium
received
or
paid
and
the
cost
to
close
the
position
is
recorded
as
a
realized
gain
or
loss.
The
Funds
did
not
hold
any
option
contracts
at
period
end.
Certain
or
all
Funds
invest in
value
recovery
instruments
(VRI)
primarily
to
gain
exposure
to
economic
growth.
Periodic
payments
from
VRI
are
dependent
on
established
benchmarks
for
underlying
variables.
VRI
has
a
notional
amount,
which
is
used
to
calculate
amounts
of
payments
to
holders.
Payments
are
recorded
upon
receipt
as
realized
gains.
The
risks
of
investing
in
VRI
include
growth
risk,
liquidity,
and
the
potential
loss
of
investment.
The
following
Funds
have
invested
in
derivatives
during
the
period. 
Franklin
Strategic
Income
Fund –
Futures,
forwards,
options,
swaps
and
VRI
4.
Mortgage
Dollar
Rolls 
Franklin
Strategic
Income
Fund
enters
into
mortgage
dollar
rolls,
typically
on
a
to-be-announced
basis.
Mortgage
dollar
rolls
are
agreements
between
the
Fund
and
a
financial
institution
where
the
Fund
sells
(or
buys)
mortgage-backed
securities
for
delivery
on
a
specified
date
and
simultaneously
contracts
to
repurchase
(or
sell)
substantially
similar
(same
type,
coupon,
and
maturity)
securities
at
a
future
date
and
at
a
predetermined
price.
Gains
or
losses
are
realized
on
the
initial
sale,
and
the
difference
between
the
repurchase
price
and
the
sale
price
is
recorded
as
an
unrealized
gain
or
loss
to
the
Fund
upon
entering
into
the
mortgage
dollar
roll.
In
addition,
the
Fund
may
invest
the
cash
proceeds
that
are
received
from
the
initial
sale.
During
the
period
between
the
sale
and
repurchase,
the
Fund
is
not
entitled
to
principal
and
interest
paid
on
the
mortgage
backed
3.
Derivative
Financial
Instruments
(continued)
Franklin
Strategic
Series
Notes
to
Statements
of
Investments
(unaudited)
57
Quarterly
Statement
of
Investments
securities.
Transactions
in
mortgage
dollar
rolls
are
accounted
for
as
purchases
and
sales
and
may
result
in
an
increase
to
the
Fund’s
portfolio
turnover
rate.
The
risks
of
mortgage
dollar
roll
transactions
include
the
potential
inability
of
the
counterparty
to
fulfill
its
obligations.
5.
Concentration
of
Risk 
Investing
in
foreign
securities
may
include
certain
risks
and
considerations
not
typically
associated
with
investing
in
U.S.
securities,
such
as
fluctuating
currency
values
and
changing
local,
regional
and
global
economic,
political
and
social
conditions,
which
may
result
in
greater
market
volatility.
Political
and
financial
uncertainty
in
many
foreign
regions
may
increase
market
volatility
and
the
economic
risk
of
investing
in
foreign
securities.
In
addition,
certain
foreign
securities
may
not
be
as
liquid
as
U.S.
securities.
6.
Novel
Coronavirus
Pandemic 
The
global
outbreak
of
the
novel
coronavirus
disease,
known
as
COVID-19, has
caused
adverse
effects
on
many
companies,
sectors,
nations,
regions
and
the
markets
in
general, and
may
continue for
an unpredictable duration.
The
effects
of
this
pandemic
may
materially
impact
the
value
and
performance
of
the
Funds, their ability
to
buy
and
sell
fund
investments
at
appropriate
valuations
and their ability
to
achieve their investment
objectives.
7. Restricted
Securities 
At
July
31,
2021,
investments
in
restricted
securities,
excluding
securities
exempt
from
registration
under
the
Securities
Act
of
1933,
were
as
follows:
Shares
Issuer
Acquisition
Date
Cost
Value
Franklin
Biotechnology
Discovery
Fund
2,333,755
Amunix
Pharmaceuticals,
Inc.
..................
2/26/21
$
4,125,379
$
3,349,197
189,499
Artiva
Biotherapeutics
,
Inc.
.....................
2/22/21
2,084,489
2,084,489
415,600
a
ARYA
Sciences
Acquisition
Corp.
................
2/08/21
4,156,000
3,258,304
189,737
b
Centessa
Pharmaceuticals
PLC
.................
1/28/21
2,087,101
3,720,081
370,698
Day
One
Therapeutics
Holding
Company
LLC
......
2/01/21
4,999,991
8,131,794
80,195
Intarcia
Therapeutics,
Inc.
.....................
3/26/14
2,597,516
779,505
Pipeline
Therapeutics,
Inc.
.....................
2/09/21
2,088,995
1,504,537
189,800
Soaring
Eagle
Acquisition
Corp.
.................
5/11/21
1,898,000
1,898,000
Total
Restricted
Securities
(Value
is
1.8%
of
Net
Assets)
..............
$24,037,471
$23,946,402
Shares
/
Warrants
Issuer
Acquisition
Date
Cost
Value
Franklin
Growth
Opportunities
Fund
255,039
Avidxchange
,
Inc.
............................
7/30/20
$
12,499,971
$
15,627,737
16,669
CELONIS
SE
...............................
6/16/21
6,149,572
6,164,029
2,610,594
ClearMotion
,
Inc.,
C
..........................
11/06/17
5,499,999
8,281,031
3,698,772
ClearMotion
,
Inc.,
D
..........................
12/21/18
10,000,000
12,293,635
642,459
c
Confluent,
Inc.
..............................
4/13/20
9,616,776
24,249,400
112,760
Databricks
,
Inc.,
G
...........................
2/01/21
20,000,005
24,846,328
416,700
d
Dragoneer
Growth
Opportunities
Corp.
II
..........
2/02/21
4,167,000
3,852,684
4.
Mortgage
Dollar
Rolls 
(continued)
Franklin
Strategic
Series
Notes
to
Statements
of
Investments
(unaudited)
58
Quarterly
Statement
of
Investments
Shares/
Warrants
Issuer
Acquisition
Date
Cost
Value
Franklin
Growth
Opportunities
Fund
(continued)
920,577
Fanatics,
Inc.,
E
.............................
8/13/20
$
15,916,776
$
25,425,038
109,362
Fanatics,
Inc.,
F
.............................
3/22/21
3,813,453
3,814,966
2,077,218
e
Figs,
Inc.
..................................
10/23/20
17,756,521
72,352,101
201,294
Gitlab
,
Inc.,
E
...............................
9/11/19
3,749,986
8,958,943
415,102
HashiCorp
,
Inc.,
E
...........................
3/06/20
12,004,812
22,111,823
1,673,284
f
Legalzoom.com,
Inc.
.........................
7/20/18
16,479,337
58,905,940
2,167,003
Lucid
Group,
Inc.
............................
2/22/21
32,505,045
46,426,867
1,396,875
g
Marqeta
,
Inc.
...............................
8/20/20
-
10/19/20
12,799,970
36,110,134
517,056
OneTrust
LLC,
C
............................
4/01/21
10,139,623
11,406,255
509,182
Optoro
,
Inc.,
E
..............................
7/24/18
10,020,702
12,978,872
3,595,577
h
Proterra
,
Inc.
...............................
9/21/16
-
8/02/19
22,294,007
35,255,331
1,500,000
i
Soaring
Eagle
Acquisition
Corp.,
A
...............
5/11/21
15,000,000
15,000,000
23,001
Sweetgreen
,
Inc.,
............................
1/21/21
22,165
928,488
Sweetgreen
,
Inc.,
H
..........................
11/09/18
12,107,484
14,560,423
100,835
Sweetgreen
,
Inc.,
I
...........................
9/16/19
1,724,278
1,772,862
76,670
Sweetgreen
,
Inc.,
J
..........................
1/21/21
1,311,057
1,347,997
1,753,060
Talkdesk
,
Inc.,
C
............................
7/15/20
11,517,955
29,444,829
805,800
Tanium,
Inc.,
G
..............................
9/14/15
4,000,233
8,815,248
504,854
Tempus
Labs,
Inc.,
F
.........................
5/29/19
12,499,983
25,604,215
126,131
Tempus
Labs,
Inc.,
G
.........................
2/06/20
4,837,427
6,413,412
2,315,191
j
Wheels
Up
Experience,
Inc.,
A
..................
5/16/19
-
7/28/21
17,499,998
16,305,393
Total
Restricted
Securities
(Value
is
8.9%
of
Net
Assets)
..............
$305,911,970
$548,347,658
Shares
Issuer
Acquisition
Date
Cost
Value
Franklin
Natural
Resources
Fund
138,200
Alussa
Energy
Acquisition
Corp.
.................
1/29/21
$
1,382,000
$
1,228,598
150,000
Ivanhoe
Capital
Acquisition
Corp.,
A
..............
7/09/21
1,500,000
1,500,000
173,800
Li-Cycle
Holdings
Corp.
.......................
2/16/21
1,738,000
1,738,000
141,414
Lucid
Group,
Inc.
............................
2/22/21
2,121,210
3,029,718
74,343
Sunlight
Financial
Holdings,
Inc.,
A
...............
1/28/21
743,430
610,356
Total
Restricted
Securities
(Value
is
3.2%
of
Net
Assets)
..............
$7,484,640
$8,106,672
Shares
/
Warrants
Issuer
Acquisition
Date
Cost
Value
Franklin
Small
Cap
Growth
Fund
3,436,485
1661,
Inc.,
F
................................
5/28/21
$
19,999,999
$
19,999,999
292,188
k
Alkami
Technology,
Inc
........................
9/24/20
4,675,011
8,884,866
1,297,305
Allbirds
,
Inc.,
E
..............................
9/22/20
14,999,998
15,800,122
3,698,772
ClearMotion
,
Inc.,
D
..........................
12/21/18
10,000,000
12,293,634
1,431,280
Legalzoom.com,
Inc.
.........................
7/20/18
14,095,961
50,386,482
1,199,415
Marqeta
,
Inc.
...............................
8/20/20
10,000,003
31,005,663
7. Restricted
Securities 
(continued)
Franklin
Strategic
Series
Notes
to
Statements
of
Investments
(unaudited)
59
Quarterly
Statement
of
Investments
Shares/
Warrants
Issuer
Acquisition
Date
Cost
Value
Franklin
Small
Cap
Growth
Fund
(continued)
750,000
New
Starship
Parent,
Inc.
......................
2/02/21
$
7,500,000
$
7,080,000
709,046
Newsela
,
Inc.,
D
.............................
1/21/21
15,000,010
15,254,167
508,130
Optoro
,
Inc.,
E
..............................
7/24/18
9,999,998
12,952,057
3,243,564
l
Proterra
,
Inc.
...............................
9/21/16
-
5/21/18
19,762,396
31,803,775
596,471
Rent
the
Runway,
Inc.,
144A,
F
.................
3/21/19
13,333,328
13,036,414
508,787
Rent
the
Runway,
Inc.,
G
......................
4/30/20
-
4/30/21
7,500,009
9,037,653
1,542,673
Smule
,
Inc.,
144A,
G
.........................
5/31/16
11,099,995
9,370,140
352,675
Smule
,
Inc.,
144A,
H
.........................
4/27/17
2,999,995
2,532,151
714,286
Sunlight
Financial
Holdings,
Inc.,
A
...............
1/28/21
7,142,860
5,864,288
33,990
Sweetgreen
,
Inc.,
1/20/26
......................
1/21/21
32,754
383,435
Sweetgreen
,
Inc.,
H
..........................
11/09/18
4,999,992
6,012,976
41,641
Sweetgreen
,
Inc.,
I
...........................
9/16/19
712,061
732,124
113,300
Sweetgreen
,
Inc.,
J
..........................
1/21/21
1,937,430
1,992,019
2,500,000
TPG
Pace
Governance
LLC,
A
..................
1/28/21
25,000,000
25,000,000
361,111
Tula
eTechnology
,
Inc.
........................
11/01/18
3,611,111
Tula
eTechnology
,
Inc.,
E
......................
9/08/17
6,500,000
9,479,643
1,984,450
m
Wheels
Up
Experience,
Inc.,
A
..................
5/16/19
-
7/28/21
14,999,997
13,976,052
Total
Restricted
Securities
(Value
is
7.2%
of
Net
Assets)
..............
$222,259,043
$302,526,979
Principal
Amount
*
/
Shares
/
Warrants
Issuer
Acquisition
Date
Cost
Value
Franklin
Small-Mid
Cap
Growth
Fund
344,335
n
Alkami
Technology,
Inc.
.......................
9/24/20
$
5,509,373
$
10,470,554
772,477
Allbirds
,
Inc.
E
..............................
9/22/20
8,931,711
9,408,143
64,741
Blaize
,
Inc.
Ltd.,
2/28/24
.......................
3/01/21
1,294,805
Blaize
,
Inc.,
D
..............................
3/02/21
-
3/22/21
13,521,010
13,521,001
75,943
Databricks
,
Inc.,
G
...........................
2/01/21
13,469,851
16,733,812
775,014
Fanatics,
Inc.,
E
.............................
8/13/20
13,399,992
21,404,793
18,700
Fanatics,
Inc.,
F
.............................
3/22/21
652,069
652,328
728,215
Lucid
Group,
Inc.
............................
2/22/21
10,923,225
15,601,612
1,070,236
o
Marqeta
,
Inc.
...............................
8/20/20
8,922,986
27,666,302
675,200
New
Starship
Parent,
Inc.
......................
2/02/21
6,752,000
6,373,888
423,782
Newsela
,
Inc.,
D
.............................
1/21/21
8,965,193
9,117,097
767,526
OneTrust
LLC,
C
............................
4/01/21
15,051,415
16,931,624
513,050
Phononic
Devices,
Inc.
........................
1/17/20
-
11/03/20
47
2,113,853
2,970,061
Phononic
Devices,
Inc.,
F
......................
6/06/19
7,499,998
10,820,143
117,795
Phononic
,
Inc.,
Advance
Term
Loan,
B,
12%,
PIK,
7/31/26
..................................
8/25/20
-
7/01/21
114,434
105,809
281,258
Phononic
,
Inc.,
Advance
Term
Loan,
D,
12%,
PIK,
12/01/25
.................................
1/15/21
-
7/01/21
279,704
252,243
572,775
Phononic
,
Inc.,
Term
Loan,
A,
12%,
PIK,
1/17/24
....
1/17/20
-
7/01/21
565,995
526,138
7. Restricted
Securities 
(continued)
Franklin
Strategic
Series
Notes
to
Statements
of
Investments
(unaudited)
60
Quarterly
Statement
of
Investments
8.
Holding
of
5%
Voting
Securities
of
Portfolio
Companies 
The
1940
Act
defines
"affiliated
companies"
to
include
investments
in
portfolio
companies
in
which
a
fund
owns
5%
or
more
of
the
outstanding
voting
securities.
Additionally,
as
defined
in
the
1940
Act,
an
investment
is
deemed
to
be
a
“Controlled
Affiliate”
of
a
fund
when
a
fund
owns,
either
directly
or
indirectly,
25%
or
more
of
the
affiliated
companies’
outstanding
shares
or
has
the
power
to
exercise
control
over
management
or
policies
of
such
company.
During
the
period
ended
July
31,
2021,
investments
in
“affiliated
companies”
were
as
follows:
Principal
Amount*/
Shares/
Warrants
Issuer
Acquisition
Date
Cost
Value
Franklin
Small-Mid
Cap
Growth
Fund
(continued)
114,103
Phononic
,
Inc.,
Term
Loan,
C,
12%,
PIK,
8/25/24
....
12/03/20
-
7/01/21
$
113,109
$
102,774
1,264,594
p
Proterra
,
Inc.
...............................
9/21/16
7,135,914
12,399,588
271,200
q
Soaring
Eagle
Acquisition
Corp.,
A
...............
5/11/21
2,712,000
2,712,000
963,371
Sunlight
Financial
Holdings,
Inc.,
A
...............
1/28/21
9,633,710
7,909,276
Total
Restricted
Securities
(Value
is
3.1%
of
Net
Assets)
..............
$134,153,736
$184,822,978
Principal
Amount
*
/
Shares
/
Warrants
Issuer
Acquisition
Date
Cost
Value
Franklin
Strategic
Income
Fund
125,940,079
K2016470219
South
Africa
Ltd.,
A
...............
2/08/13
-
2/01/17
$
977,123
$
12,532,821
K2016470219
South
Africa
Ltd.,
B
...............
2/01/17
9,307
6,000,000
WorkCapital
BSD
SARL,
2/13/26
................
2/15/19
750,000
20,000,000
WorkCapital
BSD
SARL,
Term
Loan,
6.5%,
11/02/22
.
2/13/19
19,530,078
Total
Restricted
Securities
(Value
is
—%
of
Net
Assets)
..............
$21,266,508
$—
*
In
U.S.
dollars
unless
otherwise
indicated.
a
The
Fund
also
invests
in
unrestricted
securities
of
the
issuer,
valued
at
$1,649,574
as
of
July
31,
2021.
b
The
Fund
also
invests
in
unrestricted
securities
of
the
issuer,
valued
at
$1,477,824
as
of
July
31,
2021.
c
The
Fund
also
invests
in
unrestricted
securities
of
the
issuer,
valued
at
$4,777,261
as
of
July
31,
2021.
d
The
Fund
also
invests
in
unrestricted
securities
of
the
issuer,
valued
at
$10,615,158
as
of
July
31,
2021.
e
The
Fund
also
invests
in
unrestricted
securities
of
the
issuer,
valued
at
$21,443,240
as
of
July
31,
2021.
f
The
Fund
also
invests
in
unrestricted
securities
of
the
issuer,
valued
at
$319,986
as
of
July
31,
2021.
g
The
Fund
also
invests
in
unrestricted
securities
of
the
issuer,
valued
at
$11,746,174
as
of
July
31,
2021.
h
The
Fund
also
invests
in
unrestricted
securities
of
the
issuer,
valued
at
$6,391,422
as
of
July
31,
2021.
i
The
Fund
also
invests
in
unrestricted
securities
of
the
issuer,
valued
at
$11,940,516
as
of
July
31,
2021.
j
The
Fund
also
invests
in
unrestricted
securities
of
the
issuer,
valued
at
$28,000,000
as
of
July
31,
2021.
k
The
Fund
also
invests
in
unrestricted
securities
of
the
issuer,
valued
at
$15,174,461
as
of
July
31,
2021.
l
The
Fund
also
invests
in
unrestricted
securities
of
the
issuer,
valued
at
$4,724,987
as
of
July
31,
2021.
m
The
Fund
also
invests
in
unrestricted
securities
of
the
issuer,
valued
at
$16,000,000
as
of
July
31,
2021.
n
The
Fund
also
invests
in
unrestricted
securities
of
the
issuer,
valued
at
$3,522,159
as
of
July
31,
2021.
o
The
Fund
also
invests
in
unrestricted
securities
of
the
issuer,
valued
at
$5,679,911
as
of
July
31,
2021.
p
The
Fund
also
invests
in
unrestricted
securities
of
the
issuer,
valued
at
$6,168,638
as
of
July
31,
2021.
q
The
Fund
also
invests
in
unrestricted
securities
of
the
issuer,
valued
at
$11,593,743
as
of
July
31,
2021.
7. Restricted
Securities 
(continued)
Franklin
Strategic
Series
Notes
to
Statements
of
Investments
(unaudited)
61
Quarterly
Statement
of
Investments
Value
at
Beginning
of
Period
Purchase
s
a
Sale
s
a
Realized
Gain
(Loss)
Net
Change
in
Unrealized
Appreciation
(Depreciation)
Value
at
End
of
Period
Number
of
Shares/Principal
Amount
Held
at
End
of
Period
Investment
Income
Franklin
Biotechnology
Discovery
Fund
Non-Controlled
Affiliates
Dividends
Artiva
Biotherapeutics
,
Inc.
$
2,084,489
$
$
$
$
$
2,084,489
189,499
$
Total
Affiliated
Securities
(Value
is
0.2%
of
Net
Assets)
..........
$2,084,489
$—
$—
$
$
$2,084,489
$—
Franklin
Growth
Opportunities
Fund
Non-Controlled
Affiliates
Dividends
Avidxchange
,
Inc.
....
13,792,310
1,835,427
15,627,737
255,039
ClearMotion
,
Inc.,
C
...
7,703,411
577,620
8,281,031
2,610,594
ClearMotion
,
Inc.,
D
...
11,706,569
587,066
12,293,635
3,698,772
HashiCorp
,
Inc.,
E
....
19,097,102
3,014,721
22,111,823
415,102
Optoro
,
Inc.,
E
.......
12,164,900
813,972
12,978,872
509,182
Talkdesk
,
Inc.,
C
.....
28,638,800
806,029
29,444,829
1,753,060
Tempus
Labs,
Inc.,
F
..
22,633,975
2,970,240
25,604,215
504,854
Tempus
Labs,
Inc.,
G
..
5,814,772
598,640
6,413,412
126,131
Wheels
Up
Experience,
Inc
.............
35,000,000
(7,000,000)
28,000,000
3,500,000
Wheels
Up
Experience,
Inc.,
A
...........
22,526,068
(6,220,675)
16,305,393
2,315,191
Total
Affiliated
Securities
(Value
is
2.9%
of
Net
Assets)
..........
$179,077,907
$—
$—
$
$
(2,016,960)
$177,060,947
$—
Franklin
Small
Cap
Growth
Fund
Non-Controlled
Affiliates
Dividends
Bridge
Investment
Group
Holdings
Inc
......
24,016,000
(360,240)
23,655,760
1,501,000
ClearMotion
,
Inc.,
D
...
11,706,569
587,065
12,293,634
3,698,772
Optoro
,
Inc.,
E
.......
12,139,766
812,291
12,952,057
508,130
TPG
Pace
Governance
LLC,
A
..........
25,000,000
25,000,000
2,500,000
Wheels
Up
Experience,
Inc.
............
20,000,000
(4,000,000)
16,000,000
2,000,000
Wheels
Up
Experience,
Inc.,
A
...........
14,999,997
(1,023,945)
13,976,052
1,984,450
Total
Affiliated
Securities
(Value
is
2.5%
of
Net
Assets)
..........
$68,846,335
$39,015,997
$—
$
$
(3,984,829)
$103,877,503
$—
8.
Holding
of
5%
Voting
Securities
of
Portfolio
Companies 
(continued)
Franklin
Strategic
Series
Notes
to
Statements
of
Investments
(unaudited)
62
Quarterly
Statement
of
Investments
9.
Investments
in
Affiliated
Management
Investment
Companies 
Certain
or
all
Funds
invest
in
one
or
more
affiliated
management
investment
companies.
As
defined
in
the
1940
Act,
an
investment
is
deemed
to
be
a
“Controlled
Affiliate”
of
a
fund
when
a
fund
owns,
either
directly
or
indirectly,
25%
or
more
of
the
affiliated
fund’s
outstanding
shares
or
has
the
power
to
exercise
control
over
management
or
policies
of
such
fund.
The
Funds
do
not
invest
for
purposes
of
exercising
a
controlling
influence
over
the
management
or
policies.
During
the
period
ended
July
31,
2021,
investments
in
affiliated
management
investment
companies
were
as
follows: 
Value
at
Beginning
of
Period
Purchases
a
Sales
a
Realized
Gain
(Loss)
Net
Change
in
Unrealized
Appreciation
(Depreciation)
Value
at
End
of
Period
Number
of
Shares/Principal
Amount
Held
at
End
of
Period
Investment
Income
Franklin
Small-Mid
Cap
Growth
Fund
Non-Controlled
Affiliates
Dividends
Blaize
,
Inc.
Ltd.,
2/28/24
$
$
$
$
$
$
64,741
$
Blaize
,
Inc.,
D
.......
13,521,001
13,521,001
1,294,805
Phononic
Devices,
Inc.
.
2,113,853
2,113,853
513,050
Phononic
Devices,
Inc.,
F
10,389,829
430,314
10,820,143
2,970,061
Interest
Phononic
,
Inc.,
Advance
Term
Loan,
B,
12%,
PIK,
7/31/26
..........
101,784
3,065
960
105,809
117,795
3,198
b
Phononic
,
Inc.,
Advance
Term
Loan,
D,
12%,
PIK,
12/01/25
......
249,684
2,559
252,243
281,258
7,529
b
Phononic
,
Inc.,
Term
Loan,
A,
12%,
PIK,
1/17/24
.
506,783
15,554
3,801
526,138
572,775
15,922
b
Phononic
,
Inc.,
Term
Loan,
C,
12%,
PIK,
8/25/24
98,759
2,660
1,355
102,774
114,103
3,069
b
Total
Affiliated
Securities
(Value
is
0.5%
of
Net
Assets)
..........
$24,618,156
$270,963
$—
$
$
2,552,842
$27,441,961
$29,718
*
In
U.S.
dollars
unless
otherwise
indicated.
a
May
include
accretion,
amortization,
partnership
adjustments,
and/or
corporate
actions.
b
Includes
non-cash
dividend/interest
received.
    aa
Value
at
Beginning
of
Period
Purchases
Sales
Realized
Gain
(Loss)
Net
Change
in
Unrealized
Appreciation
(Depreciation)
Value
at
End
of
Period
Number
of
Shares
Held
at
End
of
Period
Investment
Income
a      
a  
a  
a  
a  
a  
a  
a  
Franklin
Biotechnology
Discovery
Fund
Non-Controlled
Affiliates
Dividends
Institutional
Fiduciary
Trust
-
Money
Market
Portfolio,
0.01%
..
$62,712,992
$62,874,769
$(114,672,457)
$—
$—
$10,915,304
10,915,304
$542
8.
Holding
of
5%
Voting
Securities
of
Portfolio
Companies 
(continued)
Franklin
Strategic
Series
Notes
to
Statements
of
Investments
(unaudited)
63
Quarterly
Statement
of
Investments
    aa
Value
at
Beginning
of
Period
Purchases
Sales
Realized
Gain
(Loss)
Net
Change
in
Unrealized
Appreciation
(Depreciation)
Value
at
End
of
Period
Number
of
Shares
Held
at
End
of
Period
Investment
Income
a      
a  
a  
a  
a  
a  
a  
a  
Franklin
Biotechnology
Discovery
Fund
(continued)
Non-Controlled
Affiliates
Income
from
securities
loaned
Institutional
Fiduciary
Trust
-
Money
Market
Portfolio,
0.01%
..
$28,782,225
$80,044,820
$(76,197,665)
$
$
$32,629,380
32,629,380
$944
Total
Affiliated
Securities
....
$91,495,217
$142,919,589
$(190,870,122)
$—
$—
$43,544,684
$1,486
Franklin
Growth
Opportunities
Fund
Non-Controlled
Affiliates
Dividends
Institutional
Fiduciary
Trust
-
Money
Market
Portfolio,
0.01%
..
$74,672,064
$155,226,951
$(216,307,884)
$—
$—
$13,591,131
13,591,131
$1,458
Non-Controlled
Affiliates
Income
from
securities
loaned
Institutional
Fiduciary
Trust
-
Money
Market
Portfolio,
0.01%
..
$50,044,540
$256,564,130
$(224,073,773)
$82,534,897
82,534,897
$2,007
Total
Affiliated
Securities
....
$124,716,604
$411,791,081
$(440,381,657)
$—
$—
$96,126,028
$3,465
Franklin
Natural
Resources
Fund
Non-Controlled
Affiliates
Dividends
Institutional
Fiduciary
Trust
-
Money
Market
Portfolio,
0.01%
..
$11,479,563
$16,272,027
$(23,493,119)
$—
$—
$4,258,471
4,258,471
$310
Non-Controlled
Affiliates
Income
from
securities
loaned
Institutional
Fiduciary
Trust
-
Money
Market
Portfolio,
0.01%
..
$450,105
$5,900,073
$(5,022,949)
$1,327,229
1,327,229
$22
Total
Affiliated
Securities
....
$11,929,668
$22,172,100
$(28,516,068)
$—
$—
$5,585,700
$332
Franklin
Small
Cap
Growth
Fund
Non-Controlled
Affiliates
Dividends
Institutional
Fiduciary
Trust
-
Money
Market
Portfolio,
0.01%
..
$205,154,775
$161,546,187
$(275,017,010)
$—
$—
$91,683,952
91,683,952
$3,543
9.
Investments
in
Affiliated
Management
Investment
Companies 
(continued)
Franklin
Strategic
Series
Notes
to
Statements
of
Investments
(unaudited)
64
Quarterly
Statement
of
Investments
    aa
Value
at
Beginning
of
Period
Purchases
Sales
Realized
Gain
(Loss)
Net
Change
in
Unrealized
Appreciation
(Depreciation)
Value
at
End
of
Period
Number
of
Shares
Held
at
End
of
Period
Investment
Income
Franklin
Small
Cap
Growth
Fund
(continued)
Non-Controlled
Affiliates
Income
from
securities
loaned
Institutional
Fiduciary
Trust
-
Money
Market
Portfolio,
0.01%
..
$64,722,231
$370,133,465
$(339,175,864)
$
$
$95,679,832
95,679,832
$2,100
Total
Affiliated
Securities
....
$269,877,006
$531,679,652
$(614,192,874)
$—
$—
$187,363,784
$5,643
Franklin
Small-Mid
Cap
Growth
Fund
Non-Controlled
Affiliates
Dividends
Institutional
Fiduciary
Trust
-
Money
Market
Portfolio,
0.01%
..
$213,329,128
$276,411,271
$(211,699,944)
$—
$—
$278,040,455
278,040,455
$6,471
Non-Controlled
Affiliates
Income
from
securities
loaned
Institutional
Fiduciary
Trust
-
Money
Market
Portfolio,
0.01%
..
$84,881,180
$334,632,405
$(356,426,730)
$63,086,855
63,086,855
$1,620
Total
Affiliated
Securities
....
$298,210,308
$611,043,676
$(568,126,674)
$—
$—
$341,127,310
$8,091
Franklin
Strategic
Income
Fund
Controlled
Affiliates
Dividends
Franklin
Floating
Rate
Income
Fund
...................
$269,318,469
$—
$—
$
$
5,205,899
$
274,524,367
34,705,988
$
2,401,925
Non-Controlled
Affiliates
Dividends
Institutional
Fiduciary
Trust
-
Money
Market
Portfolio,
0.01%
..
$50,800,930
$1,304,839
$(1,408,519)
$—
$—
$50,697,250
50,697,250
$1,278
Non-Controlled
Affiliates
Income
from
securities
loaned
Institutional
Fiduciary
Trust
-
Money
Market
Portfolio,
0.01%
..
$3,737,000
$23,384,000
$(23,319,000)
$3,802,000
3,802,000
$79
Total
Affiliated
Securities
....
$323,856,399
$24,688,839
$(24,727,519)
$—
$5,205,899
$329,023,617
$2,403,282
9.
Investments
in
Affiliated
Management
Investment
Companies 
(continued)
Franklin
Strategic
Series
Notes
to
Statements
of
Investments
(unaudited)
65
Quarterly
Statement
of
Investments
10. Fair
Value
Measurements 
The
Funds
follow
a
fair
value
hierarchy
that
distinguishes
between
market
data
obtained
from
independent
sources
(observable
inputs)
and
the
Funds'
own
market
assumptions
(unobservable
inputs).
These
inputs
are
used
in
determining
the
value
of
the
Funds’
financial
instruments
and
are
summarized
in
the
following
fair
value
hierarchy:
• Level
1
quoted
prices
in
active
markets
for
identical
financial
instruments
• Level
2
other
significant
observable
inputs
(including
quoted
prices
for
similar
financial
instruments,
interest
rates,
prepayment
speed,
credit
risk,
etc.)
• Level
3
significant
unobservable
inputs
(including
the
Funds'
own
assumptions
in
determining
the
fair
value
of
financial
instruments)
The
input
levels
are
not
necessarily
an
indication
of
the
risk
or
liquidity
associated
with
financial
instruments
at
that
level. 
A
summary
of
inputs
used
as
of
July
31,
2021,
in
valuing
the
Funds’
assets
and
liabilities carried
at
fair
value,
is
as
follows:  
Level
1
Level
2
Level
3
Total
Franklin
Biotechnology
Discovery
Fund
Assets:
Investments
in
Securities:
a
Common
Stocks
:
Biotechnology
.........................
$
1,028,679,396
$
$
11,851,875
b
$
1,040,531,271
Capital
Markets
........................
17,479,050
5,156,304
22,635,354
Life
Sciences
Tools
&
Services
............
98,651,195
98,651,195
Pharmaceuticals
.......................
151,396,441
151,396,441
Preferred
Stocks
........................
6,938,223
6,938,223
Warrants
..............................
255,891
255,891
Short
Term
Investments
...................
43,544,684
43,544,684
Total
Investments
in
Securities
...........
$1,340,006,657
$—
$23,946,402
$1,363,953,059
Franklin
Growth
Opportunities
Fund
Assets:
Investments
in
Securities:
Common
Stocks
:
Airlines
..............................
44,305,393
44,305,393
Auto
Components
......................
32,255,442
32,255,442
Automobiles
..........................
48,786,390
48,786,390
Beverages
...........................
67,847,625
67,847,625
Biotechnology
.........................
85,110,573
85,110,573
Capital
Markets
........................
289,983,337
65,279,551
355,262,888
Chemicals
...........................
76,171,828
76,171,828
Commercial
Services
&
Supplies
...........
18,780,300
6,164,029
24,944,329
Consumer
Finance
.....................
21,397,169
21,397,169
Electric
Utilities
........................
26,206,962
26,206,962
Entertainment
.........................
64,019,989
64,019,989
Equity
Real
Estate
Investment
Trusts
(REITs)
.
151,986,532
151,986,532
Food
Products
........................
70,280,134
70,280,134
Health
Care
Equipment
&
Supplies
.........
484,842,266
72,352,101
557,194,367
Health
Care
Providers
&
Services
..........
117,841,201
117,841,201
Health
Care
Technology
.................
122,084,607
122,084,607
Hotels,
Restaurants
&
Leisure
.............
96,257,250
96,257,250
Industrial
Conglomerates
................
93,451,177
93,451,177
Interactive
Media
&
Services
..............
257,657,149
257,657,149
Internet
&
Direct
Marketing
Retail
..........
476,237,859
476,237,859
IT
Services
...........................
795,854,031
36,110,134
831,964,165
Life
Sciences
Tools
&
Services
............
40,022,753
42,678,781
82,701,534
Machinery
............................
6,391,422
35,255,331
b
41,646,753
Franklin
Strategic
Series
Notes
to
Statements
of
Investments
(unaudited)
66
Quarterly
Statement
of
Investments
Level
1
Level
2
Level
3
Total
Franklin
Growth
Opportunities
Fund
(continued)
Assets:
(continued)
Investments
in
Securities:
Common
Stocks:
Media
...............................
$
32,462,921
$
$
$
32,462,921
Pharmaceuticals
.......................
81,440,733
81,440,733
Professional
Services
...................
161,632,400
58,905,940
220,538,340
Road
&
Rail
..........................
53,248,590
53,248,590
Semiconductors
&
Semiconductor
Equipment
.
268,381,334
268,381,334
Software
.............................
1,144,818,850
39,877,137
1,184,695,987
Specialty
Retail
........................
17,229,143
17,229,143
Technology
Hardware,
Storage
&
Peripherals
.
236,273,363
236,273,363
Textiles,
Apparel
&
Luxury
Goods
..........
67,258,280
67,258,280
Wireless
Telecommunication
Services
.......
48,795,848
48,795,848
Convertible
Preferred
Stocks
...............
65,492,587
65,492,587
Preferred
Stocks
........................
152,583,290
152,583,290
Warrants
..............................
22,165
22,165
Escrows
and
Litigation
Trusts
...............
b
Short
Term
Investments
...................
96,126,028
96,126,028
Total
Investments
in
Securities
...........
$5,651,133,486
$42,678,781
c
$576,347,658
$6,270,159,925
Level
1
Level
2
Level
3
Total
Franklin
Natural
Resources
Fund
Assets:
Investments
in
Securities:
a
Common
Stocks
:
Agricultural
Products
....................
$
2,254,841
$
$
$
2,254,841
Construction
Machinery
&
Heavy
Trucks
.....
1,005,936
1,005,936
Construction
Materials
..................
2,688,420
2,688,420
Consumer
Finance
.....................
610,356
610,356
Copper
..............................
13,855,743
2,260,792
16,116,535
Diversified
Chemicals
...................
2,033,570
2,033,570
Diversified
Metals
&
Mining
...............
11,000,449
6,182,299
17,182,748
Electrical
Components
&
Equipment
........
1,282,869
1,282,869
Environmental
&
Facilities
Services
.........
829,500
1,738,000
2,567,500
Fertilizers
&
Agricultural
Chemicals
.........
3,694,020
3,694,020
Food
Distributors
......................
1,525,806
1,525,806
Gold
................................
21,105,685
517,943
21,623,628
Heavy
Electrical
Equipment
..............
1,307,276
1,307,276
Industrial
Gases
.......................
7,213,415
7,213,415
Integrated
Oil
&
Gas
....................
39,856,840
39,856,840
Investment
Banking
&
Brokerage
..........
5,758,316
5,758,316
Metal
&
Glass
Containers
................
2,298,416
2,298,416
Oil
&
Gas
Drilling
......................
2,301,238
2,301,238
Oil
&
Gas
Equipment
&
Services
...........
22,667,985
1,101,474
23,769,459
Oil
&
Gas
Exploration
&
Production
.........
51,989,711
3,083,882
55,073,593
Oil
&
Gas
Refining
&
Marketing
............
14,713,317
14,713,317
Oil
&
Gas
Storage
&
Transportation
.........
17,067,579
17,067,579
Paper
Packaging
......................
1,018,800
1,018,800
Semiconductor
Equipment
...............
908,180
908,180
Steel
................................
3,541,870
3,541,870
Trading
Companies
&
Distributors
..........
2,493,264
2,493,264
Warrants
..............................
192,067
192,067
Convertible
Bonds
.......................
1,124,740
1,124,740
Short
Term
Investments
...................
5,585,700
5,585,700
Total
Investments
in
Securities
...........
$234,432,497
$14,271,130
d
$8,106,672
$256,810,299
10. Fair
Value
Measurements 
(continued)
Franklin
Strategic
Series
Notes
to
Statements
of
Investments
(unaudited)
67
Quarterly
Statement
of
Investments
Level
1
Level
2
Level
3
Total
Franklin
Small
Cap
Growth
Fund
Assets:
Investments
in
Securities:
Common
Stocks
:
Aerospace
&
Defense
...................
$
103,706,097
$
$
$
103,706,097
Airlines
..............................
64,212,650
29,976,052
94,188,702
Banks
...............................
111,986,026
111,986,026
Biotechnology
.........................
395,986,135
395,986,135
Building
Products
......................
38,949,672
38,949,672
Capital
Markets
........................
145,708,074
25,000,000
170,708,074
Commercial
Services
&
Supplies
...........
28,968,636
28,968,636
Communications
Equipment
..............
77,707,451
77,707,451
Construction
&
Engineering
...............
83,134,292
83,134,292
Consumer
Finance
.....................
6,180,760
5,864,288
12,045,048
Diversified
Consumer
Services
............
43,863,972
43,863,972
Electronic
Equipment,
Instruments
&
Components
........................
34,866,830
34,866,830
Equity
Real
Estate
Investment
Trusts
(REITs)
.
81,286,988
81,286,988
Food
&
Staples
Retailing
.................
80,472,145
80,472,145
Food
Products
........................
121,208,523
121,208,523
Health
Care
Equipment
&
Supplies
.........
186,097,052
186,097,052
Health
Care
Providers
&
Services
..........
144,549,264
144,549,264
Health
Care
Technology
.................
133,485,679
133,485,679
Hotels,
Restaurants
&
Leisure
.............
136,257,183
136,257,183
Household
Durables
....................
103,479,928
103,479,928
Insurance
............................
6,004,100
6,004,100
IT
Services
...........................
236,515,595
31,005,663
267,521,258
Life
Sciences
Tools
&
Services
............
86,255,273
86,255,273
Machinery
............................
82,363,237
31,803,775
b
114,167,012
Personal
Products
.....................
41,707,884
41,707,884
Pharmaceuticals
.......................
64,066,891
64,066,891
Professional
Services
...................
68,521,714
50,386,482
118,908,196
Road
&
Rail
..........................
7,080,000
7,080,000
Semiconductors
&
Semiconductor
Equipment
.
268,865,783
268,865,783
Software
.............................
310,763,166
8,884,866
319,648,032
Specialty
Retail
........................
330,334,523
330,334,523
Textiles,
Apparel
&
Luxury
Goods
..........
47,452,550
47,452,550
Trading
Companies
&
Distributors
..........
115,670,685
115,670,685
Convertible
Preferred
Stocks
...............
35,254,166
35,254,166
Preferred
Stocks
........................
93,238,933
b
93,238,933
Warrants
..............................
32,754
32,754
Escrows
and
Litigation
Trusts
...............
b
Short
Term
Investments
...................
187,363,784
187,363,784
Total
Investments
in
Securities
...........
$3,967,992,542
$—
$318,526,979
$4,286,519,521
Franklin
Small-Mid
Cap
Growth
Fund
Assets:
Investments
in
Securities:
Common
Stocks
:
Aerospace
&
Defense
...................
94,834,483
94,834,483
Airlines
..............................
29,139,936
29,139,936
Banks
...............................
29,202,876
29,202,876
Biotechnology
.........................
186,736,556
186,736,556
Capital
Markets
........................
284,639,395
18,313,612
302,953,007
Commercial
Services
&
Supplies
...........
66,991,760
66,991,760
Communications
Equipment
..............
15,367,756
15,367,756
Consumer
Finance
.....................
7,909,276
7,909,276
Containers
&
Packaging
.................
61,687,176
61,687,176
10. Fair
Value
Measurements 
(continued)
Franklin
Strategic
Series
Notes
to
Statements
of
Investments
(unaudited)
68
Quarterly
Statement
of
Investments
Level
1
Level
2
Level
3
Total
Franklin
Small-Mid
Cap
Growth
Fund
(continued)
Assets:
(continued)
Investments
in
Securities:
Common
Stocks:
Electrical
Equipment
....................
$
46,113,000
$
$
$
46,113,000
Electronic
Equipment,
Instruments
&
Components
........................
118,967,073
118,967,073
Entertainment
.........................
156,703,062
156,703,062
Equity
Real
Estate
Investment
Trusts
(REITs)
.
149,908,814
149,908,814
Food
&
Staples
Retailing
.................
28,483,200
28,483,200
Food
Products
........................
36,568,135
36,568,135
Health
Care
Equipment
&
Supplies
.........
380,262,841
380,262,841
Health
Care
Providers
&
Services
..........
63,954,360
63,954,360
Health
Care
Technology
.................
139,743,571
139,743,571
Hotels,
Restaurants
&
Leisure
.............
250,143,719
250,143,719
Household
Durables
....................
49,092,440
49,092,440
Interactive
Media
&
Services
..............
140,020,228
140,020,228
Internet
&
Direct
Marketing
Retail
..........
67,804,190
67,804,190
IT
Services
...........................
325,666,301
27,666,302
353,332,603
Life
Sciences
Tools
&
Services
............
276,975,864
276,975,864
Machinery
............................
110,731,188
12,399,588
b
123,130,776
Personal
Products
.....................
38,939,925
38,939,925
Pharmaceuticals
.......................
38,253,439
38,253,439
Professional
Services
...................
277,165,505
277,165,505
Road
&
Rail
..........................
62,456,258
6,373,888
68,830,146
Semiconductors
&
Semiconductor
Equipment
.
323,322,385
323,322,385
Software
.............................
1,146,310,420
10,470,554
1,156,780,974
Specialty
Retail
........................
296,674,219
296,674,219
Textiles,
Apparel
&
Luxury
Goods
..........
141,485,121
141,485,121
Trading
Companies
&
Distributors
..........
66,622,228
66,622,228
Convertible
Preferred
Stocks
...............
66,953,507
66,953,507
Preferred
Stocks
........................
33,749,287
33,749,287
Warrants
..............................
b
Senior
Floating
Rate
Interests
...............
986,964
986,964
Escrows
and
Litigation
Trusts
...............
b
Short
Term
Investments
...................
341,127,310
341,127,310
Total
Investments
in
Securities
...........
$5,842,094,734
$—
$184,822,978
$6,026,917,712
Franklin
Strategic
Income
Fund
Assets:
Investments
in
Securities:
Common
Stocks
:
Energy
Equipment
&
Services
.............
2,642,945
2,642,945
Machinery
............................
6,046,866
6,046,866
Media
...............................
3,734,547
46,663
3,781,210
Multiline
Retail
........................
b
Oil,
Gas
&
Consumable
Fuels
.............
17,397
21,817
39,214
Specialty
Retail
........................
8
8
Management
Investment
Companies
.........
308,946,242
308,946,242
Warrants
:
Oil,
Gas
&
Consumable
Fuels
.............
5,252
b
5,252
Paper
&
Forest
Products
.................
8,601
8,601
Software
.............................
b
Convertible
Bonds
.......................
472,447
472,447
Corporate
Bonds
:
Aerospace
&
Defense
...................
27,504,342
27,504,342
Air
Freight
&
Logistics
...................
20,055,552
20,055,552
Airlines
..............................
28,859,130
28,859,130
10. Fair
Value
Measurements 
(continued)
Franklin
Strategic
Series
Notes
to
Statements
of
Investments
(unaudited)
69
Quarterly
Statement
of
Investments
Level
1
Level
2
Level
3
Total
Franklin
Strategic
Income
Fund
(continued)
Assets:
(continued)
Investments
in
Securities:
Corporate
Bonds:
Auto
Components
......................
$
$
41,551,379
$
$
41,551,379
Automobiles
..........................
11,816,638
11,816,638
Banks
...............................
88,303,277
88,303,277
Beverages
...........................
20,278,563
20,278,563
Biotechnology
.........................
6,593,811
6,593,811
Building
Products
......................
27,367,153
27,367,153
Capital
Markets
........................
18,573,421
18,573,421
Chemicals
...........................
118,536,896
118,536,896
Commercial
Services
&
Supplies
...........
39,194,674
39,194,674
Communications
Equipment
..............
12,857,595
12,857,595
Construction
&
Engineering
...............
3,577,810
3,577,810
Consumer
Finance
.....................
21,839,827
21,839,827
Containers
&
Packaging
.................
66,418,000
66,418,000
Diversified
Financial
Services
.............
22,385,589
22,385,589
Diversified
Telecommunication
Services
.....
42,135,667
42,135,667
Electric
Utilities
........................
83,062,468
83,062,468
Electrical
Equipment
....................
9,878,640
9,878,640
Electronic
Equipment,
Instruments
&
Components
........................
13,339,477
13,339,477
Energy
Equipment
&
Services
.............
14,655,144
14,655,144
Entertainment
.........................
21,638,174
21,638,174
Equity
Real
Estate
Investment
Trusts
(REITs)
.
63,776,682
63,776,682
Food
&
Staples
Retailing
.................
7,570,542
7,570,542
Food
Products
........................
61,756,601
61,756,601
Gas
Utilities
..........................
2,997,529
2,997,529
Health
Care
Providers
&
Services
..........
76,481,116
76,481,116
Hotels,
Restaurants
&
Leisure
.............
119,894,620
119,894,620
Household
Durables
....................
23,751,561
23,751,561
Household
Products
....................
34,394,237
34,394,237
Independent
Power
and
Renewable
Electricity
Producers
..........................
61,131,328
61,131,328
Insurance
............................
11,153,816
11,153,816
Interactive
Media
&
Services
..............
17,218,417
17,218,417
Internet
&
Direct
Marketing
Retail
..........
17,610,636
17,610,636
IT
Services
...........................
31,221,886
31,221,886
Life
Sciences
Tools
&
Services
............
2,160,375
2,160,375
Machinery
............................
17,094,950
17,094,950
Marine
..............................
12,750,000
12,750,000
Media
...............................
102,446,847
102,446,847
Metals
&
Mining
.......................
58,169,328
58,169,328
Mortgage
Real
Estate
Investment
Trusts
(REITs)
............................
1,375,640
1,375,640
Multiline
Retail
........................
b
Multi-Utilities
..........................
8,657,974
8,657,974
Oil,
Gas
&
Consumable
Fuels
.............
205,202,604
205,202,604
Paper
&
Forest
Products
.................
11,771,555
11,771,555
Personal
Products
.....................
15,728,979
15,728,979
Pharmaceuticals
.......................
63,715,758
63,715,758
Real
Estate
Management
&
Development
....
34,895,083
34,895,083
Road
&
Rail
..........................
31,027,749
31,027,749
Software
.............................
19,026,712
19,026,712
Specialty
Retail
........................
48,081,903
48,081,903
Thrifts
&
Mortgage
Finance
...............
29,401,510
29,401,510
Tobacco
.............................
15,778,630
15,778,630
10. Fair
Value
Measurements 
(continued)
Franklin
Strategic
Series
Notes
to
Statements
of
Investments
(unaudited)
70
Quarterly
Statement
of
Investments
A
reconciliation
in
which
Level
3
inputs
are
used
in
determining
fair
value
is
presented
when
there
are
significant
Level
3
assets
and/or
liabilities
at
the
beginning
and/or
end
of
the
period.
At July
31,
2021,
the
reconciliation
is
as
follows:
Level
1
Level
2
Level
3
Total
Franklin
Strategic
Income
Fund
(continued)
Assets:
(continued)
Investments
in
Securities:
Corporate
Bonds:
Trading
Companies
&
Distributors
..........
$
$
25,194,921
$
$
25,194,921
Wireless
Telecommunication
Services
.......
37,512,772
37,512,772
Senior
Floating
Rate
Interests
...............
57,081,350
b
57,081,350
Marketplace
Loans
......................
6,880,498
6,880,498
Loan
Participations
and
Assignments
.........
15,107,350
15,107,350
Foreign
Government
and
Agency
Securities
....
576,643,348
576,643,348
U.S.
Government
and
Agency
Securities
.......
114,956,761
114,956,761
Asset-Backed
Securities
:
Airlines
..............................
1,178,009
1,178,009
Consumer
Finance
.....................
20,145,643
20,145,643
Diversified
Financial
Services
.............
244,401,991
776,285
245,178,276
Commercial
Mortgage-Backed
Securities
......
2,103,603
2,103,603
Mortgage-Backed
Securities
................
118,362,019
118,362,019
Municipal
Bonds
.........................
34,567,509
34,567,509
Residential
Mortgage-Backed
Securities
......
335,280,035
335,280,035
Escrows
and
Litigation
Trusts
...............
165,000
b
165,000
Options
purchased
.......................
1,353,533
1,353,533
Short
Term
Investments
...................
54,499,250
89,132,069
143,631,319
Total
Investments
in
Securities
...........
$369,848,990
$3,646,373,021
$7,730,515
$4,023,952,526
Other
Financial
Instruments:
Forward
exchange
contracts
...............
$
$
1,026,429
$
$
1,026,429
Futures
contracts
........................
631,121
631,121
Swap
contracts
.........................
5,563,609
5,563,609
Total
Other
Financial
Instruments
.........
$631,121
$6,590,038
$—
$7,221,159
Liabilities:
Other
Financial
Instruments:
Options
written
..........................
$
$
35,082
$
$
35,082
Forward
exchange
contracts
................
$
$
1,140,157
$
$
1,140,157
Futures
contracts
........................
7,420,459
7,420,459
Swap
contracts
..........................
544,789
544,789
Total
Other
Financial
Instruments
.........
$7,420,459
$1,720,028
$—
$9,140,487
a
For
detailed
categories,
see
the
accompanying
Statements
of
Investments.
b
Includes
securities
determined
to
have
no
value
at
July
31,
2021.
c
Includes
foreign
securities
valued
at
$42,678,781,
which
were
categorized
as
Level
2
as
a
result
of
the
application
of
market
level
fair
value
procedures.
See
the
Financial
Instrument
Valuation
note
for
more
information.
d
Includes
foreign
securities
valued
at
$13,146,390,
which
were
categorized
as
Level
2
as
a
result
of
the
application
of
market
level
fair
value
procedures.
See
the
Financial
Instrument
Valuation
note
for
more
information.
10. Fair
Value
Measurements 
(continued)
Franklin
Strategic
Series
Notes
to
Statements
of
Investments
(unaudited)
71
Quarterly
Statement
of
Investments
Balance
at
Beginning
of
Period
Purchases
a
Sales
b
Transfer
Into
Level
3
Transfer
Out
of
Level
3
Net
Accretion
(
Amortiza
-
tion
)
Net
Realized
Gain
(Loss)
Net
Unr
ealized
Appreciatio
n
(
Depreciation
)
Balance
at
End
of
Period
Net
Change
in
Unrealized
Appreciation
(Depreciation)
on
Assets
Held
at
Period
End
a
a
a
a
a
a
a
a
a
a
a
Franklin
Biotechnology
Discovery
Fund
Assets:
Investments
in
Securities:
Common
Stocks
:
Biotechnology
......
$
$
7,087,09
3
$
$
$
$
$
$
4,764,782
$
11,851,875
c
$
4,764,78
2
Capital
Markets
.....
5,631,994
1,898,000
(1,035,890)
(1,337,800)
5,156,304
(1,162,735)
Convertible
Preferred
Stocks
:
Pharmaceuticals
....
5,000,000
(5,000,000)
Preferred
Stocks
:
Biotechnology
......
5,574,503
(720,769)
4,853,734
(720,769)
Health
Care
Providers
&
Services
........
2,084,489
2,084,489
Pharmaceuticals
....
2,087,102
2,087,101
(4,174,203)
Escrows
and
Litigation
Trusts
...........
851,316
(852,046)
(1,087,487)
1,088,217
Total
Investments
in
Securities
............
$21,229,404
$11,072,194
$(11,062,139)
$—
$—
$—
$(1,087,487)
$3,794,430
$23,946,402
$2,881,278
Franklin
Growth
Opportunities
Fund
Assets:
Investments
in
Securities:
Common
Stocks
:
Airlines
..........
35,000,000
17,499,998
(8,194,605)
44,305,393
(8,194,605)
Capital
Markets
.....
44,235,321
10,225,000
10,819,230
65,279,551
18,826,041
Commercial
Services
&
Supplies
........
6,149,572
14,457
6,164,029
14,457
Health
Care
Equipment
&
Supplies
.......
20,963,721
51,388,380
72,352,101
(116,321,391)
IT
Services
........
11,524,036
2,446,575
22,139,523
36,110,134
22,139,523
Machinery
.........
22,294,006
12,961,325
35,255,331
c
12,961,325
Professional
Services
.
26,204,625
32,701,315
58,905,940
32,701,315
Software
..........
13,792,310
9,616,777
16,468,050
39,877,137
16,468,050
Convertible
Preferred
Stocks
:
Internet
&
Direct
Marketing
Retail
...
27,858,025
1,381,979
29,240,004
1,381,979
Software
..........
31,034,048
5,218,535
36,252,583
Preferred
Stocks
:
Airlines
..........
22,526,068
(17,499,998)
(5,026,070)
Automobiles
.......
51,786,112
(22,294,007)
(29,492,105)
Commercial
Services
&
Supplies
........
12,164,900
813,972
12,978,872
813,972
Food
&
Staples
Retailing
16,925,725
755,557
17,681,282
755,557
Health
Care
Providers
&
Services
........
28,448,746
3,568,881
32,017,627
3,568,881
IT
Services
........
21,029,873
(2,446,575)
3,528,525
22,111,823
3,014,721
Software
..........
76,397,495
(9,616,775)
1,012,966
67,793,686
1,629,225
Warrants
:
Food
&
Staples
Retailing
c
22,165
22,165
22,165
Escrows
and
Litigation
Trusts
...........
c
c
Total
Investments
in
Securities
............
$439,891,005
$68,231,928
$(51,857,355)
$—
$—
$—
$—
$120,082,080
$576,347,658
$(10,218,785)
10. Fair
Value
Measurements 
(continued)
Franklin
Strategic
Series
Notes
to
Statements
of
Investments
(unaudited)
72
Quarterly
Statement
of
Investments
Balance
at
Beginning
of
Period
Purchases
a
Sales
b
Transfer
Into
Level
3
Transfer
Out
of
Level
3
Net
Accretion
(
Amortiza
-
tion
)
Net
Realized
Gain
(Loss)
Net
Unr
ealized
Appreciatio
n
(
Depreciation
)
Balance
at
End
of
Period
Net
Change
in
Unrealized
Appreciation
(Depreciation)
on
Assets
Held
at
Period
End
a
a          
a
a
a
a
a
a
a
a
a
Franklin
Natural
Resources
Fund
Assets:
Investments
in
Securities:
Common
Stocks
Consumer
Finance
...
$
743,430
$
$
$
$
$
$
$
(133,074)
$
610,356
$
(133,074)
Environmental
&
Facilities
Services
..
1,738,000
1,738,000
Investment
Banking
&
Brokerage
.......
3,796,238
1,314,999
647,079
5,758,316
755,106
Total
Investments
in
Securities
.
$6,277,668
$1,314,999
$—
$—
$—
514,005
$8,106,672
622,032
Balance
at
Beginning
of
Period
Purchases
a
Sales
b
Transfer
Into
Level
3
Transfer
Out
of
Level
3
Net
Accretion
(
Amortiza
-
tion
)
Net
Realized
Gain
(Loss)
Net
Unr
ealized
Appreciatio
n
(
Depreciation
)
Balance
at
End
of
Period
Net
Change
in
Unrealized
Appreciation
(Depreciation)
on
Assets
Held
at
Period
End
a
a
a
a
a
a
a
a
a
a
a
Franklin
Small
Cap
Growth
Fund
Assets:
Investments
in
Securities:
Common
Stocks
:
Airlines
..........
$
20,000,000
$
14,999,997
$
$
$
$
$
$
(5,023,945)
$
29,976,052
$
(5,023,945)
Capital
Markets
.....
30,328,348
(3,364,000)
(1,964,348)
25,000,000
Consumer
Finance
...
7,142,860
(1,278,572)
5,864,288
(1,278,572)
IT
Services
........
11,554,574
19,451,089
31,005,663
19,451,089
Machinery
.........
19,762,396
c
12,041,379
31,803,775
c
12,041,379
Professional
Services
.
22,414,698
27,971,784
50,386,482
27,971,784
Road
&
Rail
.......
7,500,000
(420,000)
7,080,000
(420,000)
Software
..........
15,494,946
4,675,011
(5,500,000)
(5,785,091)
8,884,866
(4,285,861)
Convertible
Preferred
Stocks
:
Diversified
Consumer
Services
........
14,854,244
399,923
15,254,167
399,923
Specialty
Retail
.....
19,999,999
19,999,999
Preferred
Stocks
:
Airlines
..........
19,308,057
(14,999,997)
(4,308,060)
Auto
Components
....
8,082,642
1,397,001
9,479,643
c
1,397,001
Automobiles
.......
46,716,172
(19,762,395)
(26,953,777)
Commercial
Services
&
Supplies
........
12,139,766
812,291
12,952,057
812,291
Food
&
Staples
Retailing
8,380,798
356,321
8,737,119
356,321
Software
..........
24,381,344
(185,419)
24,195,925
(185,419)
Specialty
Retail
.....
21,926,375
147,692
22,074,067
147,692
Textiles,
Apparel
&
Luxury
Goods
....
15,570,065
230,056
15,800,12
1
230,056
10. Fair
Value
Measurements 
(continued)
Franklin
Strategic
Series
Notes
to
Statements
of
Investments
(unaudited)
73
Quarterly
Statement
of
Investments
Balance
at
Beginning
of
Period
Purchases
a
Sales
b
Transfer
Into
Level
3
Transfer
Out
of
Level
3
Net
Accretion
(Amortiza-
tion)
Net
Realized
Gain
(Loss)
Net
Unrealized
Appreciation
(Depreciation)
Balance
at
End
of
Period
Net
Change
in
Unrealized
Appreciation
(Depreciation)
on
Assets
Held
at
Period
End
a
a
a
a
a
a
a
a
a
a
a
Franklin
Small
Cap
Growth
Fund
(continued)
Assets:
Investments
in
Securities:
Warrants
:
Food
&
Staples
Retailing
$
c
$
$
$
$
$
$
$
32,754
$
32,754
$
32,754
Escrows
and
Litigation
Trusts
:
c
c
Total
Investments
in
Securities
............
$285,794,889
$59,437,403
$(43,626,392)
$—
$—
$—
$—
$16,921,078
$318,526,978
$51,646,493
Franklin
Small-Mid
Cap
Growth
Fund
Assets:
Investments
in
Securities:
Common
Stocks
:
Capital
Markets
.....
18,263,167
2,712,000
(4,634,000)
1,972,445
18,313,612
4,678,387
Consumer
Finance
...
9,633,710
(1,724,434)
7,909,276
(1,724,434)
IT
Services
........
10,310,127
17,356,175
27,666,302
17,356,175
Machinery
.........
7,135,914
5,263,674
12,399,588
c
5,263,674
Road
&
Rail
.......
6,752,000
(378,112)
6,373,888
(378,112)
Software
..........
18,260,372
5,509,372
(6,481,600)
(6,817,590)
10,470,554
(5,050,762)
Convertible
Preferred
Stocks
:
Diversified
Consumer
Services
........
8,878,072
239,025
9,117,097
239,025
Internet
&
Direct
Marketing
Retail
...
20,938,178
1,118,943
22,057,121
1,118,943
Semiconductors
&
Semiconductor
Equipment
.......
47
2,113,806
2,113,853
2,113,806
Software
..........
29,123,650
4,541,786
33,665,436
4,541,786
Preferred
Stocks
:
Automobiles
.......
18,213,603
(7,135,914)
(11,077,689)
Semiconductors
&
Semiconductor
Equipment
.......
10,389,829
430,314
10,820,143
430,314
Software
..........
13,521,001
13,521,001
Textiles,
Apparel
&
Luxury
Goods
....
9,271,156
136,987
9,408,143
136,987
Warrants
:
Semiconductors
&
Semiconductor
Equipment
.......
2,022,312
(47)
(2,022,265)
c
Software
..........
c
c
Senior
Floating
Rate
Interests
:
Semiconductors
&
Semiconductor
Equipment
.......
949,608
28,527
154
8,675
986,964
8,675
Escrows
and
Litigation
Trusts
...........
c
c
Total
Investments
in
Securities
............
$176,526,785
$15,385,860
$(18,251,561)
$—
$—
$154
$—
$11,161,740
$184,822,978
$28,734,464
10. Fair
Value
Measurements 
(continued)
Franklin
Strategic
Series
Notes
to
Statements
of
Investments
(unaudited)
74
Quarterly
Statement
of
Investments
Significant
unobservable
valuation
inputs
for
material
Level
3
assets
and/or
liabilities
and
impact
to
fair
value
as
a
result
of
changes
in
unobservable
valuation
inputs
as
of
July
31,
2021,
are
as
follows:
a
Purchases
include
all
purchases
of
securities
and
securities
received
in
corporate
actions.
b
Sales
include
all
sales
of
securities,
maturities,
paydowns
and
securities
tendered
in
corporate
actions.
c
Includes
securities
determined
to
have
no
value.
Description
Fair
Value
at
End
of
Period
Valuation
Technique
Unobservable
Inputs
Amount
/
Range
(Weighted
Average)
a
Impact
to
Fair
Value
if
Input
Increases
b
Franklin
Biotechnology
Discovery
Fund
Assets:
Investments
in
Securities:
Common
Stock:
Biotechnology
.............
$11,851,875
Market
comparables
Discount
for
lack
of
marketability
5.0%
-
7.5%
(6.7%)
Decrease
c
Capital
Markets
1,898,000
Market
comparables
Discount
for
lack
of
marketability
0.3%
Decrease
Preferred
Stocks:
Biotechnology
..............
4,853,734
Market
comparables
Volatility
of
peers
(28.0)%
-
(18.8)%
((21.7)%)
Decrease
c
All
Other
Investments
..........
5,342,793
d,e
Total
.......................
$23,946,402
10. Fair
Value
Measurements 
(continued)
Franklin
Strategic
Series
Notes
to
Statements
of
Investments
(unaudited)
75
Quarterly
Statement
of
Investments
Description
Fair
Value
at
End
of
Period
Valuation
Technique
Unobservable
Inputs
Amount
/
Range
(Weighted
Average)
a
Impact
to
Fair
Value
if
Input
Increases
b
Franklin
Growth
Opportunities
Fund
Assets:
Investments
in
Securities:
Common
Stock:
Airlines
....................
$16,305,393
Market
comparables
Discount
for
lack
of
marketability
12.0%
Decrease
c
Capital
Markets
.............
61,426,867
Market
comparables
Discount
for
lack
of
marketability
0.3%
-
9.7%
(7.4%)
Decrease
c
Health
Care
Equipment
&
Supplies
73,352,101
Market
comparables
Discount
for
lack
of
marketability
4.3%
Decrease
IT
Services
.................
36,110,134
Market
comparables
Discount
for
lack
of
marketability
3.7%
Decrease
c
Machinery
.................
32,255,331
Market
comparables
Discount
for
lack
of
marketability
11.1%
Decrease
c
Professional
Services
.........
58,905,940
Market
comparables
Discount
for
lack
of
marketability
4.3%
Decrease
c
Software
...................
39,877,137
Market
comparables
EV
/
EBITDA
multiple
20.7x
Increase
c
Discount
for
lack
of
marketability
3.7%
-
4.5%
(4.0%)
Decrease
Convertible
Preferred
Stocks:
Internet
&
Direct
Marketing
Retail
25,425,038
Market
comparables
EV
/
EBITDA
multiple
45.6x
Increase
c
EV
/
revenue
multiple
3.6x
Increase
c
Discount
for
lack
of
marketability
11.6%
Decrease
c
Software
...................
36,252,583
Market
comparables
EV
/
revenue
multiple
17.1x
-
61.7x
(43.9x)
Increase
c
Discount
for
lack
of
marketability
7.3%
Decrease
c
Preferred
Stocks:
Commercial
Services
&
Supplies
.
12,978,872
Discounted
cash
flow
Discount
for
lack
of
marketability
6.4%
Decrease
Discount
rate
19.2%
Decrease
c
Long
term
growth
rate
5.0%
Increase
Market
comparables
EV
/
revenue
multiple
11.1x
13.5x
(12.3x)
Increase
Food
&
Staples
Retailing
.......
14,560,423
Discounted
cash
flow
Discount
for
lack
of
marketability
9.1%
Decrease
c
Discount
rate
17.9%
Decrease
c
Terminal
Multiple
32.5x
Increase
Market
comparables
EV
/
revenue
multiple
4.4x
Increase
c
Health
Care
Providers
&
Services
32,017,627
Discounted
cash
flow
Discount
for
lack
of
marketability
4.1%
Decrease
c
Discount
rate
8.0%
Decrease
f
10. Fair
Value
Measurements 
(continued)
Franklin
Strategic
Series
Notes
to
Statements
of
Investments
(unaudited)
76
Quarterly
Statement
of
Investments
Long
term
growth
rate
5.0%
Increase
f
IT
Services
.................
22,111,823
Market
comparables
Discount
for
lack
of
marketability
5.5%
Decrease
c
EV
/
revenue
multiple
32.6x
Increase
c
Software
...................
67,793,686
Discounted
cash
flow
Discount
for
lack
of
marketability
6.8%-9.9%
(9.0%)
Decrease
c
Discount
rate
8.6%-10.3%
(9.8%)
Decrease
c
Long
term
growth
rate
2.0%
Increase
c
Terminal
Multiple
34.6x
Increase
c
Market
comparables
EV
/
revenue
multiple
32.5x
Increase
c
Discount
for
lack
of
marketability
6.1%
-
8.7%
(8.1%)
Decrease
c
All
Other
Investments
..........
44,974,703
d,e
Total
.......................
$576,347,658
Description
Fair
Value
at
End
of
Period
Valuation
Technique
Unobservable
Inputs
Amount
/
Range
(Weighted
Average)
a
Impact
to
Fair
Value
if
Input
Increases
b
Franklin
Natural
Resources
Fund
Assets:
Investments
in
Securities:
Common
Stock:
Environmental
&
Facilities
Services
...................
$1,738,000
Market
comparables
Discount
for
lack
of
marketability
1.9
%
Decrease
Investment
Banking
&
Brokerage
4,529,718
Market
comparables
Discount
for
lack
of
marketability
2.9%
-
9.7%
(7.4%)
Decrease
c
All
Other
Investments
..........
1,838,954
d
Total
.......................
$8,106,672
10. Fair
Value
Measurements 
(continued)
Franklin
Strategic
Series
Notes
to
Statements
of
Investments
(unaudited)
77
Quarterly
Statement
of
Investments
Description
Fair
Value
at
End
of
Period
Valuation
Technique
Unobservable
Inputs
Amount
/
Range
(Weighted
Average)
a
Impact
to
Fair
Value
if
Input
Increases
b
Franklin
Small
Cap
Growth
Fund
Assets:
Investments
in
Securities:
Common
Stock:
Airlines
...................
$13,976,052
Market
comparables
Discount
for
lack
of
marketability
12.0%
Decrease
c
Capital
Markets
.............
25,000,000
Market
comparables
Discount
for
lack
of
marketability
1.3%
Decrease
IT
Services
.................
31,005,663
Market
comparables
Discount
for
lack
of
marketability
3.7%
Decrease
c
Machinery
.................
31,803,775
Market
comparables
Discount
for
lack
of
marketability
11.1%
Decrease
c
Professional
Services
.........
50,386,482
Market
comparables
Discount
for
lack
of
marketability
4.3%
Decrease
Software
...................
8,884,866
Market
comparables
Discount
for
lack
of
marketability
2.8%
Decrease
Convertible
Preferred
Stocks:
Diversified
Consumer
Services
..
15,254,167
Discounted
cash
flow
Discount
for
lack
of
marketability
11.8%
Decrease
c
Discount
rate
14.6%
Decrease
f
Long
term
growth
rate
5.0%
Increase
Preferred
Stock:
Auto
Components
...........
9,478,643
Market
comparables
EV
/
EBITDA
multiple
27.2x
Increase
c
Discount
for
lack
of
marketability
6.0%
Decrease
c
Commercial
Services
&
Supplies
.
12,952,057
Discounted
cash
flow
Discount
for
lack
of
marketability
6.4%
Decrease
Discount
rate
19.2%
Decrease
c
Long
term
growth
rate
5.0%
Increase
Market
comparables
EV
/
revenue
multiple
11.1x
13.5%x
(12.3%)
Increase
Food
&
Staples
Retailing
.......
16,012,976
Discounted
cash
flow
Discount
for
lack
of
marketability
9.1%
Decrease
c
Discount
rate
17.9%
Decrease
c
Terminal
Multiple
32.5x
Increase
Market
comparables
EV
/
revenue
multiple
4.4x
Increase
c
Software
...................
21,663,774
Discounted
cash
flow
Discount
for
lack
of
marketability
9.9%
Decrease
c
Discount
rate
10.3%
Decrease
c
Long
term
growth
rate
2.0%
Increase
c
Market
comparables
Discount
for
lack
of
marketability
8.0%
Decrease
c
EV
/
revenue
multiple
3.0x
Increase
c
10. Fair
Value
Measurements 
(continued)
Franklin
Strategic
Series
Notes
to
Statements
of
Investments
(unaudited)
78
Quarterly
Statement
of
Investments
Specialty
Retail
..............
22,074,067
Discounted
cash
flow
Discount
for
lack
of
marketability
9.7%
Decrease
c
Discount
rate
13.2%
Decrease
f
Long
term
growth
rate
4.0%
Increase
c
Textiles,
Apparel
&
Luxury
Goods
15,800,122
Market
comparables
Discount
for
lack
of
marketability
8.0%
Decrease
c
EV
/
revenue
multiple
5.6x
Increase
c
All
Other
Investments
..........
54,233,335
d,e
Total
.......................
$318,526,979
Description
Fair
Value
at
End
of
Period
Valuation
Technique
Unobservable
Inputs
Amount
/
Range
(Weighted
Average)
a
Impact
to
Fair
Value
if
Input
Increases
b
Franklin
Small-Mid
Cap
Growth
Fund
Assets:
Investments
in
Securities:
Common
Stock:
Capital
Markets
.............
$15,601,612
Market
comparables
Discount
for
lack
of
marketability
9.7%
Decrease
c
IT
Services
.................
27,666,302
Market
comparables
Discount
for
lack
of
marketability
3.7%
Decrease
c
Machinery
..................
12,399,588
Market
comparables
Discount
for
lack
of
marketability
11.1%
Decrease
c
Software
...................
10,470,554
Market
comparables
Discount
for
lack
of
marketability
2.8%
Decrease
Convertible
Preferred
Stocks:
Diversified
Consumer
Services
..
9,117,097
Discounted
cash
flow
Discount
for
lack
of
marketability
11.8%
Decrease
c
Discount
rate
14.6%
Decrease
f
Long
term
growth
rate
5.0%
Increase
Internet
&
Direct
Marketing
Retail
21,404,793
Market
comparables
EV
/
EBITDA
multiple
45.6x
Increase
c
EV
/
revenue
multiple
3.6x
Increase
c
Discount
for
lack
of
marketability
11.6%
Decrease
c
Software
...................
33,665,436
Market
comparables
Discount
for
lack
of
marketability
7.3%
Decrease
c
EV
/
revenue
multiple
17.1x
61.7%x
(35.5%)
Increase
c
Preferred
Stocks:
Semiconductors
&
Semiconductor
Equipment
..................
10,820,143
Market
comparables
Discount
for
lack
of
marketability
8.3%
Decrease
c
Textiles,
Apparel
&
Luxury
Goods
.
9,408,143
Market
comparables
Discount
for
lack
of
marketability
8.0%
Decrease
c
EV
/
revenue
multiple
5.6x
Increase
c
All
Other
Investments
..........
34,269,310
d,e
Total
.......................
$184,822,978
10. Fair
Value
Measurements 
(continued)
Franklin
Strategic
Series
Notes
to
Statements
of
Investments
(unaudited)
79
Quarterly
Statement
of
Investments
11.
Subsequent
Events
The
Funds
have evaluated
subsequent
events
through
the
issuance
of
the
Statements of
Investments
and
determined
that
no
events
have
occurred
that
require
disclosure.
Abbreviations
a
Weighted
based
on
the
relative
fair
value
of
the
financial
instruments.
b
Represents
the
directional
change
in
the
fair
value
that
would
result
from
a
significant
and
reasonable
increase
in
the
corresponding
input.
A
significant
and
reasonable
decrease
in
the
input
would
have
the
opposite
effect.
Significant
impacts,
if
any,
to
fair
value
and/or
net
assets
have
been
indicated.
c
Represents
a
significant
impact
to
fair
value
but
not
net
assets.
d
Includes
fair
value
of
immaterial
assets
and/or
liabilities
developed
using
various
valuation
techniques
and
unobservable
inputs.
May
also
include
values
derived
using
private
transaction
prices
or
non-public
third
party
pricing
information
which
is
unobservable
e
Includes
securities
determined
to
have
no
value
at
July
31,
2021.
f
Represents
a
significant
impact
to
fair
value
and
net
assets.
Abbreviations
List
EBITDA
-
Earnings
before
interest,
taxes,
depreciation
and
amortization
EV
-
Enterprise
value
Selected
Portfolio
ADR
American
Depositary
Receipt
BZDIOVRA
Brazil
Inter-Bank
Deposit
Rate
CLO
Collateralized
Loan
Obligation
CMT
Constant
Monthly
U.S.
Treasury
Securities
Yield
Curve
Rate
Index
CVR
Contingent
Voting
Rights
ETF
Exchange-Traded
Fund
EURIBOR
Euro
Inter-Bank
Offer
Rate
FHLMC
Federal
Home
Loan
Mortgage
Corp.
FNMA
Federal
National
Mortgage
Association
FRN
Floating
Rate
Note
GDP
Gross
Domestic
Product
GNMA
Government
National
Mortgage
Association
GO
General
Obligation
LIBOR
London
Inter-Bank
Offered
Rate
MBS
Mortgage-Backed
Security
PIK
Payment-In-Kind
TBA
To-Be-Announced
TBD
To
Be
Determined
T-Note
Treasury
Note
VRI
Value
Recovery
Instrument
Currency
AUD
Australian
Dollar
BRL
Brazilian
Real
CAD
Canadian
Dollar
COP
Colombian
Peso
DOP
Dominican
Peso
EUR
Euro
GBP
British
Pound
IDR
Indonesian
Rupiah
USD
United
States
Dollar
UYU
Uruguayan
Peso
Counterparty
BNDP
BNP
Paribas
SA
BOFA
Bank
of
America,
N.A.
BZWS
Barclays
Bank
plc
CITI
Citibank
NA
CITI
Citigroup,
Inc
FBCO
Credit
Suisse
Group
AG
GSCO
Goldman
Sachs
Group,
Inc.
JPHQ
JPMorgan
Chase
Bank
NA
MSCO
Morgan
Stanley
10. Fair
Value
Measurements 
(continued)
For
additional
information
on
the
Funds'
significant
accounting
policies,
please
refer
to
the Funds'
most
recent
semiannual
or
annual
shareholder
report.